Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42063,0.160838972888407,0.00320802980973417,0.154551234461328,0.167126711315486,0
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42108,0.114075516677857,0.0034756191949855,0.107263303055685,0.120887730300028,2.17603295939354e-227
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42097,0.154693813837011,0.00534441254098293,0.144218765256684,0.165168862417337,8.86775247324081e-179
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39868,0.0906834771707757,0.00390631875014362,0.0830270924204942,0.0983398619210572,1.71291309806764e-116
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42222,0.0597405484269481,0.00272301915985061,0.0544034308736409,0.0650776659802553,7.13603264044073e-105
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42077,0.0620686461387278,0.00333927727780105,0.0555236626742378,0.0686136296032179,3.6271236508011e-76
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39858,-0.106986813770751,0.00605959857946797,-0.118863626986508,-0.0951100005549938,7.75156021448019e-69
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,41972,0.129704084781183,0.00768194285691247,0.114647476781634,0.144760692780731,2.65490871262039e-63
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,42050,-0.0943991110503321,0.00607517529887854,-0.106306454636134,-0.0824917674645302,5.60432306131364e-54
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42108,-0.0576493342669204,0.00378520182748999,-0.0650683298488008,-0.05023033868504,6.01836226875401e-52
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFP,Properdin,39917,0.0381434553186602,0.00253929994559462,0.0331664274252947,0.0431204832120256,1.63308640507451e-50
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,42222,0.0830720055748244,0.00553943566852763,0.0722147116645103,0.0939292994851386,1.9550881493533e-50
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42029,0.0462291046864004,0.00312312754547807,0.0401077746972634,0.0523504346755374,3.46069501970135e-49
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,42007,-0.0660780548990707,0.00449311683988993,-0.0748845639052549,-0.0572715458928864,1.39896343849182e-48
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42236,0.039227830672441,0.00270407442801305,0.0339278447935354,0.0445278165513466,2.46499635692738e-47
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39883,0.112315832191942,0.00785884090110093,0.0969125040257844,0.1277191603581,6.20428091856929e-46
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,41943,0.0528477602060518,0.00392296368200992,0.0451587513893123,0.0605367690227912,4.27735615536814e-41
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,42072,-0.0535846566414104,0.00411522687722205,-0.0616505013207657,-0.0455188119620552,1.58594842214002e-38
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42048,0.0859374601127413,0.00660977963436227,0.0729822920293913,0.0988926281960914,2.0426742989125e-38
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42114,0.0467637385328883,0.00371348266234791,0.0394853125146864,0.0540421645510902,3.68415653924464e-36
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,41995,0.0443650642185947,0.00353928240619749,0.0374280707024477,0.0513020577347418,7.62803292560052e-36
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41828,0.0741880142598274,0.00601489624420278,0.06239881762119,0.0859772108984649,9.21892499287404e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42187,0.0430348575824633,0.00349121961170825,0.0361920671435152,0.0498776480214115,9.98575854404245e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39675,0.0561982883616702,0.00468197062047606,0.0470216259455371,0.0653749507778033,5.47932175853648e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,39808,0.0416510303151829,0.00349430219334776,0.0348021980162213,0.0484998626141445,1.46959461146108e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,42111,0.0543099734544871,0.00456255647878062,0.0453673627560771,0.0632525841528971,1.65153780453213e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,42222,0.054102633246433,0.00457469806221432,0.0451362250444929,0.0630690414483731,4.08889009736148e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,42108,-0.0514122003802423,0.00436368021850177,-0.0599650136085058,-0.0428593871519789,6.93550668784979e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,39917,-0.0344333708699451,0.00294693255790368,-0.0402093586834363,-0.0286573830564539,2.31595715997268e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39869,0.0380799635366191,0.00327455440801572,0.0316618368969083,0.0444980901763299,4.41321667966311e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,39917,0.0291044319552901,0.0025047319969399,0.0241951572412879,0.0340137066692923,4.90465544518931e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42092,0.05565072577925,0.00481327219763531,0.0462167122718848,0.0650847392866152,8.97109999447232e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42056,0.15396958839028,0.0133814627338801,0.127741921431875,0.180197255348685,1.70526140106119e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,39673,0.0382619742959953,0.00334226345890604,0.0317111379165394,0.0448128106754511,3.55942677975776e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42108,0.0470413022983067,0.00413555177794079,0.0389356208135428,0.0551469837830707,7.62725495086547e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,39907,0.0432121930142839,0.00382684710746538,0.0357115726836517,0.050712813344916,2.0684564067181e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,39927,-0.0601477030642598,0.00532768922477615,-0.070589973944821,-0.0497054321836985,2.11920384847079e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42222,0.0333206630420207,0.00301150737160835,0.0274181085936683,0.039223217490373,2.46385769128221e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,42092,0.0390191576827655,0.00352966940008805,0.032101005658593,0.0459373097069381,2.75370637908571e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42056,-0.0566518429501276,0.00512618488578937,-0.0666991653262748,-0.0466045205739804,2.8535424622218e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,41943,-0.0691535891047944,0.0062878894019464,-0.0814778523326093,-0.0568293258769794,5.15941421359968e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,42080,0.0601326670991261,0.00548094114479571,0.0493900224553265,0.0708753117429257,6.89480000015249e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,42003,-0.0272822085618267,0.00249435584668765,-0.0321711460213345,-0.0223932711023189,9.98112766597063e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42174,0.0678078999562264,0.00622012935683485,0.0556164464168301,0.0799993534956227,1.47688787868306e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,42056,0.0455681141719872,0.00418456327874515,0.0373663701456467,0.0537698581983277,1.68307393147615e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,42072,0.0723707183494658,0.0067523246024616,0.0591361621286411,0.0856052745702906,1.07470630423189e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42187,0.0687983738539439,0.00645631329750962,0.056143999790825,0.0814527479170627,2.07871278740427e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FST,Follistatin,42092,0.0561350148101149,0.00527193431695765,0.0458020235488779,0.0664680060713519,2.269582071702e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,42194,-0.043036802464372,0.00408124690700461,-0.0510360464021011,-0.035037558526643,6.74320939808576e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,42187,0.0415999312733027,0.00397395707239639,0.0338109754114058,0.0493888871351996,1.51343952914626e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,41918,0.0584514435894503,0.00560002077784227,0.0474754028648795,0.0694274843140212,2.08985722842406e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39575,0.0358316397230701,0.0034481296014119,0.0290733057043028,0.0425899737418374,3.54205094974733e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,41995,0.0337275947134633,0.00324737268353437,0.027362744253736,0.0400924451731907,3.57366152359019e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,39590,0.0931278151600452,0.00898759624906947,0.075512126511869,0.110743503808221,4.82286035817732e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42025,-0.0717617651649369,0.00700874584352993,-0.0854989070182556,-0.0580246233116183,1.63361476109659e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,39356,0.0259503412605182,0.00253328787733272,0.0209850970209461,0.0309155855000903,1.63604661887579e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,42055,0.0345964714237582,0.00339527989358528,0.027941722832331,0.0412512200151853,2.70424086596534e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42236,0.0177157719340528,0.00174248505540564,0.0143005012254577,0.0211310426426478,3.39671541610442e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42048,-0.039187448375432,0.00385739698256796,-0.0467479464612652,-0.0316269502895988,3.69208209274439e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,42065,0.0448935041256517,0.00443059882136028,0.0362095304357855,0.0535774778155178,4.82904699370313e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,39917,0.0230199620218992,0.00227502196898007,0.0185609189626982,0.0274790050811001,5.77944738673441e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,42222,0.0465958916590844,0.00461420405189181,0.0375520517173765,0.0556397316007924,6.81746491718428e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39904,0.0292558233918012,0.00291226222650183,0.0235477894278576,0.0349638573557448,1.20531713210358e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,42072,0.0417344876783463,0.0041833136824387,0.0335351928607665,0.0499337824959262,2.32975090490722e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42111,0.0710573272735691,0.00713140362768973,0.0570797761632972,0.085034878383841,2.63614533640368e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,39675,0.126901138739044,0.0127438537094322,0.101923185468557,0.151879092009531,2.919280322667e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,41995,0.0423897891127755,0.00426405250728053,0.0340322461985056,0.0507473320270453,3.31497306981274e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39895,0.0299769551905781,0.00302336854818673,0.0240511528361321,0.0359027575450241,4.44697633683785e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42236,-0.0426096538664084,0.00430226953996667,-0.0510421021647431,-0.0341772055680737,4.78435281428998e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,41922,0.0292906767345117,0.00296331401467421,0.0234825812657502,0.0350987722032731,5.83350034624599e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,42072,-0.0511121592673181,0.00519510105993331,-0.0612945573447874,-0.0409297611898488,9.1664409850035e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39868,0.0816553319347062,0.00831523056306062,0.0653574800311073,0.097953183838305,1.13883971979345e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39575,0.0495024416366319,0.00504728490165755,0.0396097632293831,0.0593951200438807,1.2915073129972e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39675,0.0376411402916453,0.00386205339863525,0.0300715156303202,0.0452107649529703,2.35017144823103e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41834,-0.087652447355541,0.00900929223996906,-0.10531066014588,-0.0699942345652017,2.69072380804973e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39802,0.0438537284392915,0.00451105757664571,0.0350120555890659,0.0526954012895171,2.99265512218282e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41924,0.0752163767002031,0.00781706705036544,0.0598949252814869,0.0905378281189194,7.59817146342308e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,41995,0.0244289960146112,0.00253891127000331,0.0194527299254047,0.0294052621038177,7.60865362483418e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41995,0.0471639610033134,0.00491698784633927,0.0375266648244884,0.0568012571821384,1.01410358911755e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41766,0.0520275930713208,0.00548074109738814,0.04128534052044,0.0627698456222015,2.63107507158199e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42142,0.0438879828161641,0.00463349736726722,0.0348063279763204,0.0529696376560079,3.19689780937884e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,41995,0.0249870544289608,0.00264239494006556,0.0198079603464323,0.0301661485114893,3.7166363004854e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41864,0.0548159639254507,0.00584187086750832,0.0433658970251344,0.066266030825767,7.42026218273356e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39221,-0.111904490187595,0.0119862977555113,-0.135397633788397,-0.0884113465867923,1.19962989104973e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,42072,0.0268929972577662,0.00288557265116483,0.0212372748614831,0.0325487196540492,1.34408418644969e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41771,0.0374405716456234,0.00402927999412567,0.029543182857137,0.0453379604341097,1.74688140123766e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42051,-0.0940835204108196,0.0101347359419528,-0.113947602857047,-0.0742194379645921,1.89166498851001e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,42072,0.0404960339773455,0.00438389798874008,0.031903593919415,0.0490884740352761,2.89709899511073e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42048,0.0333471959180831,0.00362098040308186,0.0262500743280426,0.0404443175081235,3.7570530281772e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42072,0.0455133306736552,0.00495219736736075,0.0358070238336281,0.0552196375136822,4.47379750181653e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,39675,0.051899621104739,0.00564677450504057,0.0408319430748595,0.0629672991346185,4.58502047808166e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,39927,0.0572394565887019,0.00623718892682445,0.045014566292126,0.0694643468852779,5.19301662991789e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,42157,0.0414031821121411,0.00452814759538204,0.0325280128251923,0.0502783513990899,6.89460188499299e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41771,0.0528005522920561,0.00577742840768822,0.0414767926129872,0.064124311971125,7.20698922556029e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,39917,-0.0338952337581697,0.00371036577567959,-0.0411675506785017,-0.0266229168378377,7.63081810564734e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,42063,0.0375357528865865,0.00411453511525675,0.0294712640606832,0.0456002417124897,8.35289639163171e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,42111,0.0353133327540479,0.00387185416403817,0.0277244985925331,0.0429021669155627,8.51903804440162e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,42157,0.0414247878261973,0.00455158414573234,0.0325036829005619,0.0503458927518327,1.01662669909466e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,39904,0.0250166534138425,0.0027515303786694,0.0196236538716504,0.0304096529560345,1.13522529524864e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,41943,0.0339775865182352,0.00373860849708047,0.0266499138639575,0.0413052591725129,1.14610526757703e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,42048,0.0337766960070317,0.00373217778966653,0.0264616275392854,0.0410917644747781,1.62171320105603e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42072,0.0325286603275308,0.00359688088987751,0.0254787737833709,0.0395785468716908,1.72101425843471e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,39675,0.02988237669592,0.00330480914384935,0.0234049507739753,0.0363598026178648,1.7926368518254e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42108,0.0242251968888907,0.0026838765622471,0.0189647988268864,0.029485594950895,2.01478288809061e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42187,0.0327136015280051,0.0036272196324223,0.0256042510484574,0.0398229520075528,2.15078816619736e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REN,Renin,42072,-0.0792137266177224,0.00878325851343954,-0.0964289133040639,-0.0619985399313809,2.15700990793298e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELN,Elastin,39895,0.0338474934941023,0.00375367863587273,0.0264902833677918,0.0412047036204129,2.24101908907019e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41900,0.0240637913515126,0.0026734476220254,0.0188238340123428,0.0293037486906824,2.53604532932239e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42048,0.0393410983730796,0.00438148290883604,0.0307533918717609,0.0479288048743982,3.09253186164547e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,41901,0.0265950507778506,0.00296206683881956,0.0207893997737643,0.0324007017819369,3.10796598697054e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42124,0.0281088719828413,0.00314953594352086,0.0219357815335404,0.0342819624321421,5.03456261479417e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42173,0.027358693201503,0.00307030803074406,0.0213408894612447,0.0333764969417613,5.7078616839588e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,42187,0.0605931855737131,0.00686357135047779,0.0471405857267767,0.0740457854206496,1.19208679328686e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42063,0.0341868305744933,0.00387907175195029,0.0265838499406707,0.0417898112083158,1.36436117140351e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,42236,0.0187372429615629,0.00212835070269747,0.0145656755842759,0.02290881033885,1.4821839910035e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,42174,0.0215748855007769,0.00245702921632568,0.0167591082367786,0.0263906627647752,1.81399901263232e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,42048,0.0380326729350624,0.00433354748951355,0.0295389198556158,0.0465264260145089,1.89034449382811e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,42108,0.0510766315481781,0.00583200169185894,0.0396459082321345,0.0625073548642216,2.22154241773569e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,39648,0.0485324541709125,0.00556438975241514,0.0376262502561789,0.0594386580856462,3.12526661138759e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39889,0.0139669639666908,0.00160307659993457,0.010824933830819,0.0171089941025625,3.3833987954974e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,39868,0.0284278514850402,0.00327200483357246,0.0220147220112381,0.0348409809588422,4.18980531148825e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42164,0.0333265768908984,0.00385183095684478,0.0257769882154826,0.0408761655663142,5.6174834966236e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,39869,0.0315747203495394,0.0036559808671805,0.0244089978498656,0.0387404428492132,6.57800255042825e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,41888,0.0376074251879193,0.00437165954973534,0.0290389724704381,0.0461758779054006,8.66306607400653e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42222,0.0396315971745456,0.00461328316877164,0.0305895621637531,0.048673632185338,9.57027580977813e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39675,0.0276596810259919,0.0032235072410915,0.0213416068334526,0.0339777552185313,1.06943241554788e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42066,0.036628221739224,0.00427443583501989,0.028250327502585,0.045006115975863,1.15511885007863e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39675,0.0370999322742865,0.00432859963966604,0.0286158769805411,0.045583987568032,1.16314785896157e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42072,0.0250674056915324,0.00292605869099037,0.0193323306571913,0.0308024807258735,1.1770502479749e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42063,0.0319979797509844,0.00374065354266699,0.0246662988073571,0.0393296606946118,1.31499808187893e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,42085,0.0177245751687296,0.0020773074708612,0.0136530525258416,0.0217960978116175,1.58407272976906e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,42236,0.0233508858104106,0.0027428469315002,0.0179749058246702,0.028726865796151,1.86448770745133e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42111,0.0248502427527982,0.00291952629684614,0.0191279712109797,0.0305725142946166,1.89259134138479e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39868,0.0253451138180422,0.00298602842935184,0.0194924980965126,0.0311977295395718,2.36715540136416e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HLA_E,,42048,0.0269216208273767,0.00317498639827947,0.0206986474867489,0.0331445941680044,2.50009123953564e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,42095,0.0339505772793098,0.00401961272507967,0.0260721363381536,0.0418290182204659,3.31360821541432e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,42174,0.0343249386200812,0.00406846529950284,0.0263507466330557,0.0422991306071068,3.58774506577489e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41865,0.0219798825799834,0.00260524387871425,0.0168736045777034,0.0270861605822633,3.59700353684637e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42063,0.0261527887876573,0.00310026191909654,0.0200762754262281,0.0322293021490866,3.62605990032429e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,42072,0.0319891390997178,0.00379421926695266,0.0245524693364906,0.039425808862945,3.77209551742197e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,41567,0.0214527185814428,0.0025609035980037,0.0164333475293555,0.02647208963353,5.98353174057313e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39861,0.0181186580893499,0.00216426527623598,0.0138766981479274,0.0223606180307724,6.34838176752577e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,42174,0.0319035947874033,0.00381470093554977,0.0244267809537258,0.0393804086210809,6.68725328348227e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42174,0.0428816245235499,0.00513057433449991,0.0328256988279301,0.0529375502191697,6.99132223399711e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,42124,0.0254975959317035,0.00306135044408494,0.019497349061297,0.03149784280211,8.94092383457889e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,41995,0.0218280458690148,0.00262307750309622,0.0166868139629462,0.0269692777750834,9.5170773492794e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,41995,0.0250879902828595,0.00301767836980596,0.0191733406780399,0.0310026398876792,1.01666110892209e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42042,0.0299424508211727,0.00360459352931409,0.0228774475037171,0.0370074541386284,1.07708859546964e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42069,0.0344263957497139,0.00414580372896528,0.026300620440942,0.0425521710584859,1.1027790271103e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39904,0.0330599765238491,0.00398126300316718,0.0252567010376414,0.0408632520100567,1.12218588336221e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41842,0.0354412363021225,0.00427413050567073,0.0270639405110079,0.0438185320932371,1.21997367599766e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41893,0.0438763821194594,0.00532051256058304,0.0334481775007166,0.0543045867382022,1.78104803001139e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42236,0.0264919291016219,0.00321652736650951,0.0201875354632633,0.0327963227399805,1.93854785156716e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,42172,0.0459627804755779,0.0055908764937854,0.0350046625477586,0.0569208984033973,2.19949058825917e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39869,0.0481671249408643,0.00587899615462853,0.0366442924777924,0.0596899574039362,2.8209801983473e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39917,0.0215725598443768,0.00264608366287686,0.0163862358651381,0.0267588838236154,3.93567415267833e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42187,0.0233803234088675,0.00287967375297701,0.0177361628530325,0.0290244839647024,5.09891609190226e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42222,0.024151888749132,0.00298276798375601,0.0183056635009702,0.0299981139972938,6.10151422769779e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39869,0.0247014019141539,0.00305115285994866,0.0187211423086546,0.0306816615196533,6.27553063468332e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39597,-0.109700944909417,0.013560471623099,-0.136279469290691,-0.0831224205281427,6.60656700337197e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,39868,0.0785976524639635,0.00972919306474361,0.059528434057066,0.097666870870861,7.22249923055163e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39858,0.0377537744353052,0.00467652587576639,0.0285877837188031,0.0469197651518073,7.55414866179729e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42108,0.0323405894443441,0.00400775522991532,0.02448538919371,0.0401957896949781,7.65110959359512e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42063,0.02639859760859,0.00327311619757686,0.0199832898613394,0.0328139053558407,7.92106362146357e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42063,0.0230002695252641,0.00286935780467017,0.0173763282281105,0.0286242108224176,1.1836806024874e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42187,0.0522330063308017,0.0065209664059088,0.0394519121752205,0.065014100486383,1.23984642411463e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39575,0.0220583768985494,0.00276935141937784,0.0166304481165688,0.02748630568053,1.81283236870578e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41995,0.0297532631135123,0.00374096903630109,0.0224209638023622,0.0370855624246625,1.96011144572131e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,39895,0.0239134708520361,0.0030137644503315,0.0180064925293864,0.0298204491746859,2.30820784557447e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,39512,-0.0860903078509009,0.0108492847851194,-0.107354906029735,-0.0648257096720669,2.30878194914027e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,42174,0.0240610773524375,0.00304069047602901,0.0181013240194207,0.0300208306854544,2.70565139277569e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42187,0.0288794329091094,0.00365182957413873,0.0217218469437975,0.0360370188744213,2.81180291244814e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,42072,0.0221295610984676,0.00279991316805936,0.0166417312890712,0.0276173909078639,2.91775453939843e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,39917,0.0172325681821351,0.00218555779423567,0.0129488749054332,0.021516261458837,3.44095596551931e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42175,0.0295362866825027,0.00374803641014954,0.0221901353186096,0.0368824380463958,3.50879086300124e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,41995,0.0245732493997422,0.00312194220723572,0.0184542426735602,0.0306922561259242,3.78300865474019e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,42092,0.0701128675749713,0.00891770518109705,0.0526341654200211,0.0875915697299215,4.05938766694608e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,39597,0.0354971053585406,0.00453138737559625,0.0266155861023719,0.0443786246147092,5.17707360857105e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,42187,0.0393672571454767,0.0050280220491129,0.0295123339292154,0.049222180361738,5.25648168742409e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,42048,0.042164797080915,0.0053854990061203,0.0316092190289192,0.0527203751329108,5.27079940005388e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,41943,0.0288665569675696,0.00368937813082047,0.0216353758311615,0.0360977381039778,5.4904110056344e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39896,0.0166802373221552,0.00213195964602265,0.0125015964159508,0.0208588782283596,5.57726790159743e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,42111,0.0347624846229597,0.0044443050393186,0.0260516467458953,0.0434733225000242,5.59194015257338e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42187,0.0281365334541126,0.0036069995277997,0.0210668143796252,0.0352062525286,6.61233339140217e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,41997,0.037304501669957,0.0047951940606132,0.0279059213111551,0.0467030820287588,7.80839403041178e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42174,0.0235415468181948,0.00302919664441085,0.0176043213951495,0.02947877224124,8.30870433600215e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41919,0.0216077986000612,0.00278627426389636,0.0161467010428243,0.0270688961572981,9.46771501135304e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39869,0.0251925000455164,0.00324897078552798,0.0188245173058815,0.0315604827851512,9.67095891961729e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,41842,-0.0372703693655276,0.0048095995890827,-0.0466971845601297,-0.0278435541709255,9.92192741127578e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,41995,0.0716125301574044,0.00925185402475409,0.0534788962688864,0.0897461640459224,1.06232279914848e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,42108,0.0257066467651981,0.00333114542290563,0.0191776017363031,0.0322356917940931,1.27373607400688e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,39673,0.032101697046073,0.0041596903983314,0.0239487038653435,0.0402546902268026,1.29004107562782e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,39904,0.0267367228710861,0.00347088373108244,0.0199337907581645,0.0335396549840077,1.4384241862303e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42048,0.0287495476433011,0.00373802719454775,0.0214230143419875,0.0360760809446147,1.55987357907863e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,41945,0.0584896248707296,0.00760808397973473,0.0435777802704495,0.0734014694710097,1.60097114233322e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,41995,0.0267705356699869,0.00348313212468479,0.0199435967056047,0.0335974746343691,1.62643147945507e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42070,0.0289494090512116,0.00377029090104631,0.0215596388851608,0.0363391792172623,1.72302705479778e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42187,0.0278415052235192,0.00363440598447192,0.0207180694939542,0.0349649409530842,1.9765436921009e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,41995,0.0312706001922412,0.00408492547024274,0.0232641462705654,0.039277054113917,2.06321282813376e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39895,0.0282296461193933,0.00370284416948215,0.0209720715472082,0.0354872206915783,2.66101239773571e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39904,0.0190760551918412,0.00250557915227119,0.0141651200533897,0.0239869903302928,2.88159481139935e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39895,0.0255033265820171,0.00335006212178983,0.018937204823309,0.0320694483407252,2.89599318833542e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39864,0.0504827558370674,0.00663971265283337,0.037468919037514,0.0634965926366209,3.11962367489563e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42236,0.0225802888918948,0.00297409322772279,0.0167510661655581,0.0284095116182315,3.34589260787052e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42174,0.0240727671824529,0.00317199330960031,0.0178556602956363,0.0302898740692695,3.4292983852284e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42210,0.0426926350436375,0.00563065688709999,0.0316565475449215,0.0537287225423535,3.61768052011893e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41903,0.0335540030466394,0.00442851634977868,0.0248741110010731,0.0422338950922056,3.77537390632144e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42210,0.0427858693872653,0.00564743781002679,0.0317168912796127,0.0538548474949178,3.78875991535095e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,39798,0.0250514159739169,0.00330703573676486,0.0185696259298577,0.031533206017976,3.86848646934323e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42003,0.0361151302168871,0.00477288642957047,0.0267602728149289,0.0454699876188452,4.07668497027901e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,42141,0.0493096797917345,0.00652824578619156,0.0365143180507991,0.06210504153267,4.51578059225818e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42210,0.0313645423251597,0.00415568802734573,0.0232193937915621,0.0395096908587574,4.72287836604283e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42104,0.0398061904669327,0.00527435562235976,0.0294684534471076,0.0501439274867578,4.73445672989665e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39872,0.0296832099148199,0.00393584985923897,0.0219689441907115,0.0373974756389282,4.99311901407712e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,39764,0.0897665429813823,0.011907571932809,0.0664277019930767,0.113105383969688,5.11796848198637e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,39597,0.024440838770102,0.00324484575843821,0.0180809410835631,0.0308007364566409,5.3802417957018e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39868,0.030764353742103,0.00408816994238409,0.0227515406550302,0.0387771668291758,5.66426152617203e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,42111,0.0631213229790003,0.00841446260000444,0.0466289762829916,0.079613669675009,6.70119837165323e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41828,-0.0442218297620757,0.00591046205167086,-0.0558063353833506,-0.0326373241408008,7.78408850979055e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,39917,0.0244922619050534,0.00328884224743801,0.0180461311000749,0.0309383927100319,1.02365489883762e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,42048,0.0452889921701799,0.00608990489556064,0.033352778574881,0.0572252057654788,1.09450469271046e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42236,0.0328294549946658,0.00441493054778172,0.0241761911210137,0.041482718868318,1.09961342339557e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,42059,0.031451804917099,0.00424304805400244,0.0231354307312542,0.0397681791029437,1.31285344107275e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39597,0.0241914570096998,0.00327393184107181,0.017774550601199,0.0306083634182005,1.58527777282392e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42174,0.0359851248128692,0.00487832048691578,0.0264236166585143,0.0455466329672241,1.71877121968809e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,39897,0.0307164802540973,0.00416457334815925,0.0225539164917052,0.0388790440164895,1.74980106222083e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,39675,0.0314263043403358,0.00426300048178493,0.0230708233960374,0.0397817852846343,1.80242085980214e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39512,-0.0445773546164746,0.00606249213471387,-0.0564598392005137,-0.0326948700324354,2.0773222047479e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42063,0.0422960173830983,0.00577165245992413,0.030983578561647,0.0536084562045495,2.46486932302131e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,42008,0.0865001032669351,0.0118085439153231,0.0633553571929018,0.109644849340968,2.52136950798032e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39597,0.0256660941784637,0.00351416961489631,0.0187783217332669,0.0325538666236605,2.99543129489355e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42236,0.0193800919363068,0.00265491723876856,0.0141764541483205,0.0245837297242932,3.04374601802323e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,42174,0.0362953484590363,0.00497216714371027,0.0265499008573642,0.0460407960607085,3.04433933321683e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42053,0.0175569545561483,0.00240660711616132,0.0128400046084722,0.0222739045038245,3.14639599972468e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42142,0.0215144871920382,0.00294974154563342,0.0157329937625967,0.0272959806214797,3.18339345492108e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41771,0.0409883686486385,0.005622387401501,0.0299684893416966,0.0520082479555805,3.27129926607226e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42111,0.0170542675759214,0.00233983179831005,0.0124681972512337,0.0216403379006091,3.30402187989903e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,42072,0.0193264119273108,0.00265273169278797,0.0141270578094464,0.0245257660451752,3.38354111062987e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,39664,0.0164869622933744,0.00226860853232025,0.0120404895700267,0.0209334350167221,3.91061819245866e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,42111,0.0327050741663366,0.00450336918593988,0.0238784705618944,0.0415316777707787,4.01216225442319e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42050,0.0183795354155255,0.00254003401760293,0.0134010687410238,0.0233580020900273,4.87355627554967e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,39675,0.0243185597188136,0.00336015506095159,0.0177326557993485,0.0309044636382787,4.87875854195131e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39927,0.0207027100339221,0.00286162366749003,0.0150939276456417,0.0263114924222026,4.97037405937207e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,42187,0.0271010461885705,0.0037513417435517,0.0197484163712091,0.0344536760059318,5.30280558048902e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,39850,0.0504402320922484,0.00700218596932856,0.0367159475923644,0.0641645165921324,6.24368335328639e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42072,0.0273704221132501,0.00380890617633466,0.0199049660076341,0.034835878218866,7.02764888626674e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39869,0.0480558108457744,0.0066955776295743,0.0349324786918088,0.06117914299974,7.55996794841039e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42048,0.0383746997115746,0.00535165043289756,0.0278854648630954,0.0488639345600538,7.85534607475645e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,42063,0.0218782044278187,0.00305630851438794,0.0158878397396184,0.0278685691160191,8.58688683874291e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,42041,0.0312676897778352,0.00438974315744909,0.022663793189235,0.0398715863664355,1.11058362422496e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42142,0.0241534419152815,0.00339493619215634,0.0174993669786551,0.030807516851908,1.17921157005473e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42174,-0.111876799198764,0.0157268398757928,-0.142701405355318,-0.0810521930422103,1.18590909416441e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42222,0.0580691316921995,0.00818041424751331,0.0420355197670734,0.0741027436173256,1.32307221826223e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,41943,-0.025960960221393,0.00366761771439077,-0.033149490941599,-0.0187724295011871,1.53089052582188e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,42110,0.0219279290324069,0.00309975291051451,0.0158524133277985,0.0280034447370154,1.57839680046844e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42142,0.0330028121666698,0.00467347050126703,0.0238428099841865,0.0421628143491532,1.72455582094139e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42020,0.031397160996073,0.00444610316017826,0.0226827988021236,0.0401115231900224,1.72542084426149e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41842,0.0335790627560951,0.00476201773888133,0.0242455079878877,0.0429126175243025,1.85865586697857e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,39675,0.0412181405773557,0.00584860528454221,0.029754874219653,0.0526814069350584,1.92965367458559e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,42108,0.0210284734187993,0.00298954839034634,0.0151689585737205,0.0268879882638781,2.1035968379757e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39895,0.0193848784133941,0.0027573981968585,0.0139803779475515,0.0247893788792368,2.18235396356777e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,41995,0.0237131952452118,0.00337718356988313,0.0170939154482408,0.0303324750421827,2.2993254658073e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,42063,0.0189472034495979,0.00270015649547546,0.013654896718466,0.0242395101807298,2.37395743459657e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,41943,0.0389662529102219,0.00555554352424951,0.0280773876026929,0.049855118217751,2.42861548436177e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42108,0.0207361211891841,0.00297323959123562,0.0149085715903623,0.0265636707880059,3.21805821682311e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,42070,0.0180993020364437,0.00259678193107228,0.013009609451542,0.0231889946213453,3.31931513128641e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41874,0.0210203394369686,0.00302644748928132,0.0150885023579773,0.02695217651596,3.94548885455643e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39872,-0.0335266727849381,0.00483673233569097,-0.0430066681628924,-0.0240466774069838,4.3858528274636e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42005,0.0265812783248617,0.00383600402915453,0.0190627104277188,0.0340998462220046,4.41876867512856e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39927,0.030586871324895,0.00441732764677557,0.0219289091372149,0.0392448335125751,4.61862380842615e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,42050,0.0175698267116555,0.0025387977671468,0.0125937830880478,0.0225458703352633,4.70335691755447e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39927,0.0200214784615731,0.00289328316166708,0.0143506434647057,0.0256923134584406,4.76064299076394e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,39675,0.0350883552974291,0.00507585513542423,0.0251396792319976,0.0450370313628606,5.0132216776799e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,42033,0.0684827750027988,0.00991717879978178,0.0490451045552265,0.0879204454503711,5.22872120194895e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41667,-0.0750931802022438,0.0108894117788616,-0.0964364272888126,-0.053749933115675,5.59542933861789e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,39895,0.0345665041251481,0.00502546735390333,0.0247165881114976,0.0444164201387987,6.37854861060927e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41842,0.0320282734841815,0.00465821417336512,0.0228981737043858,0.0411583732639771,6.44722422240918e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42008,0.0234367051633218,0.0034230257146637,0.016727574762581,0.0301458355640627,7.88183994625477e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,41943,0.0250537538598065,0.00366030696651378,0.0178795522054395,0.0322279555141735,7.9977047604565e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42097,0.0199997349928661,0.0029252225284631,0.0142662988370784,0.0257331711486538,8.43476693140063e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,41967,0.0161239409923474,0.00235885292301481,0.0115005892632383,0.0207472927214564,8.5263954812219e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,41766,0.0469290176431384,0.0068718218849162,0.0334602467487027,0.0603977885375742,8.91399304348519e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,41995,0.0272179257557905,0.00398784734371072,0.0194017449621175,0.0350341065494636,9.15695889821981e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41924,0.0242158615956477,0.00354909859094813,0.0172596283573893,0.031172094833906,9.29449088761843e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,41943,0.0193303458103997,0.00283310960055802,0.013777450993306,0.0248832406274934,9.29962300512344e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39597,0.0192623587660161,0.00282488193148573,0.0137255901803041,0.0247991273517282,9.66043736549289e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42236,0.0370992390370356,0.00544883535011626,0.0264195217508077,0.0477789563232635,1.02637844534554e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39564,0.0420152078608956,0.00617084314490078,0.0299203552968901,0.0541100604249011,1.03657682422059e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,39675,0.0432325879939581,0.00635487325790974,0.030777036408455,0.0556881395794612,1.07701216782705e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,39863,0.0353399558382911,0.00519595627235557,0.0251558815444742,0.045524030132108,1.08828047730445e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,41842,-0.0609013875575753,0.00895909994397164,-0.0784612234477597,-0.0433415516673908,1.10846376600353e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41886,0.0223530406905909,0.00329955269286454,0.0158859174125764,0.0288201639686054,1.3003440928358e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,41995,0.0395434859807453,0.00584281360509823,0.0280915713147527,0.0509954006467378,1.36115642744039e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41842,0.0275970497580776,0.00408264325680237,0.019595068974745,0.0355990305414103,1.44165499685604e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,42114,0.0332398892554625,0.0049185774388382,0.0235994774753396,0.0428803010355853,1.45615058483004e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,41995,0.0298431419085016,0.00441668667002913,0.0211864360352445,0.0384998477817587,1.46794954629545e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,41642,0.0192836101128709,0.00285620514471554,0.0136854480292285,0.0248817721965134,1.52540801001122e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42070,0.0253915359292731,0.00376306984522409,0.0180159190326339,0.0327671528259124,1.56498206862361e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,41995,0.0152852940794694,0.00226626103937059,0.0108434224423031,0.0197271657166358,1.59615050106626e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39575,-0.0369834500823043,0.00549432454600381,-0.0477523261924717,-0.0262145739721368,1.76651119091611e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39868,0.0222920921649436,0.00331222021886582,0.0158001405359666,0.0287840437939206,1.77582980048329e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39883,0.0360135862539199,0.00535501860093578,0.0255177497960858,0.0465094227117541,1.83820223379793e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,41919,0.0235374909982399,0.00350102310837715,0.0166754857058207,0.0303994962906591,1.85233379006006e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42142,0.0312619669130488,0.00465044222433327,0.0221471001533556,0.0403768336727421,1.85959729509098e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,42048,0.0652146084527368,0.00972832174800539,0.0461470978266462,0.0842821190788274,2.114820951503e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42236,0.0205918427686749,0.00307536426552558,0.0145641288082448,0.026619556729105,2.22980682609581e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39868,0.0343132331597065,0.00512879767690205,0.0242607897129785,0.0443656766064345,2.3325501493433e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,42048,0.0426598819721248,0.00639796090628054,0.0301198785958149,0.0551998853484346,2.69930925197441e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,41766,0.0245129735154566,0.00368452203449231,0.0172913103278516,0.0317346367030615,2.98616943591551e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,42174,0.020951947720863,0.00315723920436346,0.0147637588803106,0.0271401365614154,3.34175897333548e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41903,0.0212887582136624,0.00321526292618617,0.0149868428783375,0.0275906735489873,3.70080986871941e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,42048,0.0376949815192841,0.00570044799290651,0.0265221034531874,0.0488678595853809,3.91798967168284e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39858,0.0275441561860236,0.00417143379866973,0.019368145940631,0.0357201664314163,4.20930083782401e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41749,0.0326074981391763,0.00493907587096681,0.0229269094320814,0.0422880868462713,4.21384613714296e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,41766,0.0341098313919607,0.00517054947718966,0.023975554416669,0.0442441083672525,4.35761957226691e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41842,0.0288959247213829,0.00438116011519921,0.0203088508955925,0.0374829985471734,4.39930951183918e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42149,0.0217327421737551,0.00329537350225691,0.0152738101093315,0.0281916742381786,4.41249497959913e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,42085,0.0220792628933947,0.00335007010904437,0.0155131254796678,0.0286454003071217,4.54069847011684e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,41943,0.0261372498906358,0.00396770279321758,0.0183605524159293,0.0339139473653422,4.64061756383426e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,42072,-0.0486199846282313,0.00738550620157146,-0.0630955767833113,-0.0341443924731512,4.77604482881217e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41757,0.0279487190270334,0.00424778542053231,0.01962305960279,0.0362743784512767,4.89581589868685e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39675,0.0298366416394955,0.00453672381967501,0.0209446629529325,0.0387286203260585,5.02688370619824e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,42156,0.0267567074515356,0.00407114470300033,0.018777263833655,0.0347361510694163,5.1361945195517e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,42174,0.0213623038762232,0.00326730432867212,0.0149583873920258,0.0277662203604205,6.44886840905459e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39635,0.0244037910612175,0.00373247414432547,0.0170881417383396,0.0317194403840955,6.49979353050056e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42128,0.022638656312124,0.00347195977793246,0.0158336151473764,0.0294436974768716,7.25971879740121e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41807,0.0376247122223526,0.00578438969581846,0.0262873084185484,0.0489621160261567,8.07468999892331e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,39927,0.0182259363169702,0.00280511831950692,0.0127279044107367,0.0237239682232038,8.51548220090514e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,39675,-0.0167430276100983,0.0025773023011382,-0.0217945401203292,-0.0116915150998675,8.58273554770054e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,42174,0.0171282156963305,0.00263946493187462,0.0119548644298563,0.0223015669628048,8.9244159937734e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,41580,0.0221410669713309,0.00341205750458462,0.0154534342623451,0.0288286996803168,8.95073257573798e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42039,0.0188574189169384,0.00290689461455163,0.0131599054724172,0.0245549323614596,9.05476673258775e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,41990,0.0207853386600505,0.00321536851475176,0.0144832163711371,0.027087460948964,1.05246445940809e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39675,0.0257433936974228,0.00398591748871537,0.0179309954195406,0.0335557919753049,1.10112877895022e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42092,-0.0549944567512462,0.00852453611908195,-0.0717025475446468,-0.0382863659578456,1.14668560984005e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42213,0.0886564832690241,0.013748974978093,0.0617084923119618,0.115604474226086,1.16987398609097e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42072,0.0238679447290244,0.00370628374199506,0.0166036285947141,0.0311322608633347,1.23642686769117e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,42039,0.0205674727942253,0.00319542675101251,0.0143044363622408,0.0268305092262098,1.26382323045859e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,41995,0.050527265780464,0.0078600026256548,0.0351216606341806,0.0659328709267474,1.3332188650909e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42174,0.0212866342164266,0.00331449399485472,0.0147902259865114,0.0277830424463419,1.38713373520556e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39869,-0.0710555008987585,0.011095233014897,-0.0928021576079566,-0.0493088441895603,1.57230147423434e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,42222,0.00640149354994335,0.000999820441255172,0.00444184548508321,0.00836114161480349,1.57717616024303e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,39858,0.0254054448916585,0.00397059123532187,0.0176230860704276,0.0331878037128894,1.63242103961932e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41828,0.02186903258279,0.00341947997959216,0.0151668518227894,0.0285712133427906,1.65484616757576e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42051,0.0201638559107745,0.00315321135862721,0.0139835616478652,0.0263441501736838,1.66174599302984e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,41943,0.0321018617223325,0.00502301744778886,0.0222567475246663,0.0419469759199986,1.70337432388441e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39725,0.00925100681907158,0.00144835767129714,0.00641222578332918,0.012089787854814,1.75646353273305e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,39597,0.03019689981189,0.00473397537355561,0.020918308079721,0.039475491544059,1.85694881274834e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39917,0.0126524736021127,0.00198440509505009,0.00876303961581452,0.0165419075884109,1.88908042421723e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,39904,0.0329744258995407,0.00517852820033459,0.0228245106268849,0.0431243411721965,1.99547018177125e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,42072,0.0203876758632576,0.00320288073456588,0.0141100296235085,0.0266653221030067,2.01069293003733e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42187,0.0280012423938296,0.00440155817560973,0.0193741883696345,0.0366282964180246,2.05974080479223e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,41997,-0.0240797503818611,0.00378625371980195,-0.0315008076726729,-0.0166586930910493,2.08600737825771e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39904,0.0150888616818975,0.00237355315539536,0.0104366974973226,0.0197410258664725,2.13549432293414e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,41995,0.053034394733419,0.00835617693397542,0.0366562879428272,0.0694125015240109,2.27025964062244e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,39895,-0.0591080002855698,0.00931658932990333,-0.0773685153721803,-0.0408474851989592,2.31861987988785e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,41842,0.0233936773903955,0.00369498791365626,0.0161515010796292,0.0306358537011617,2.51127117659075e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39895,0.0187452730754084,0.00296213797898214,0.0129394826366034,0.0245510635142134,2.57276488615549e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42236,0.0156672652415416,0.00247767288657561,0.0108110263838534,0.0205235040992298,2.63883364579598e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,42092,0.0210436265565333,0.00333087420362234,0.0145151131174335,0.027572139995633,2.73736195323045e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39597,0.0201607721721784,0.0031979685802257,0.013892753754936,0.0264287905894208,3.00703759849465e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39904,-0.0160588380636283,0.00254793292961959,-0.0210527866056827,-0.0110648895215739,3.03408925067552e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41847,0.0997698130941189,0.0158556886773416,0.0686926632865295,0.130846962901708,3.22506397566878e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41828,0.0239441444268042,0.00381402011851247,0.0164686649945198,0.0314196238590886,3.53836257143254e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,41995,0.0281356440260167,0.00448243717758243,0.0193500671579552,0.0369212208940783,3.56124345507594e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,42198,0.0193795399343087,0.00309397536537683,0.0133153482181701,0.0254437316504473,3.87425416707206e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,39904,0.0190279485868646,0.00303860771078268,0.0130722774737305,0.0249836196999987,3.93706357411091e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,42071,0.0370920092855297,0.00594007576794507,0.0254494607803573,0.048734557790702,4.38301483510028e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42187,0.0191505690846192,0.0030676772959374,0.0131379215845819,0.0251632165846565,4.42891342921155e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,39904,0.0567333380536688,0.00909241153553406,0.038912211444022,0.0745544646633156,4.54279699564822e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,42174,0.0249411845560789,0.00399896132970804,0.0171032203498512,0.0327791487623067,4.59520150639742e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41842,0.0368460964821169,0.00592115742091645,0.0252406279371207,0.0484515650271131,5.03125152776049e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42008,0.0180774056055024,0.00290535478698676,0.0123829102230083,0.0237719009879964,5.05141940351169e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,39917,0.0183136395162312,0.00294613351324075,0.0125392178302793,0.024088061202183,5.27399348100349e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,39597,0.0114894466127669,0.00184851700200289,0.00786635328884119,0.0151125399366925,5.30167651496885e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39601,0.0264192247396462,0.00425992463078383,0.0180697724633099,0.0347686770159825,5.78226574577416e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,42222,0.0325301732288131,0.00525453146523287,0.0222312915569567,0.0428290549006695,6.15465467239841e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42024,0.0256382844707777,0.00415242416965607,0.0174995330982518,0.0337770358433036,6.83757328147176e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,41837,0.0491213561154431,0.00796347733484423,0.0335129405391484,0.0647297716917378,7.10250403297868e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39575,0.0425900350033915,0.0069140265020524,0.0290385430593688,0.0561415269474142,7.53184377250763e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39675,0.0192890486919618,0.00313525010377589,0.0131439584885611,0.0254341388953626,7.89969281380321e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42108,0.0167588450455849,0.00272487714596294,0.0114180858394975,0.0220996042516723,7.95117225401881e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,41943,0.0284703846779111,0.00464437111130943,0.0193674172997446,0.0375733520560776,9.03086359144019e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41849,0.0190311111604696,0.0031092300927396,0.0129370201787,0.0251252021422392,9.57082156213277e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,42050,0.0181290514936152,0.00296373412602498,0.0123201326066062,0.0239379703806241,9.80200053111949e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,39652,0.0191979864868909,0.00313814721767817,0.0130472179402416,0.0253487550335401,9.81989226667037e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42108,0.0162132749078389,0.00265278503891601,0.0110138162315635,0.0214127335841142,1.01228067656509e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39872,0.0238756138359985,0.00390871940850449,0.0162145237953297,0.0315367038766673,1.04021173242339e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,42029,-0.0415098192640462,0.00680135383232609,-0.0548404727754054,-0.0281791657526871,1.06847122943176e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41706,0.0217334296300138,0.0035649595970864,0.0147461088197245,0.0287207504403032,1.11528769348283e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,42072,-0.0415326997490704,0.00681324286820486,-0.0548866557707519,-0.0281787437273889,1.11810034388356e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,41995,0.0141783796366891,0.00232788100909917,0.00961573285885478,0.0187410264145235,1.15509159998993e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,41943,0.0441313735188774,0.00724750337310152,0.0299262669075985,0.0583364801301564,1.1660403555119e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42172,0.0188465763535275,0.00309979793282702,0.0127709724051866,0.0249221803018685,1.2345467547708e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42048,0.025037345560632,0.00412089070319271,0.0169603997823743,0.0331142913388897,1.26771441450509e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41771,0.0375772538189649,0.00619837237586008,0.0254284439622792,0.0497260636756507,1.37737848540465e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,42222,-0.0191588740617355,0.00316332521721965,-0.025358991487486,-0.012958756635985,1.42722067637471e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,41995,0.0131008600876667,0.00216382316649469,0.00885976668133708,0.0173419534939963,1.44623321877443e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41828,0.0276186855682982,0.00456218427140795,0.0186768043963386,0.0365605667402577,1.45270519735991e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42027,0.0312970306907503,0.00517294900831995,0.0211580506344432,0.0414360107470574,1.48575139478816e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42222,0.0297968956824724,0.00494469908489416,0.0201052854760798,0.0394885058888649,1.72373493915683e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39759,0.0215480766850132,0.0035788782062311,0.0145334754008003,0.0285626779692262,1.78904967512492e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,39675,-0.0632791190887473,0.0105174490210359,-0.0838933191699776,-0.042664919007517,1.83768053040385e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,41766,0.0292978170604606,0.00487262817485429,0.0197474658377461,0.038848168283175,1.87249450589203e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,39895,0.0437674710619758,0.00727997754771062,0.029498715068463,0.0580362270554886,1.88871627524158e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42108,0.0222394030549682,0.00370397918758928,0.0149796038472932,0.0294992022626432,1.97219159669009e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39869,0.0574362106648408,0.00957858684191478,0.0386621804546878,0.0762102408749937,2.08034690195674e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39895,0.0230903118720014,0.00385128514056928,0.0155417929964856,0.0306388307475172,2.09083889701976e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,39597,0.0209653545102847,0.00349737051103738,0.0141105083086514,0.027820200711918,2.10383296170144e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,42072,0.053971656462481,0.0090080984515473,0.0363157834974482,0.0716275294275137,2.13270604536189e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,41828,0.0150668416786537,0.00252165525665187,0.0101243973756161,0.0200092859816914,2.36031604300612e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,41808,0.0235748405063019,0.00394808490084721,0.0158365941006414,0.0313130869119625,2.41548531566557e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39597,0.0267811607670556,0.00448504807104935,0.0179904665477989,0.0355718549863124,2.42779973998436e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,41771,0.0245561954440884,0.00411300074833681,0.0164947139773483,0.0326176769108286,2.42786718779278e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,41903,0.0361917393807155,0.00606350379075704,0.0243072719508317,0.0480762068105993,2.45112904976947e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,42222,0.0378711240742577,0.00635241747878308,0.0254203858158429,0.0503218623326726,2.558213954402e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,39872,-0.0334525972514146,0.00562092566390174,-0.044469611552662,-0.0224355829501672,2.7370242161467e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41995,0.0223675896597345,0.00375933638038347,0.0149992903541829,0.0297358889652861,2.75041594301737e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,42236,0.0372998200740337,0.00626943710866364,0.0250117233410529,0.0495879168070144,2.75607042953663e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,41730,0.0310661756111345,0.00522159050228133,0.0208318582266631,0.0413004929956059,2.75707421555663e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,39904,0.0166963321472249,0.00280699940956725,0.0111946133044731,0.0221980509899767,2.7929103732845e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42111,0.0175088589999107,0.00294620672188765,0.0117342938250109,0.0232834241748105,2.87010651089521e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42072,0.0207501200346514,0.00349356072252127,0.0139027410185097,0.0275974990507931,2.92879412050466e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,42041,0.0475022451809447,0.00800542587737856,0.0318116104612827,0.0631928799006067,3.03367708203984e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,42091,0.0344345834139726,0.00580797109530293,0.0230509600671789,0.0458182067607664,3.12520422222991e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41857,0.0264289346486485,0.00446358131105431,0.017680315278982,0.0351775540183149,3.27876474754193e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,39847,0.0391671092815275,0.00662082765348247,0.0261902870807018,0.0521439314823531,3.40002543244472e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,41766,0.0329496892523859,0.00557509515597345,0.0220225027466779,0.0438768757580938,3.50235913253937e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,39880,0.0121416096958923,0.00205538537614938,0.00811305435863948,0.0161701650331451,3.57976839761228e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,41828,0.0300198800777118,0.00508266970732366,0.0200578474513574,0.0399819127040661,3.58422341949632e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42236,0.0229009887028093,0.00388114597983507,0.0152939425823325,0.030508034823286,3.70833002568705e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42164,0.0195968667058017,0.00332210452851852,0.0130855418299054,0.026108191581698,3.7457996294804e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39597,0.0553447977783263,0.0094041905120811,0.0369125843746474,0.0737770111820053,4.09371769388086e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,41842,0.0185047667983845,0.0031581397783864,0.0123148128327471,0.0246947207640218,4.75619796632631e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42048,0.0307574469432024,0.00525062372299884,0.0204662244461247,0.0410486694402801,4.7981665729143e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42114,0.0190281220375157,0.00324878082060998,0.0126605116291202,0.0253957324459113,4.82250486324032e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41766,0.0316456690324626,0.00540349013743912,0.0210548283630819,0.0422365097018432,4.83935658084529e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42063,0.0229199597681105,0.00391668179890733,0.0152432634422521,0.0305966560939689,4.97347118571431e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,39868,0.0416504076220033,0.00712684528032984,0.0276817908725568,0.0556190243714498,5.23241377885994e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39872,0.038050706940634,0.00651476564936141,0.0252817662678856,0.0508196476133824,5.34221725274378e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,41943,0.0462940453555628,0.00793331678193676,0.0307447444629667,0.0618433462481588,5.49086295602306e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,42002,0.0244428145515716,0.0041939591507671,0.0162226546160681,0.0326629744870751,5.73511115200867e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,42236,0.0168411726228715,0.00289346219405723,0.0111699867225193,0.0225123585232237,6.00186654917886e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,39895,-0.0571022297423898,0.0098131736848522,-0.0763360501647001,-0.0378684093200795,6.08323176004419e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,39800,-0.0155812096374553,0.0026782683287458,-0.0208306155617971,-0.0103318037131135,6.13170012816875e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,39675,0.0177856332541875,0.00305903215529722,0.0117899302298049,0.02378133627857,6.26308878866698e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,42174,0.036181982418893,0.00622467095252066,0.0239816273519525,0.0483823374858335,6.28640894600419e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41360,0.0264788775266291,0.00455839908058737,0.0175444153286779,0.0354133397245804,6.44189056514753e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,39917,0.0437876227802049,0.00753983739710708,0.029009541481875,0.0585657040785348,6.51177400730907e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,41995,0.018955704304904,0.00326716310857026,0.0125520646121063,0.0253593439977017,6.70558228417783e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,41967,0.0178552925897893,0.00308084673538438,0.0118168329884359,0.0238937521911427,6.96213252051458e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,41995,0.028565240557905,0.00493677016100426,0.0188891710423367,0.0382413100734734,7.35977641734297e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,42174,-0.0235021906899523,0.00406354858810113,-0.0314667459226305,-0.0155376354572741,7.47020027537047e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,42164,0.0380994616463125,0.00658860176076936,0.0251858021952045,0.0510131210974204,7.51608105074448e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,39584,0.0174033675432709,0.00301395340321821,0.0114960188729632,0.0233107162135786,7.93847191547075e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41766,0.0184374014772064,0.0031946785489843,0.0121758315211972,0.0246989714332156,8.04414119635594e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,41886,0.0270826178313873,0.00469866348729374,0.0178732373962916,0.036291998266483,8.40186016743783e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39872,0.0306341059515367,0.00531876365938583,0.0202093291791405,0.041058882723933,8.65031159917321e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42174,0.0325351464947382,0.00565998531472397,0.0214415752778792,0.0436287177115972,9.20979018979359e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42236,0.025144893358421,0.00437945383743313,0.0165611638370521,0.03372862287979,9.58076607852162e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39868,0.0192006130257482,0.0033482048180563,0.0126381315823578,0.0257630944691385,1.00256303106463e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39868,0.0275611525510568,0.00481084583827883,0.0181318947080303,0.0369904103940833,1.0363515891665e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42136,0.0149238821333827,0.00260670404171639,0.00981474221161855,0.0200330220551468,1.05509776069264e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,39917,0.0116541643777121,0.00203550542712417,0.00766457374054873,0.0156437550148755,1.05790379040592e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41766,0.0237894605533357,0.00416275552936654,0.0156304597157773,0.0319484613908941,1.12190756378011e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,39895,0.0334890042565823,0.00586189218510364,0.0219996955737791,0.0449783129393854,1.1380528887088e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41800,0.0293228360199526,0.00513593977374002,0.0192563940634222,0.0393892779764831,1.15856513024722e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39353,0.0306506644139317,0.00536939951207459,0.0201266413702655,0.0411746874575978,1.17064559376174e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,41995,0.020260621248858,0.00355748507335636,0.0132879505050795,0.0272332919926364,1.25810405964938e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42063,-0.0245648063370647,0.0043148119210105,-0.0330218377022452,-0.0161077749718841,1.27331921766615e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39895,-0.0515679044773972,0.00905958040735765,-0.0693246820758182,-0.0338111268789762,1.28623280316512e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,41967,0.0251016122296542,0.00442262773259009,0.0164332618737776,0.0337699625855307,1.40973318438515e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,41995,0.00930373085135272,0.00164102233780986,0.0060873270692454,0.01252013463346,1.46195155372294e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,39892,0.0217759402873046,0.00384494167232592,0.0142398546095458,0.0293120259650634,1.5191336532677e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39675,0.0141653741522368,0.0025047083267555,0.00925614583179606,0.0190746024726776,1.59244410000582e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BSG,Basigin,42210,0.0127781971743988,0.00226101289215687,0.00834661190577136,0.0172097824430263,1.62210657696679e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,39858,0.0275288834362826,0.00487044770453412,0.0179828059353957,0.0370749609371694,1.62231429425981e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,42201,0.0417555663036327,0.00738984328205547,0.027271473470804,0.0562396591364614,1.63287090064862e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39872,0.0157451163890352,0.00278656418306592,0.010283450590226,0.0212067821878444,1.63986192378845e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41895,0.0261531002362085,0.00466408568938415,0.0170114922850155,0.0352947081874014,2.09556746909666e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,39576,0.0272087452437622,0.00485267595247924,0.0176975003769029,0.0367199901106215,2.10891382666011e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,41888,0.0291127662806428,0.00519822502534681,0.0189242452309631,0.0393012873303226,2.17948687529303e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RETN,Resistin,42034,0.0259635963064688,0.00463876857336806,0.0168716099026674,0.0350555827102702,2.22248763908981e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39869,0.08503148191526,0.0151916725966159,0.0552558036258928,0.114807160204627,2.22877982428082e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,42070,0.0179452449522915,0.00321360534499353,0.0116465784761042,0.0242439114284789,2.39393076740873e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42048,0.0164569172610283,0.00294711872417532,0.0106805645616447,0.0222332699604119,2.395065281883e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39575,0.0513994180232851,0.0092048637667703,0.0333578850404153,0.0694409510061549,2.40720322105898e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42108,0.0172974503922771,0.00310626701010248,0.0112091670524762,0.0233857337320779,2.61746215197374e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41919,0.0245270696247294,0.00440460478696887,0.0158940442422704,0.0331600950071884,2.61904582344308e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42054,0.0187912775872012,0.00338294363992632,0.0121607080529456,0.0254218471214568,2.83345308420809e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41932,0.061493256352883,0.0110824443816841,0.0397716653647822,0.0832148473409839,2.93273972061433e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39597,0.0304534379817067,0.00549082694929675,0.019691417161085,0.0412154588023283,2.98626085201485e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39869,0.0453414761088281,0.00818207025678046,0.0293046184055384,0.0613783338121178,3.06517443465184e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39872,0.0557583748761261,0.0100627447372885,0.0360353951910405,0.0754813545612116,3.07381173051407e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42221,0.0167762953184461,0.00302943763698937,0.0108385975499469,0.0227139930869452,3.12038763000522e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42142,-0.0276528392719409,0.00500476457934567,-0.0374621778474584,-0.0178435006964234,3.34989804004353e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,41943,0.0241737655329426,0.00438046182261563,0.0155880603606159,0.0327594707052692,3.4819670074713e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,41842,0.0288050831419555,0.00522311078587211,0.0185677860016461,0.0390423802822648,3.55461409796291e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,39863,0.0152823531808281,0.00277214893300554,0.00984894127213725,0.020715765089519,3.60913640754113e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42174,0.0375941647596933,0.00682723318679534,0.0242127877135744,0.0509755418058122,3.72688033727934e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,42142,0.0278011228885411,0.00505375184999311,0.0178957692625546,0.0377064765145276,3.84308473291306e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,42021,0.0261430476614267,0.00475251416423339,0.0168281198995292,0.0354579754233241,3.84801592345741e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,42222,0.0205924425745563,0.0037439209276817,0.0132543575563002,0.0279305275928124,3.86124208087435e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,42222,0.0283980386831517,0.00516430417456245,0.0182760025010093,0.0385200748652941,3.89030840770876e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,39869,0.0353341089313629,0.00642978172061199,0.0227317367589634,0.0479364811037624,3.983443921155e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,39675,0.0275856465573616,0.00502155166389677,0.0177434052961239,0.0374278878185993,4.02867595176245e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,42063,0.0257876803806008,0.00469873770287425,0.0165781544829673,0.0349972062782344,4.133601853144e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,39917,0.00880968203214291,0.00160964201121035,0.00565478369017063,0.0119645803741152,4.5173506062616e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,39869,0.0206463077200105,0.00377876866381456,0.013239921138934,0.0280526943010871,4.76049971909783e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39675,-0.015547474740267,0.00284615597030602,-0.0211259404420668,-0.00996900903846719,4.79296544564065e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,39858,0.0619884632092755,0.0113588065286003,0.0397252024132189,0.0842517240053321,4.93659659297504e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41828,0.0221817605740608,0.00408145138380123,0.0141821158618104,0.0301814052863112,5.58385109725153e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42063,0.0158710425536083,0.00293121677991954,0.010125857664966,0.0216162274422506,6.25182272651298e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42048,0.0251007733769788,0.00464473139483626,0.0159970998430997,0.0342044469108579,6.62305735097624e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39927,0.0166309290380688,0.00307823047837745,0.010597597300449,0.0226642607756886,6.69531767076063e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42048,0.038449045915166,0.00713858409170515,0.0244574210954239,0.0524406707349081,7.32190626607357e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,42108,0.0129599617645566,0.00240646659262175,0.00824328724301797,0.0176766362860952,7.34639632050805e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,41995,-0.045448502744145,0.00845435146959515,-0.0620190316245515,-0.0288779738637385,7.75420629134194e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39675,0.0401573952113505,0.00747144780422742,0.0255133575150648,0.0548014329076363,7.82318722709113e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,39917,0.0192717749912426,0.00359043132730629,0.0122345295897223,0.0263090203927629,8.13954491646514e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42155,0.0290907219411598,0.00542053512395658,0.0184664730982049,0.0397149707841147,8.14821345201001e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,42222,0.050373019947192,0.00939458616785299,0.0319596310582002,0.0687864088361839,8.36858149717004e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42048,0.0342523049971187,0.00638886049509376,0.0217301384267349,0.0467744715675024,8.40118359737209e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39869,0.0604106599696508,0.0112718563969776,0.0383178214315747,0.0825034985077269,8.51339547364574e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,42048,0.0517359303874846,0.00967268597053511,0.0327774658852357,0.0706943948897334,9.00575445122013e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42111,0.0198277373834954,0.00371146127402991,0.0125532732863968,0.0271022014805941,9.32636222301083e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,41995,0.0431901590828866,0.00808999519203526,0.0273337685064975,0.0590465496592757,9.51366081961789e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,42187,0.0183998412689804,0.00344725596966826,0.0116432195684306,0.0251564629695302,9.57344385822623e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39868,0.0394519052221376,0.00739155473319361,0.0249644579450781,0.0539393524991971,9.61029025096747e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42072,0.035621406244367,0.00667533098553168,0.0225377575127249,0.0487050549760091,9.6411849186634e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41771,0.016131463083376,0.00303279506230034,0.0101871847612673,0.0220757414054846,1.06041289824561e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,41943,0.0245152904633293,0.00461436165572808,0.0154711416181023,0.0335594393085564,1.09674669375222e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,42072,-0.0180489984693398,0.00340149193012836,-0.0247159226523914,-0.0113820742862882,1.13707286915839e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,39869,0.0210854485358518,0.00397564815806965,0.0132931781460353,0.0288777189256683,1.15658264874103e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41828,0.053374999379405,0.0100666062770462,0.0336444510763945,0.0731055476824156,1.16266585089266e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,42138,0.0349807835809047,0.00660907334254892,0.0220269998295088,0.0479345673323006,1.22309894261999e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39869,0.0553111177258578,0.010450012422609,0.0348290933775442,0.0757931420741715,1.22637005082458e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,42050,-0.0330579406501463,0.00624677015902017,-0.0453016101618259,-0.0208142711384668,1.22882485932136e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,42063,0.014134522711094,0.00267110774395252,0.00889915153294701,0.0193698938892409,1.2313035840411e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,41954,0.0265898571712468,0.00502646940356102,0.0167379771402672,0.0364417372022264,1.24270825950951e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41859,0.0194574123677811,0.00368311634852686,0.0122385043246684,0.0266763204108937,1.29190742453926e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42108,0.0159122926362216,0.00301576270116933,0.0100013977419297,0.0218231875305135,1.33801735543835e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,42048,0.0221420798407149,0.00419686721136081,0.0139162201064477,0.0303679395749821,1.34186621097233e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,41995,0.0181816237850611,0.00344630857269293,0.011426858982583,0.0249363885875393,1.34325068345103e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42048,0.0208202973675114,0.00394955794064546,0.0130791638038463,0.0285614309311765,1.37368511307827e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39575,-0.0358347093157056,0.00681368869424543,-0.0491895391564266,-0.0224798794749846,1.4738690126284e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,39297,0.0139339737882306,0.00265451008330974,0.00873113402494351,0.0191368135515177,1.5571410350291e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,39858,0.0195901365032135,0.00373365464749235,0.0122721733941285,0.0269080996122985,1.57484865596151e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42063,0.014004321798608,0.00267033604975587,0.00877046314108654,0.0192381804561296,1.59163030944051e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,42149,0.0348616462373316,0.00664743319853645,0.0218326771682002,0.0478906153064631,1.59171299759063e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41842,0.0197040995306258,0.00376116038788026,0.0123322251703805,0.0270759738908711,1.64071802999208e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42174,0.0444520000315668,0.00848621133810347,0.0278190258088841,0.0610849742542496,1.64624571148885e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,41943,-0.0300021244908,0.00573008087408124,-0.0412330830039993,-0.0187711659776008,1.66677431066055e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,41809,0.0322488234492826,0.00616714732144788,0.0201612146992448,0.0443364321993204,1.72908303785724e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42070,0.0178888572864233,0.00342180263826043,0.0111821241154329,0.0245955904574138,1.74005968503713e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42046,0.0556307080464095,0.0106521177961465,0.0347525571659623,0.0765088589268567,1.79155507765835e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42111,0.0723910475792139,0.0138648495138633,0.0452159425320419,0.099566152626386,1.80411957249436e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41771,0.0476117782183435,0.00912224597225366,0.0297321761127263,0.0654913803239606,1.82326074452499e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,39895,0.0217430340787155,0.00416557799653622,0.0135785012055045,0.0299075669519265,1.82401520143898e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39869,0.0299404383048238,0.0057386204018162,0.018692742317264,0.0411881342923835,1.84715811515943e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,42098,0.02206080371029,0.00422878879805318,0.0137723776661057,0.0303492297544742,1.84721256634105e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42039,0.0192626170023136,0.00369568898616544,0.0120190665894294,0.0265061674151979,1.89393575740872e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41900,0.0195039359082656,0.003742447878426,0.0121687380665506,0.0268391337499805,1.90076607356629e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42174,0.0120060793252326,0.00230659398279389,0.00748515511895659,0.0165270035315086,1.96708561796217e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,41995,0.03876113680074,0.00745981735358474,0.0241398947877139,0.0533823788137661,2.0662350791808e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39581,0.02035394446203,0.00392493667865092,0.0126610685718742,0.0280468203521858,2.18915845062877e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42092,0.029327694880348,0.0056630518389399,0.0182281132760258,0.0404272764846702,2.26556988313147e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42063,0.0667748940464603,0.0129072995798603,0.0414765868699342,0.0920732012229864,2.33148162678634e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41842,0.0479603000127775,0.00928496466338049,0.0297617692725517,0.0661588307530033,2.43444485458047e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,42072,0.0306243673924882,0.00593296204957715,0.018995761775317,0.0422529730096594,2.48155446588422e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42174,0.0158343070381965,0.00306778651797989,0.00982144546295591,0.0218471686134371,2.48469487346319e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39872,0.0268186102743329,0.00520263586297623,0.0166214439828995,0.0370157765657663,2.58185574842714e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,41995,0.0311004861765858,0.00603552967934933,0.0192708480050611,0.0429301243481105,2.60134051091268e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41771,0.0624379424840573,0.0121230230489233,0.0386768173081676,0.0861990676599471,2.63738115910274e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39512,0.0339368001231403,0.00659444141234928,0.0210116949549358,0.0468619052913449,2.70331833068341e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,41828,0.030062778750018,0.0058491316961422,0.0185984806255793,0.0415270768744567,2.79100901662302e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39869,0.0225411390887787,0.00440654154920292,0.0139043176523409,0.0311779605252164,3.18256767451394e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,42187,0.0303288684552525,0.00593022295294613,0.018705631467478,0.0419521054430269,3.1921299783657e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39675,0.0136333579041788,0.00266915838310061,0.00840180747330159,0.018864908335056,3.31464839283073e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42222,0.0303172036934297,0.00594883132995389,0.0186574942867201,0.0419769131001394,3.50940075255657e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,42048,0.0309136441780829,0.00606794211323972,0.0190204776361331,0.0428068107200328,3.54241952557678e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,39927,-0.012027735560855,0.00236337516803961,-0.0166599508902127,-0.0073955202314974,3.65305232355129e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,42187,0.0254588259009277,0.00500765837639055,0.0156438154832022,0.0352738363186531,3.74526469600738e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C3,Complement C3,39383,0.0253499392149791,0.00498970533671414,0.0155701167550193,0.0351297616749388,3.82847918128842e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,41995,-0.0444182251649277,0.00874443234419196,-0.0615573125595439,-0.0272791377703114,3.83315017213289e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42048,0.0201316236426191,0.00396702080465926,0.012356262865487,0.0279069844197513,3.93191383984618e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42174,0.0379497353812801,0.00748429006213537,0.0232805268594947,0.0526189439030654,4.01819149141695e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,41942,0.0324805313878495,0.00640627568226814,0.0199242310506039,0.045036831725095,4.0291182839675e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39811,0.0343328655247552,0.0067903241309243,0.0210238302281436,0.0476419008213668,4.34573662271949e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39575,0.0505381551664844,0.00999548429902223,0.0309470059404008,0.070129304392568,4.34825894037898e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,39868,0.0510487780635977,0.0101003649585717,0.0312520627447972,0.0708454933823983,4.39091654396456e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39904,0.0148752081124026,0.00294593797136533,0.00910116968852653,0.0206492465362786,4.50116107856921e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,41624,-0.0219920798328922,0.00436108500365654,-0.0305398064400591,-0.0134443532257254,4.64937735052581e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39575,0.0399167354181125,0.00791701607409947,0.0243993839128775,0.0554340869233474,4.68310998049259e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,41995,0.0377169744830919,0.00748344271018557,0.0230494267711282,0.0523845221950557,4.71465566122357e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,42130,-0.0364152670804975,0.00723033138941063,-0.0505867166037423,-0.0222438175572526,4.80330254965663e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,41943,0.0182235149503043,0.00362427057860071,0.0111199446162469,0.0253270852843617,5.0156104108163e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,41943,0.0304789108810897,0.0060731212234946,0.0185755932830402,0.0423822284791391,5.27043328782481e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,41900,0.0222772176139579,0.00444050661090692,0.0135738246565803,0.0309806105713354,5.32120219763542e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42141,0.0314085435703682,0.00626853408838957,0.0191222167571246,0.0436948703836117,5.49711074824455e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41814,0.0217217504010431,0.00433922613423,0.0132168671779523,0.030226633624134,5.63165797527913e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39597,0.030359690611777,0.00606510310976808,0.0184720885166315,0.0422472927069224,5.65407417155774e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42063,0.0168476858024765,0.00336690725311462,0.0102485475863718,0.0234468240185811,5.68893954106432e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,41842,0.0166503271393334,0.00333243650347991,0.0101187515925128,0.0231819026861541,5.91427210290305e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,42187,0.0601137346557022,0.0120460832708403,0.0365034114448552,0.0837240578665491,6.10272801444537e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,41995,0.0356635165390084,0.00715517486952657,0.0216393737947363,0.0496876592832805,6.2964505366431e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,41842,0.0293761854340503,0.00590022407171196,0.0178117462534949,0.0409406246146058,6.47764609915055e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,42034,0.0217098271803476,0.00436093432857083,0.0131623958963488,0.0302572584643464,6.49568796833056e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39895,0.0331583303820996,0.00667425087187565,0.0200767986732233,0.0462398620909759,6.86031047579546e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42043,0.0500822203660162,0.010085771440511,0.0303141083426147,0.0698503323894178,6.93182386776915e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,41995,0.0322194454083258,0.00649561345882835,0.0194880430290222,0.0449508477876293,7.12895820870155e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41771,0.030518281331316,0.00615527462350021,0.0184539430692555,0.0425826195933764,7.20834471476598e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,39872,0.0263127057217638,0.00531047212389051,0.0159041803589384,0.0367212310845892,7.34294382072208e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41873,0.0207220441487935,0.00419052832338344,0.012508608634962,0.0289354796626251,7.70861929274685e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,41828,0.02666674770137,0.00540077976221604,0.0160812193674266,0.0372522760353134,8.00655468668051e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39887,0.0122669180983056,0.00248560303360415,0.00739513615244144,0.0171387000441697,8.12172910106787e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,39675,0.0582495777130194,0.0118086166521479,0.0351046890748096,0.0813944663512292,8.2235778805666e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42048,0.0326226539499015,0.00661764454315001,0.0196520706453275,0.0455932372544756,8.33605130912963e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42174,-0.0688168289947769,0.0139773632173948,-0.0962124609008707,-0.041421197088683,8.60318751393578e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41828,0.0348162094936463,0.0070716135861823,0.020955846864729,0.0486765721225636,8.60902191808615e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,39675,0.0290338064030833,0.00589708683729714,0.0174755162019809,0.0405920966041857,8.62734619740595e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42087,0.0122086285108762,0.00248024682306967,0.00734734473765963,0.0170699122840927,8.65245886969757e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39868,0.0180501155549842,0.00366788016995007,0.010861070421882,0.0252391606880863,8.72634206768781e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,41771,0.020651010597377,0.00419697144821213,0.0124249465588812,0.0288770746358728,8.73869011398905e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42111,0.0154216694782285,0.00314225673498404,0.00926284627765976,0.0215804926787972,9.31628618669593e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39895,0.0278713298216169,0.00569709289825262,0.0167050277410417,0.039037631902192,1.01089717563571e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41842,0.0199638038996289,0.00408391673487073,0.0119593270992823,0.0279682806999755,1.02852483419041e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42236,0.0169473958711623,0.00347328605561073,0.0101397552021653,0.0237550365401594,1.07636214158857e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,39869,0.0345717717579029,0.0070861434331581,0.020682930628913,0.0484606128868928,1.08201724047429e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39927,0.0387872135487904,0.00795809463731476,0.0231893480596535,0.0543850790379274,1.10881979993804e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42055,0.0504444260496585,0.0103511853996889,0.0301561026662683,0.0707327494330487,1.1100080141542e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42236,0.0142930675929594,0.00293580716809758,0.00853888554348819,0.0200472496424307,1.13690828817681e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42187,0.0325221158500375,0.00668176880565009,0.0194258489909633,0.0456183827091117,1.14409234080116e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39869,0.0476217995622759,0.00979721753463998,0.0284192531943816,0.0668243459301703,1.18520704828975e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41771,0.0236187816204807,0.00485948033352487,0.014094200166772,0.0331433630741895,1.18528387867346e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,41842,0.0250061231286652,0.00514710873303822,0.0149177900119103,0.0350944562454201,1.19762010338215e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39869,0.0137800001158722,0.00283631042182142,0.00822083168910218,0.0193391685426422,1.1991646419689e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,42048,0.0232876154462328,0.0047963953407525,0.0138866805783579,0.0326885503141077,1.21597391192301e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,42187,0.0148149284709514,0.00305264637823542,0.00883174156961,0.0207981153722928,1.22870159474108e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39868,0.0213591912907725,0.00440437517115615,0.0127266159553065,0.0299917666262386,1.25402825664904e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42222,0.0290258266071773,0.0060011320286568,0.01726360783101,0.0407880453833447,1.33439227856086e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42221,0.0122372299828165,0.00253029495699952,0.00727785186709742,0.0171966080985355,1.33733891024299e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,39904,0.0197884039827486,0.0040938346015041,0.0117644881638006,0.0278123198016967,1.35776057652127e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,39512,0.0307364695983416,0.00636311092500333,0.0182647721853351,0.0432081670113482,1.38101134329387e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42072,0.0132091632428386,0.00273723577663122,0.00784418112064142,0.0185741453650358,1.41019802188266e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39590,0.0254699142987826,0.00527835550033046,0.0151243375181349,0.0358154910794303,1.41636619415288e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,42072,0.0238819492061172,0.00495570529750337,0.0141687668230106,0.0335951315892238,1.45792907999097e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42187,-0.0646906220881797,0.0134258620480222,-0.0910053117023032,-0.0383759324740563,1.46307696607683e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,42222,0.0136608259011812,0.00283978634478086,0.00809484466541075,0.0192268071369517,1.52156431719174e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42111,0.0129658504359436,0.00269801854048841,0.00767773409658631,0.0182539667753009,1.55874599096932e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42072,-0.0383262280208533,0.00797845101386414,-0.053963992008027,-0.0226884640336796,1.57423552463741e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,41771,0.0280250647193534,0.00583723789585555,0.0165840784434766,0.0394660509952303,1.59544580899336e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41732,0.0151154659419993,0.00315810271919846,0.00892558461237034,0.0213053472716283,1.71778639726056e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,39927,0.0243212654309432,0.0050815563545512,0.0143614149760229,0.0342811158858636,1.72130432041941e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39597,0.0220588013957097,0.00460928504305807,0.0130246027113159,0.0310930000801035,1.72583017152705e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,39897,0.0116364844285174,0.00243241642162625,0.00686894824212995,0.0164040206149049,1.74084194939304e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,41792,0.0257372561578769,0.00539562662024811,0.0151618279821906,0.0363126843335632,1.8617784664522e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,42174,0.0155762051355626,0.00326808850386858,0.00917075166798017,0.021981658603145,1.89725142043435e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39512,0.0262749947275652,0.0055127214956982,0.0154700605959967,0.0370799288591337,1.90112295623127e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42048,0.0376067378087302,0.00789355245096128,0.0221353750048461,0.0530781006126143,1.91552724811178e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41771,0.0196701659242881,0.00412908279503684,0.0115771636460159,0.0277631682025603,1.91997925744344e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,39904,0.026412625639248,0.00554582503984537,0.0155428085611511,0.0372824427173449,1.93475511209914e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,42172,-0.0620403499398166,0.0130288876227442,-0.0875769696803951,-0.0365037301992381,1.93901374609974e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39575,0.0275721927323234,0.00579246197055784,0.01621896727003,0.0389254181946168,1.96053427576958e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41771,0.0244768905369328,0.00514536806702098,0.0143919691255717,0.0345618119482939,1.98504253131412e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39597,0.0454088137157628,0.00954711513480374,0.0266964680515475,0.0641211593799782,1.99692767499154e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39422,-0.0166916886212521,0.00350978455463812,-0.0235708663483428,-0.00981251089416135,2.00254830584159e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,41759,0.0205014449508065,0.00431327773440994,0.0120474205913631,0.02895546931025,2.02440548962513e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41675,0.0201364396840083,0.00424025449655357,0.0118255408707633,0.0284473384972533,2.06722725116304e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42072,0.0162991317395043,0.00343623561195414,0.00956410994007415,0.0230341535389344,2.1241023547074e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,41943,0.0247229492892883,0.00521420634917749,0.0145031048449004,0.0349427937336761,2.14377872941684e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42070,0.0123042120437986,0.00259645821103705,0.00721515395016603,0.0173932701374312,2.17137017494587e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,39868,0.0250989241313029,0.00529639140927315,0.0147179969691275,0.0354798512934782,2.17538399996622e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41542,0.016663862383594,0.00351676354172897,0.00977100584180524,0.0235567189253828,2.1769411171469e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",42187,0.0372835113835226,0.00790669880101552,0.0217863817335321,0.052780641033513,2.43594407024511e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,41842,0.0241546732916751,0.0051230434221399,0.0141135081842809,0.0341958383990693,2.44286787946142e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42102,-0.0261379310826224,0.00554781471402217,-0.0370116479221059,-0.015264214243139,2.48483175546271e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39575,0.0448974151570174,0.00953219294284445,0.0262143169890423,0.0635805133249926,2.50653227546794e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,41919,0.0168676481349449,0.00358156798445415,0.0098477748854148,0.0238875213844751,2.50744321155075e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42201,0.0194757420979924,0.00413851647098398,0.0113642498148638,0.027587234381121,2.55148941401127e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,41973,0.029665622517692,0.00631398616091886,0.0172902096422911,0.042041035393093,2.64821203021452e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,41771,0.0277273295456027,0.00590355038529987,0.0161563707904149,0.0392982883007904,2.67041099563223e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,39895,0.0336780638644458,0.00717587868857444,0.01961334163484,0.0477427860940517,2.7208224855556e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41924,0.0117354646261392,0.00250191052904914,0.00683171998920292,0.0166392092630755,2.75109212483469e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,41995,0.0217144195927469,0.00463242131625376,0.0126348738128895,0.0307939653726043,2.79304518387048e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42185,0.0414364620355158,0.00884670432890438,0.0240969215508632,0.0587760025201684,2.84290735947789e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42032,0.0174230497851304,0.00372204545731811,0.0101278406887868,0.0247182588814739,2.8821115196199e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,42121,0.0178508239892666,0.00381902832472653,0.0103655284728027,0.0253361195057306,2.97981003554619e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42108,0.0140355843253355,0.00300433668946839,0.00814708441397745,0.0199240842366935,3.01488862223674e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,39526,0.020592083686391,0.00441229381147215,0.0119439878159055,0.0292401795568764,3.09294366014899e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,42048,0.0228961650806208,0.00490780750139815,0.0132768623778805,0.0325154677833612,3.11207845745004e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42175,0.0211524848203117,0.00454222288729419,0.0122497279612151,0.0300552416794083,3.24116655319652e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,41995,0.0270013496090488,0.00580129465707761,0.0156308120811767,0.0383718871369209,3.28095170715403e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,42236,0.015301944655501,0.00328874915822261,0.00885599630538464,0.0217478930056173,3.30512649956902e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,42121,-0.0171622230270594,0.0036925672300088,-0.0243996547978766,-0.00992479125624214,3.3870412598586e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,42048,0.0329462913656736,0.00708981077155428,0.0190502622534272,0.04684232047792,3.4000825559827e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42048,0.0284179147245583,0.00611635786320068,0.016429853312685,0.0404059761364316,3.41287796071889e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,41771,0.0378576390240838,0.00816360644984364,0.0218569703823903,0.0538583076657773,3.56269017942274e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42155,0.0242724297620097,0.00523880169210396,0.0140043784454859,0.0345404810785335,3.63404229515244e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,39868,0.0143700503303047,0.00310954773511183,0.00827533676948556,0.0204647638911239,3.85636371338394e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42050,0.0173406826724354,0.00376156870097378,0.00996800801852679,0.024713357326344,4.06452581293971e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39827,0.0136495328376968,0.00296090400111922,0.0078461609955031,0.0194529046798905,4.07267130036883e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42198,0.0166025955259887,0.0036064344434742,0.00953398401677923,0.0236712070351981,4.19002081403723e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39927,0.0131757820007497,0.00286451599366505,0.00756133065316624,0.0187902333483332,4.27782033519297e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,39426,0.0415294461580901,0.00902941853414253,0.0238317858311708,0.0592271064850095,4.28621018621147e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,41942,0.0252594326342447,0.00549637818328506,0.014486531395006,0.0360323338734834,4.35356737347008e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41771,0.0232162939556416,0.00505714892816348,0.0133042820564412,0.033128305854842,4.45662274343245e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,41995,-0.0667141251850064,0.0145410490441646,-0.0952145813115691,-0.0382136690584437,4.51604078268322e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,41817,0.0279754265734198,0.00610336860111266,0.016012824115239,0.0399380290316007,4.61216250103794e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39869,0.0199435393247803,0.00435388867421788,0.0114099175233132,0.0284771611262473,4.68556757131176e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,41995,0.0531300241117084,0.0116005698419311,0.0303929072215234,0.0758671410018933,4.69279844116053e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,42072,0.0569364424381304,0.0124348026975927,0.0325642291508488,0.081308655725412,4.71843426411429e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42108,0.0170432994038082,0.00372256033919639,0.00974708113898326,0.0243395176686331,4.72770921931913e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39575,0.0191618148855697,0.00419951633219895,0.0109307628744598,0.0273928668966797,5.10084582551981e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39512,0.0273495752536888,0.00599768924256554,0.0155941043382604,0.0391050461691173,5.17059610657276e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42145,0.0329836841426633,0.00723477932877427,0.0188035166582657,0.0471638516270608,5.18367692284061e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41842,0.0458683855448997,0.010068183021949,0.0261347468218796,0.0656020242679198,5.26588175623868e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,41943,0.0194410586515979,0.00426791198061953,0.0110759511695836,0.0278061661336122,5.28073956118838e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,39917,0.00955790265675113,0.00210329832663016,0.00543543793655601,0.0136803673769463,5.57035770955791e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,39597,0.0413070615801317,0.00909385706160125,0.0234831017393933,0.0591310214208702,5.62349647812189e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,39512,-0.0380823174802332,0.00838475519788646,-0.0545164376680906,-0.0216481972923757,5.63600501388797e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,39597,0.0131625976604128,0.00290120475995331,0.00747623633090429,0.0188489589899213,5.76804921515256e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41842,0.0262755983567004,0.00580331905999922,0.014901092999102,0.0376501037142989,6.01537169505442e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42072,-0.0212619475009509,0.00469688893067651,-0.0304678498050769,-0.012056045196825,6.03923390951694e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,41766,-0.0367019656551591,0.00811594005736663,-0.0526092081675977,-0.0207947231427205,6.17324661529251e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39868,0.0111898813437871,0.00247520255214406,0.00633848434158477,0.0160412783459895,6.22363358203752e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,42236,0.00782722737449468,0.00173204519251152,0.00443241879717211,0.0112220359518173,6.26351946315598e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,39590,0.0211843865791487,0.0046874558140445,0.0119969731836215,0.030371799974676,6.26692311829086e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,41919,0.0247445904354874,0.00547806226081563,0.0140075884042888,0.035481592466686,6.32510062499351e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,41995,0.0427108638863796,0.00945996001211306,0.024169342262638,0.0612523855101212,6.38841492300588e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,42174,0.0111424107940029,0.00247298388740583,0.00629536237468749,0.0159894592133183,6.6721313047318e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42029,0.0119169534707529,0.00264856017027679,0.00672577553701041,0.0171081314044954,6.87150949386435e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,39895,0.0223837820764139,0.00497519703547788,0.0126323958868773,0.0321351682659506,6.89315488620724e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,42174,0.0552797522085188,0.0122896280018382,0.031192081324916,0.0793674230921216,6.91382900091595e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39675,0.025567580180587,0.00568647305826835,0.014422092986381,0.036713067374793,6.98781412458871e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41828,0.0356025158308998,0.00792043107042439,0.020078470932868,0.0511265607289316,7.01534146365656e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42011,0.00976656138504352,0.00217307824482308,0.00550732802519027,0.0140257947448968,7.03689632415692e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42174,0.0273967228111571,0.00610525887441364,0.0154304154173064,0.0393630302050078,7.26913392041347e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,42095,0.0132935386113615,0.00296392161971175,0.00748425223672644,0.0191028249859965,7.34750908250158e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42026,0.0404050061245843,0.00902590696074669,0.0227142284815208,0.0580957837676478,7.64804601804367e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42174,0.0315133137000375,0.00704053283184591,0.0177138693496195,0.0453127580504555,7.66794282660993e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,41766,0.0143061226463174,0.00320043046882275,0.00803327892742482,0.02057896636521,7.88501070305311e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,41997,0.0129924486877426,0.00291208128184536,0.00728476937532568,0.0187001280001595,8.20251279750931e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,42072,0.0180985183370324,0.00406408884920446,0.0101329041925917,0.0260641324814732,8.52494832607603e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42019,0.025402331879782,0.00571296727740334,0.0142049160160715,0.0365997477434926,8.80085721614679e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,41995,0.0326140928466042,0.00733512553460601,0.0182372467987765,0.046990938894432,8.80688643373351e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41771,0.0247686735451314,0.0055732934447281,0.0138450183934643,0.0356923286967984,8.89515674610418e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39831,0.0219082421056725,0.00492960999550234,0.0122462065144879,0.0315702776968571,8.90589924242839e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,39872,0.0145552727492302,0.00327675816004255,0.00813282675554678,0.0209777187429136,8.99869040204708e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42108,0.0267393098050468,0.00602462658672916,0.0149310416950577,0.038547577915036,9.13756745223168e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39869,0.0241198664286494,0.00543534636646592,0.0134665875503762,0.0347731453069226,9.18332883631058e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PI3,Elafin,41894,0.0270852370235725,0.00610772610700599,0.0151140938538408,0.0390563801933042,9.29895191559335e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,42048,0.0415182495407283,0.00936983733953535,0.023153368355239,0.0598831307262176,9.45153378868223e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,41154,-0.0198606053382116,0.00448809769873532,-0.0286572768277328,-0.0110639338486903,9.71776189293388e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42236,0.0132099706299019,0.0029865415305566,0.00735634923001098,0.0190635920297929,9.80179775525193e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,42108,0.0161412771218164,0.00365283267478366,0.00898172507924041,0.0233008291643924,1.00005751714069e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,39597,0.0456550862518889,0.0103394896631537,0.0253896865121077,0.0659204859916701,1.01690250457402e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42048,0.0204884077239392,0.00464081944757452,0.0113924016066931,0.0295844138411852,1.01879706321158e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42108,0.0107918690698718,0.00244456770517129,0.00600051636773611,0.0155832217720076,1.01966760263298e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,39597,0.0216762415737191,0.00491297362764571,0.0120468132635335,0.0313056698839047,1.03375268707515e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42072,0.0137300404841144,0.00311667081562902,0.00762136568548155,0.0198387152827473,1.06426116123768e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAX,Protein max,41766,0.0506913390837046,0.0115412004277707,0.028070586245274,0.0733120919221352,1.13082095707855e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42142,0.0155912500678295,0.00355110540218472,0.00863108347954747,0.0225514166561116,1.13929613045662e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41766,0.0292475220202788,0.00667268050534178,0.016169068229809,0.0423259758107487,1.17868610726527e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,41943,0.0137094219939746,0.00313002410916281,0.00757457474001544,0.0198442692479337,1.19598679335868e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,42048,0.031473023112672,0.00718615540689854,0.0173881585151508,0.0455578877101931,1.1975533010383e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42047,0.0279366719018011,0.00638078622616576,0.0154303308985162,0.040443012905086,1.20540106332465e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42063,0.0265702221099632,0.0060689018503991,0.0146751744831809,0.0384652697367454,1.20624791366176e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41842,0.0342932045113813,0.00783297468191332,0.0189405741348312,0.0496458348879314,1.20660654238081e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41771,0.0269046540056006,0.00614980246101405,0.0148510411820131,0.0389582668291881,1.22432898743012e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42051,-0.0363815023484431,0.00832487370284045,-0.0526982548060104,-0.0200647498908758,1.25053890661287e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42222,0.0174415694005834,0.00399241629359372,0.00961643346513968,0.0252667053360271,1.25926766217906e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42155,0.00910859342976806,0.00208588179675114,0.00502026510813582,0.0131969217514003,1.27025078898029e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,42236,0.0146392771959711,0.00335461866421167,0.00806422461411619,0.0212143297778259,1.28693704705817e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42048,0.0283130198172215,0.00649035248864361,0.0155919289394801,0.041034110694963,1.29646555506927e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42222,0.0281974993060828,0.00646421692037155,0.0155276341421545,0.040867364470011,1.29772488557642e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42111,0.00962905061159688,0.00220765241767084,0.00530205187296203,0.0139560493502317,1.30029864895857e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41771,0.024727596620587,0.00567638001383762,0.0136018917934652,0.0358533014477087,1.33324783290864e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39590,0.0316654161610201,0.00726965148598248,0.0174168992484944,0.0459139330735457,1.33761376113027e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39675,0.0137541896720577,0.0031666097173291,0.00754763462609271,0.0199607447180228,1.41474390638107e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,41943,0.0265427343860396,0.00611400307836815,0.014559288352438,0.0385261804196412,1.42684535024979e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,39895,0.015268501664861,0.00352089197461837,0.00836755339460903,0.022169449935113,1.45995999360097e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,42016,0.0311154898999395,0.00718071307596728,0.0170412922710437,0.0451896875288354,1.48024560939511e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42056,0.027147576874824,0.00627816853929923,0.0148423665377975,0.0394527872118505,1.54241511372315e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39675,0.0299598226479807,0.00694110296440139,0.0163552608377539,0.0435643844582074,1.60051149997614e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,39917,-0.00999802299834714,0.0023193747870305,-0.0145439975809269,-0.00545204841576737,1.64149177074521e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39597,0.0158124176336664,0.00367441701746675,0.00861056027943161,0.0230142749879013,1.69666083148175e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,42124,0.0149805334523378,0.00348387283497633,0.00815214269578415,0.0218089242088914,1.72021857582668e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41771,0.026558012298773,0.00618454830284124,0.0144362976252042,0.0386797269723419,1.76537983352803e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39575,0.0332607838004936,0.00775087030946838,0.0180690779939356,0.0484524896070516,1.7920804980059e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39575,0.0245523124312412,0.00572393704795722,0.013333395817245,0.0357712290452373,1.80682111992283e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,39858,0.0123152823990669,0.00287324752377327,0.00668371725247132,0.0179468475456625,1.83276704795188e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,41995,0.0209244820269556,0.00488828573003482,0.0113434419960874,0.0305055220578239,1.8774060770877e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAT,Catalase,39765,0.0242803940840685,0.00567450845378413,0.0131583575146517,0.0354024306534854,1.89423853308695e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,39904,0.0188113388013568,0.00440011052639826,0.0101871221696162,0.0274355554330974,1.92535579613272e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41771,0.0138053748691143,0.00323283555956507,0.00746901717236673,0.0201417325658618,1.96524786184162e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39821,0.0226121872009038,0.0053006907962312,0.0122228332402907,0.033001541161517,2.00735290726185e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42070,0.0118807221189142,0.00278533784926879,0.00642145993434741,0.0173399843034811,2.00860075181756e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39597,0.0172996914660834,0.00405824771922152,0.00934552593640922,0.0252538569957576,2.03522179265974e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41657,0.057221381746741,0.0134566248853046,0.030846396971544,0.0835963665219379,2.13074074085282e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,39789,0.0454174769636015,0.0106846173975193,0.0244756268644638,0.0663593270627392,2.14798365520611e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39872,0.0227297299839586,0.00534788551642601,0.0122478743717636,0.0332115855961536,2.1527206805759e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41842,0.0199624264709821,0.00470335970505942,0.0107438414490656,0.0291810114928986,2.20779297442461e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39904,-0.017944626376092,0.00422782757218722,-0.0262311684175789,-0.00965808433460507,2.20920551445159e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39597,0.0171772780419632,0.00404861962780624,0.00924198357146299,0.0251125725124634,2.22607265026826e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,41755,0.0272730672686741,0.00643234653496675,0.0146656680601393,0.0398804664772089,2.25059076665577e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,39575,0.0245695574490379,0.00579503342521445,0.0132112919356176,0.0359278229624583,2.2558997339652e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,39904,0.0185718815191638,0.00438354700780963,0.00998012938385692,0.0271636336544707,2.28602036795446e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39575,0.031578084036227,0.00745383720475119,0.0169685631149147,0.0461876049575393,2.28897751129539e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41771,0.0145479117665454,0.0034346206518424,0.00781605528893432,0.0212797682441565,2.29421863500805e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,41995,0.0245040395369021,0.0057869500248464,0.0131616174882032,0.0358464615856011,2.3073121123683e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,41766,0.0332064922958386,0.00786222803986333,0.0177965253377064,0.0486164592539707,2.42103683901307e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39597,0.0141855938401662,0.00335924976834839,0.00760146429420339,0.0207697233861291,2.43178356635879e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39872,0.0305383610263085,0.00723832417327456,0.0163512456466903,0.0447254764059266,2.47327645529793e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39858,0.0364156921591355,0.00863272076902446,0.0194955594518476,0.0533358248664235,2.48041829306802e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,41995,0.0270676120162524,0.00641744066081696,0.0144894283210512,0.0396457957114536,2.48296810407143e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",39917,0.0075964426647424,0.00180228615873395,0.00406396179362386,0.0111289235358609,2.51837199827348e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39597,0.025310600355922,0.00600515839509669,0.0135404899015324,0.0370807108103115,2.51986164107451e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,39575,-0.0358671084554693,0.00852217203683472,-0.0525705656476653,-0.0191636512632732,2.58910112613131e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,41911,0.016041323841272,0.00381605485458042,0.00856185632629438,0.0235207913562496,2.64371075204717e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,41995,0.0187299167508741,0.00446140322273852,0.00998556643430657,0.0274742670674416,2.70768094630689e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39869,0.0111855527959408,0.00266562136036778,0.0059609349296199,0.0164101706622616,2.73478589522476e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,39825,0.0129555885748367,0.0030877456163975,0.00690360716669764,0.0190075699829759,2.73992001349227e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,41995,0.0168388401481013,0.00401873977545775,0.00896211018820415,0.0247155701079985,2.80644054597265e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,42190,0.00937067280229187,0.00223917238527016,0.00498189492716236,0.0137594506774214,2.87108146908195e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39580,0.0121681355628182,0.00290872690572489,0.00646703082759745,0.017869240298039,2.89516570970378e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,41919,0.0235332543788237,0.00563702163694544,0.0124846919704107,0.0345818167872368,3.00187112237938e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39675,0.0338822565463986,0.00812279144877967,0.0179615853067904,0.0498029277860068,3.05232870888269e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,41937,-0.0222105959214623,0.00533076334231237,-0.0326588920723945,-0.01176229977053,3.11268576217249e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42174,0.030788156035618,0.00740786938468807,0.0162687320416294,0.0453075800296066,3.25651885599253e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,42142,0.021754024283759,0.00523440921644835,0.0114945822195202,0.0320134663479977,3.25907559703901e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39512,0.0306416763923451,0.00737562059599125,0.0161854600242022,0.0450978927604879,3.28550247801764e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42012,-0.0286916381664804,0.00691345583425339,-0.042242011601617,-0.0151412647313437,3.34359262857279e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41842,0.0215863401793873,0.00520147673527803,0.0113914457782424,0.0317812345805322,3.34494366126314e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,42063,0.0203032460418777,0.00489234990615925,0.0107142402258056,0.0298922518579498,3.34521393306323e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,41943,0.0252707156704456,0.00609047213946195,0.0133333902771002,0.0372080410637911,3.35676719783718e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,39597,0.0133256947109511,0.00321153150198233,0.00703109296706572,0.0196202964548364,3.35963836494159e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,42172,0.0137872673460908,0.00332461175229467,0.00727102831159324,0.0203035063805883,3.3886349234086e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,42048,0.0278833735940283,0.00673049652886465,0.0146916003974536,0.041075146790603,3.45128256097703e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39869,0.0398106768091519,0.00962341462197057,0.0209487841500896,0.0586725694682142,3.54654010914457e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39904,-0.0155253826500554,0.00375356687075854,-0.0228823737167422,-0.00816839158336869,3.55708497270519e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41771,0.0195284015663425,0.00472423525619687,0.0102689004641966,0.0287879026684884,3.59235792965319e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42222,0.015777644899514,0.0038230568460957,0.0082844534811664,0.0232708363178615,3.69759510404444e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42236,0.0282942344077001,0.00686688479660671,0.0148351402063509,0.0417533286090492,3.80468127418587e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,39868,0.0208943267748533,0.00508226209933725,0.0109330930601523,0.0308555604895543,3.96355179557017e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39679,0.020469489735986,0.00498037707354317,0.0107079506718414,0.0302310288001306,3.98461313289154e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39512,0.0292927791298883,0.00713188520526992,0.0153142841275593,0.0432712741322174,4.03235390174229e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,39895,0.0440360496390685,0.0107219842900771,0.0230209604305175,0.0650511388476195,4.03515972681837e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39597,0.0138566226372641,0.00337537343524702,0.00724089070417992,0.0204723545703482,4.06863810308574e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41828,0.0342554684117939,0.00834888159785732,0.0178916604799935,0.0506192763435942,4.10269716550259e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39869,0.0533555168867465,0.0130089789312423,0.0278579181815115,0.0788531155919815,4.13476228424505e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,39904,0.0254576471806934,0.00620862096325681,0.0132887500927101,0.0376265442686768,4.15375626747103e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42032,0.0285005649616916,0.00695245944701527,0.0148737444455416,0.0421273854778415,4.167488108299e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41771,0.0251682610618501,0.00614709771197316,0.0131199495463827,0.0372165725773175,4.25914453383901e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39512,0.0304300520523132,0.00744126434264119,0.0158451739407365,0.04501493016389,4.35658432928869e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",41995,0.0307406916121446,0.00753128349310695,0.015979375965655,0.0455020072586342,4.49604082726805e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42174,0.0126072604249587,0.0030890233932704,0.00655277457414869,0.0186617462757687,4.50389774151731e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42070,-0.0225725870846788,0.00553521156667316,-0.0334216017553582,-0.0117235724139994,4.56861446834097e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,39886,0.0195040980132247,0.00478803571442115,0.0101195480129593,0.0288886480134902,4.6627009478256e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,39597,0.0157281687552056,0.00386112465794198,0.00816036442563932,0.0232959730847719,4.66431418947132e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42048,0.0321559277434243,0.0078961943282071,0.0166793868601384,0.0476324686267103,4.68113382862782e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41828,0.0192724960305433,0.0047359974548744,0.00998994101898943,0.0285550510420971,4.74155148981228e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39872,0.0257489859767957,0.00633523133042739,0.013331932569158,0.0381660393844334,4.84806564115369e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42149,0.0181211603411902,0.00446225195812685,0.00937514650326159,0.0268671741791188,4.91399897500499e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39843,0.0199479457146721,0.00491804404203227,0.0103085793922888,0.0295873120370553,5.0241598392364e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41771,0.0206995009705426,0.00510388462166901,0.0106958871120713,0.0307031148290139,5.02858851454369e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,42111,0.0168070467949553,0.00415333649892542,0.00866650725706147,0.0249475863328491,5.22478581630447e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,41967,0.0146346681709621,0.00361686229467897,0.00754561807339129,0.0217237182685329,5.23411333568391e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,41943,0.0230700522107988,0.00570573247589729,0.0118868165580401,0.0342532878635574,5.29977248737549e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39927,0.0635582188283383,0.015730640077239,0.0327261642769499,0.0943902733797267,5.37104314479819e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42236,0.0142361460916023,0.00352973705597916,0.00731786146188318,0.0211544307213215,5.532136364906e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39872,0.0500792096028215,0.0124186512866703,0.0257386530809478,0.0744197661246953,5.55311314691955e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42142,0.0156696400971254,0.0038862403504186,0.00805260901030497,0.0232866711839459,5.55877315810583e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",41981,0.0462125686121963,0.0114708352258957,0.0237297315694408,0.0686954056549518,5.63957944551433e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39597,0.015870207510399,0.00393910580911993,0.00814956012452394,0.0235908548962741,5.64189219413222e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,41741,-0.0266838908942609,0.00662372940878423,-0.039666400535478,-0.0137013812530438,5.6442579843404e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,42174,0.0119524898135979,0.00296732042462792,0.00613654178132719,0.0177684378458686,5.65496357444019e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41771,0.0169375566431188,0.00421071089281993,0.00868456329319173,0.0251905499930458,5.79067259849298e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,42213,0.0191707363480775,0.00476699756603008,0.00982742111865856,0.0285140515774965,5.81275012190336e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,42125,0.016363262048914,0.00407058441889231,0.00838491658788509,0.0243416075099429,5.85434549459374e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,41766,0.0198774079256973,0.00495143651980057,0.0101725923468882,0.0295822235045064,5.99089717727945e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39590,0.0536398878962773,0.0133671795899344,0.0274402159000058,0.0798395598925489,6.03993291035383e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41919,0.0391755760997235,0.00976630667996913,0.020033615006984,0.058317537192463,6.07154003488861e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42174,0.0103246130568676,0.00257582905400647,0.00527598811101492,0.0153732380027203,6.14925534297933e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39576,0.0169694455412475,0.00423413442242019,0.0086705420733039,0.025268349009191,6.16993037190979e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,41995,0.0370859162942766,0.00926027486482341,0.0189357775592227,0.0552360550293305,6.23945373290922e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,41972,0.0113131797822092,0.00282493452943033,0.00577630810452577,0.0168500514598927,6.24165946983313e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42149,0.0152999667795764,0.00382528475189868,0.00780240866585496,0.0227975248932978,6.37613624201023e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41906,0.0248663966361081,0.00622505419432315,0.0126652904152347,0.0370675028569815,6.51613402073416e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,42072,0.0204932326298586,0.00513292417547609,0.0104327012459255,0.0305537640137918,6.5725364204424e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,42114,0.0155848888798148,0.00390957803517865,0.0079221159308646,0.0232476618287649,6.74544253613243e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39575,0.0331292176845655,0.00831160697747805,0.0168384680087085,0.0494199673604224,6.76605539612695e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41766,0.0153064275541076,0.00384269503611655,0.00777474528331917,0.0228381098248961,6.83439940994149e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,41771,0.0169808380826542,0.00426462190713939,0.00862217914466098,0.0253394970206474,6.8764933748897e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,39845,0.0140537646635438,0.00353378734182553,0.00712754147356573,0.0209799878535218,7.0236318157801e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,39917,0.0129956194188717,0.00327253733529962,0.00658144624168443,0.0194097925960589,7.19800508515751e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,42063,0.0233236563810567,0.00587433448541542,0.0118099607896425,0.034837351972471,7.21147637508448e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,39429,0.0303821735025693,0.00765156260870896,0.0153851107894998,0.0453792362156389,7.2120661841655e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39854,0.037708433099359,0.00950894200612048,0.0190709067673628,0.0563459594313551,7.36722039702609e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42050,-0.0408514354831325,0.0103144870424535,-0.0610678300863414,-0.0206350408799236,7.51507099271504e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,42074,0.0267235380248272,0.0067557760550539,0.0134822169569216,0.0399648590927329,7.67151761532354e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39696,0.023155475039069,0.00586239579695988,0.0116651792770276,0.0346457708011103,7.86900122925963e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42048,0.019051670283544,0.00482901385097601,0.00958680313563104,0.028516537431457,8.01214473620719e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42236,0.0148800706622066,0.00377189536866149,0.0074871557396301,0.0222729855847831,8.02046382145036e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39597,0.0386977458400957,0.00981078329732313,0.0194686105773423,0.057926881102849,8.04935921895057e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,39868,-0.0559189582539793,0.0141829483295121,-0.083717536979823,-0.0281203795281355,8.10604318368424e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39895,0.0146649483480336,0.00372020556626133,0.00737334543816141,0.0219565512579058,8.13015828570737e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39597,0.00872713233664928,0.00221401789976678,0.00438765725310639,0.0130666074201922,8.13860483680506e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,42174,0.0252408691131112,0.00641008198152947,0.0126771084293135,0.037804629796909,8.26832887365676e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39597,0.0274539859824928,0.00697341156187477,0.0137860993212182,0.0411218726437673,8.30318616848578e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39868,0.0273523833199413,0.00694841164067257,0.013733496504223,0.0409712701356595,8.31777514725601e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,41995,0.0539957244497396,0.0137186292352727,0.0271072111486051,0.0808842377508741,8.32899460450285e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42044,0.0207459729662736,0.00527605684402251,0.0104049015519895,0.0310870443805578,8.46301752065536e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,39675,0.0193431691867296,0.00492619527128197,0.00968782645501695,0.0289985119184423,8.66793453073341e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,41924,0.0268504564630881,0.0068389341707354,0.0134461454884467,0.0402547674377295,8.67626515455833e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39869,0.0210356619719619,0.00535797924513444,0.0105340226514984,0.0315373012924254,8.68684231370872e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,39590,0.0195011376526135,0.00497249377492474,0.00975504985376104,0.029247225451466,8.84233744995074e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39597,0.0171973149815749,0.00439595890866455,0.00858123552059238,0.0258133944425574,9.20577233537858e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39575,0.0207273595982717,0.00530704545389608,0.0103255505086354,0.031129168687908,9.45431704711102e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,41995,0.0156018762315142,0.00399783518473155,0.00776611926944041,0.0234376331935881,9.56380818204757e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,39872,0.0326057041070181,0.00836164624336927,0.0162168774700143,0.0489945307440218,9.69762322905902e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,39927,0.0309595339324206,0.00793986477079524,0.0153973989816619,0.0465216688831793,9.70470971178739e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,41958,0.0121552018916959,0.00311941771641468,0.00604114316752318,0.0182692606158687,9.80182993270293e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39868,0.0299968544117019,0.0077002036336291,0.0149044552897889,0.045089253533615,9.85252554448768e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,42063,0.021437677785193,0.005507656633558,0.0106426707834193,0.0322326847869667,9.97602002675745e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,41968,0.0167815536347308,0.00431216861838947,0.00832970314268748,0.0252334041267742,0.000100038096420377
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,39927,0.0101934949809171,0.00262030584883533,0.00505769551719981,0.0153292944446343,0.000100737544734712
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39858,0.0234080860595168,0.00601774697591335,0.0116133019867267,0.035202870132307,0.000100886530642505
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39575,0.0385837201348835,0.00992039999854437,0.0191397361377365,0.0580277041320304,0.000101113865258585
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39869,0.0211938803942297,0.00546251300309065,0.0104873549081721,0.0319004058802874,0.000105104027940236
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41771,0.0190793107254942,0.00491827390189954,0.00943949387777111,0.0287191275732173,0.000105280351553278
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,42108,-0.0162130447477822,0.00418496847939179,-0.0244155829673901,-0.00801050652817425,0.000107518484874064
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,39512,0.0293797364162439,0.00758727368892688,0.0145086799859472,0.0442507928465406,0.000108469415426087
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39597,0.0117120666501376,0.00302624897715037,0.00578061865492285,0.0176435146453523,0.000109392554655166
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,41995,0.0316106787306727,0.00817037934269164,0.0155967352189971,0.0476246222423483,0.000109828841411664
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39872,0.0328464293033119,0.00850413753475831,0.0161783197351856,0.0495145388714381,0.00011290400824681
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39869,0.043501146854446,0.011278305752818,0.0213956675789228,0.0656066261299693,0.000115395934579941
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39579,0.0356087248730125,0.00924486789427389,0.0174887838002357,0.0537286659457893,0.000117953490486281
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42063,0.0178537408290876,0.00463769106415482,0.00876386634334418,0.0269436153148311,0.000118807231358879
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42048,0.0203344562189349,0.0052841377326225,0.00997754626299478,0.030691366174875,0.000119535506599075
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,41828,0.016264618740633,0.00423243352608767,0.00796904902950118,0.0245601884517648,0.000122181007830462
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,42111,-0.02778450312768,0.00723082219213766,-0.0419569146242698,-0.0136120916310902,0.000122339911043519
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39742,0.0233395294044537,0.00607969743463728,0.0114233224325646,0.0352557363763427,0.00012425538422161
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39868,0.0287522520008908,0.00749440061813982,0.0140632267893368,0.0434412772124449,0.000125482159157742
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39869,0.00893795627375889,0.00233143971174139,0.00436833443874576,0.013507578108772,0.000126935406294829
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42222,0.0102621229328531,0.00267769391022083,0.00501384286882024,0.0155104029968859,0.000127444483475747
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,39512,0.0203459932114978,0.00531419323234971,0.00993017447609241,0.0307618119469033,0.000129587499144126
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,39874,0.0134124736475752,0.00350673440913098,0.00653927420567847,0.0202856730894719,0.000131596556667181
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41766,0.0276198700582276,0.00722187461529082,0.0134649958122576,0.0417747443041976,0.000131656233170901
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,39640,0.0270060367166628,0.00706749032364124,0.0131537556823259,0.0408583177509996,0.000133552044373668
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39858,0.0216173039516898,0.00565955572147771,0.0105245747375935,0.0327100331657861,0.000134379860170654
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39798,0.0114389824918236,0.00299632823593646,0.0055661791493881,0.017311785834259,0.000135445745541091
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39575,0.0130300540952825,0.00341355752415766,0.00633948134793346,0.0197206268426315,0.000135745161775975
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,41771,0.0184239272632826,0.00483169479471654,0.00895380546563816,0.027894049060927,0.000137838168679477
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39872,0.0120608664240853,0.00316601164836383,0.00585548359329224,0.0182662492548785,0.000139997368362978
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,42226,0.0140177759636257,0.00368145674022603,0.00680212075278272,0.0212334311744688,0.000140896683780483
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,39868,0.0165350425013417,0.00434380438095314,0.00802118591467355,0.0250488990880099,0.000141647584238632
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,42124,-0.00756987718441947,0.00198969424607918,-0.0114696779067347,-0.00367007646210428,0.00014269178965154
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,39927,0.00941509179273403,0.00247564256845255,0.00456283235856703,0.014267351226901,0.00014365271851264
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C5,Complement C5,39917,0.00618404661999512,0.00162638033960143,0.00299634115437632,0.00937175208561391,0.000144090165999192
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,42072,0.023302939704325,0.00613236466542052,0.0112835049601007,0.0353223744485492,0.000145337169984097
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42222,0.0194776441107312,0.00512839463995939,0.00942599061641084,0.0295292976050516,0.000146501683766762
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39858,0.0167507611480596,0.00442759702956805,0.00807267097010625,0.025428851326013,0.000155587914891877
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,42056,0.0156405217364045,0.00414213053771671,0.00752194588247971,0.0237590975903292,0.000160077767451678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39869,0.0597796703033773,0.0158334922884374,0.0287460254180401,0.0908133151887145,0.000160494026875912
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,41986,0.0227151703348955,0.00603311489017242,0.0108902651501575,0.0345400755196334,0.000167206748613876
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41842,-0.0251721277348524,0.00669606519826874,-0.0382964155234591,-0.0120478399462456,0.000171161678863824
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42048,0.02520328927238,0.00670757908010241,0.0120564342753792,0.0383501442693807,0.000172389502128798
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39889,0.01938038912063,0.00515879126161207,0.00926915824787037,0.0294916199933897,0.000172986873635522
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,42072,0.027788444681974,0.00739787671192037,0.0132886063266101,0.0422882830373379,0.000173189017391189
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39675,0.0342092099712151,0.00912484908839463,0.0163245057579616,0.0520939141844686,0.000178432734633921
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,42029,0.0270203265018423,0.00721072688146644,0.012887301814168,0.0411533511895165,0.000179539499112229
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39512,0.0193505592184051,0.0051647400701483,0.0092276686809144,0.0294734497558957,0.000180123294484332
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42187,0.0136336874159062,0.00364117258021564,0.00649698915868357,0.0207703856731289,0.000181635004885717
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,39869,0.0124925898902222,0.00333661519092916,0.00595282411600102,0.0190323556644433,0.000181949140245696
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,42118,-0.0134328822824149,0.00358886562168437,-0.0204670589009163,-0.00639870566391353,0.000182638387338435
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39869,0.0174645899008948,0.00467715453279099,0.00829736701662448,0.0266318127851652,0.000189375550343258
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42174,0.0206402886480962,0.00553547681338622,0.00979075409385919,0.0314898232023332,0.000193231137488415
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42187,0.0252446554449651,0.006770864688606,0.0119737606552974,0.0385155502346329,0.000193463406653106
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,42149,0.0281730071763798,0.00756173849341449,0.0133519997292874,0.0429940146234722,0.000195540630362245
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39850,0.0162445650123774,0.00436167660480613,0.00769567886695736,0.0247934511577974,0.000196748266567531
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42108,0.0170534429039865,0.00457994661835355,0.00807674753201349,0.0260301382759594,0.00019727651704969
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41771,0.015799062363801,0.00424412874006658,0.00748057003327047,0.0241175546943315,0.000198027302980622
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,42048,-0.0178858625888747,0.0048070005548935,-0.027307583676466,-0.00846414150128346,0.000199405417840761
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39675,0.0085890236781223,0.00230837175309198,0.00406461504206202,0.0131134323141826,0.000199563206124773
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39858,0.0287004829705687,0.00771672825564667,0.0135756955895013,0.0438252703516362,0.000200781561770983
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39895,0.029286031558092,0.00787543539301923,0.0138501781877743,0.0447218849284097,0.000201255065436678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,39575,0.012503859991513,0.00336672904905179,0.0059050710553715,0.0191026489276545,0.000205061274124396
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,42200,0.0216568954668047,0.0058398488662899,0.0102107916888765,0.0331029992447329,0.000209345726776683
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,42225,0.0178745101709206,0.00482008140152489,0.00842715062393181,0.0273218697179094,0.000209448694609703
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,41943,0.0244298417766229,0.0065904938592192,0.0115124738125533,0.0373472097406926,0.000210718719053812
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41842,0.0263757514205254,0.00712080197981138,0.0124189795400951,0.0403325233009557,0.000213053577199915
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42174,0.0187441961162195,0.00506147072644145,0.00882371349239424,0.0286646787400447,0.000213647782683568
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41771,0.024394112464695,0.00658911724887232,0.0114794426569053,0.0373087822724848,0.000214625119041824
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42149,0.0235706173459254,0.00636976452777328,0.0110858788714898,0.036055355820361,0.0002161199672669
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39845,0.0153425409093206,0.00415343336624062,0.00720181151148901,0.0234832703071522,0.000221850987689001
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39869,0.0458462225192583,0.0124325262441258,0.0214784710807717,0.0702139739577449,0.000227440181099834
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41766,0.0213681507122468,0.00580196167795372,0.00999630582345753,0.0327399956010361,0.000231501906641222
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39512,-0.0290127848362916,0.00788943057344661,-0.044476068760247,-0.0135495009123363,0.000236732453924343
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42030,0.0448978690677916,0.0122129343176959,0.0209605178051076,0.0688352203304756,0.000237604618534381
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,39895,0.0363659461955011,0.00989402401058777,0.0169736591347491,0.0557582332562531,0.000238439876493758
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39872,0.0336609749497684,0.0091725628032441,0.0156827518554099,0.0516391980441268,0.000243911695521533
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39590,0.0220500070233431,0.00601138223800306,0.0102676978368571,0.0338323162098291,0.000245568802686155
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39597,0.0116718476565003,0.00318381767738215,0.00543156500883134,0.0179121303041694,0.000247542965183614
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39575,0.0224790454182388,0.00613358166734789,0.010457225350237,0.0345008654862407,0.000248588861888339
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42088,0.0197387590613486,0.00539228136229428,0.00916988759125178,0.0303076305314454,0.000252627402977666
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39575,0.0243024164326874,0.0066433886894126,0.0112813746014387,0.0373234582639361,0.000255246182923493
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,39575,0.0235747640854906,0.00645978280585054,0.0109135897860235,0.0362359383849576,0.000264004479645004
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42072,0.0111999884448215,0.00307153161558168,0.00517978647828136,0.0172201904113616,0.000266956829924219
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,39872,0.00894511567105963,0.00245449067842734,0.00413431394134205,0.0137559174007772,0.000269233789177154
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39675,0.0498910105941345,0.0137149862379298,0.0230096375677922,0.0767723836204768,0.000276332922311376
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42016,0.0102476379970194,0.00282071848477636,0.00471902976685773,0.0157762462271811,0.000281202782185049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,39872,0.0174457713309847,0.00480344538149273,0.00803101838325892,0.0268605242787104,0.000282559030224575
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,39575,0.0288022280929423,0.00795618464136797,0.013208106195861,0.0443963499900235,0.000295808636776437
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,42037,0.0116120254843356,0.00320869791752716,0.00532297756598239,0.0179010734026888,0.00029691968052859
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,41842,0.0200336096582055,0.005542725371524,0.00916986793001843,0.0308973513863925,0.000302163907957684
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39575,0.0108289148630238,0.00299600153430383,0.00495675185578833,0.0167010778702594,0.000302326349564905
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39858,0.033746981918843,0.00935333908014894,0.0154144373217511,0.0520795265159349,0.00030988662738195
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39895,0.0150680545816205,0.0041784052842098,0.00687838022456933,0.0232577289386717,0.000312085131911738
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39536,0.0162712212941577,0.00451590449629047,0.00742004848142841,0.0251223941068871,0.00031584949893271
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,39868,0.0211902495103301,0.00588340997788059,0.00965876595368411,0.032721733066976,0.000317508888268657
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41771,0.0259357962077061,0.00720484890110283,0.0118142923615446,0.0400573000538677,0.000319668792380745
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39904,0.0238981591787274,0.00664014595022232,0.0108834731162916,0.0369128452411631,0.000320758311119346
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41771,0.0226873716420624,0.00630746701589935,0.0103247362908997,0.0350500069932252,0.000323202653779626
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39512,0.0173463236326086,0.00482407999443211,0.00789112684352172,0.0268015204216956,0.000324850687350042
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39512,0.0146978179757082,0.00409058914427577,0.00668026325292766,0.0227153726984887,0.000328229722272542
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42050,0.0155177483457065,0.00431939455007429,0.00705173502756088,0.0239837616638521,0.000328595104363406
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,39458,0.0171110362742715,0.00477578997836615,0.00775048791667386,0.0264715846318692,0.000341326989662872
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39872,0.0304179618289924,0.00851118082250621,0.0137360474168802,0.0470998762411046,0.000353195756614503
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42072,0.0143531034362009,0.00401637688510663,0.00648100474139193,0.0222252021310099,0.000353276548064137
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,41681,0.0291957545944683,0.00817063347541786,0.0131813129826493,0.0452101962062873,0.00035383949095607
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,41989,0.0125169833976779,0.0035038228336499,0.00564949064372408,0.0193844761516317,0.000354994636317379
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,39872,0.0214175397927888,0.0059957371613797,0.00966589495648463,0.033169184629093,0.000355568805108745
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,39597,0.0127782147067106,0.00357739078084269,0.00576652877625891,0.0197899006371623,0.000355864719492065
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,41828,0.0207581599207764,0.00581571036445536,0.00935936760644386,0.0321569522351089,0.000359169923468184
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39453,0.0206074250508939,0.00577445814154403,0.0092894870934676,0.0319253630083202,0.000360277348796166
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39696,0.0134788494646578,0.00377916319925483,0.00607168959411835,0.0208860093351973,0.000363134300925999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,39597,0.0109848322704032,0.00307990086025267,0.004948226584308,0.0170214379564985,0.000363153520140645
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,41943,0.0282009910164935,0.00790810095816774,0.0127011131384847,0.0437008688945023,0.000363616475434087
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,39868,0.00868302549032677,0.00243492976455206,0.00391056315180474,0.0134554878288488,0.000363935968684209
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39895,0.0103622174715372,0.00290758345773283,0.00466335389438081,0.0160610810486935,0.000366949754418393
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,39858,0.0201309836168549,0.0056562519838878,0.00904472972843485,0.031217237505275,0.000373706152405201
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,42048,0.0328833613917726,0.00924233024619042,0.0147683941092394,0.0509983286743058,0.000375106867042916
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42174,0.013403039846616,0.00376921905989509,0.00601537048922161,0.0207907092040104,0.00037794111837022
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41771,0.0263325203840217,0.00741572659404264,0.0117976962596981,0.0408673445083453,0.000385252384198663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,39858,0.0153901001043564,0.00433757241697017,0.00688845816709491,0.023891742041618,0.000389614133805049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39872,0.0295221235264136,0.0083237135132015,0.0132076450405387,0.0458366020122886,0.000391599138535864
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,42063,0.0293196052030255,0.00826941046074686,0.0131115606999617,0.0455276497060894,0.000393124931783708
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39869,0.0216457932365542,0.00611114371012762,0.00966795156470406,0.0336236349084043,0.000398679753561848
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39845,0.042226260680866,0.0119504963502045,0.0188032878344652,0.0656492335272669,0.000411848271049661
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,42063,0.0103884703704798,0.00294256727459472,0.00462103851227416,0.0161559022286854,0.000416301234017068
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,39868,0.0233671024661583,0.00662100726435493,0.0103899282280226,0.0363442767042939,0.000418421492510523
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,39590,0.0268235445800873,0.00760425081267288,0.0119192129872484,0.0417278761729261,0.000421309452420025
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42106,0.0221381133296866,0.00628167267392811,0.00982603488878753,0.0344501917705857,0.000426106422513521
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39869,0.0167217665164005,0.00474513039070028,0.00742131095062796,0.026022222082173,0.000426794102769061
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,39732,0.0124801377128266,0.00354495844789131,0.0055320191549596,0.0194282562706936,0.00043240490272263
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,42111,0.0138631764016698,0.00394164287079634,0.00613755637490895,0.0215887964284306,0.000437710944502402
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,42187,0.0239152029813534,0.00680589106092166,0.0105756565019469,0.0372547494607598,0.000443019387237933
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42072,-0.0292262882184945,0.00832106964201724,-0.0455355847168483,-0.0129169917201408,0.000445661497578643
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39868,-0.0242550707009363,0.0069066673286599,-0.0377921386651097,-0.0107180027367629,0.000446767159132736
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,42032,0.0266008195485638,0.00758485701611882,0.0117344997969709,0.0414671393001567,0.00045450571713268
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39675,0.0142087864233485,0.00405568377239677,0.00625964622945086,0.0221579266172462,0.000461127559376205
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39675,0.0266529501342967,0.00760821354696227,0.0117408515822507,0.0415650486863428,0.000461550562240845
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,41771,-0.0472047456833489,0.0134799305898544,-0.0736254096394636,-0.0207840817272342,0.000463563468109994
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,39675,0.0104778388947205,0.00299385487911277,0.00460988333165948,0.0163457944577815,0.000467469570228315
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39887,0.0149059047543443,0.00426188881197124,0.00655260268288067,0.0232592068258079,0.00047146906975931
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39850,0.026558882572218,0.00760374535632226,0.0116555416738263,0.0414622234706096,0.00047969744076829
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41747,0.0155021497147524,0.00444158994726419,0.00679663341811456,0.0242076660113902,0.000484195100790824
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41842,0.0137457682023648,0.00394508931491304,0.0060133931451352,0.0214781432595943,0.000495071297502216
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42027,0.00657528178215578,0.00188855325439056,0.00287371740355028,0.0102768461607613,0.000499918717579403
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,42112,0.0102525746485239,0.00295395141220287,0.00446282988060632,0.0160423194164416,0.000520530804529216
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39842,0.0214357988141482,0.00617705468835994,0.00932877162496272,0.0335428260033337,0.000521964468344947
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39597,0.0161434992993832,0.00465202122523816,0.00702553769791642,0.02526146090085,0.000522042651134197
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,39792,0.0161783599526196,0.00466413269171458,0.00703665987685903,0.0253200600283802,0.000524999859819366
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41766,0.0271897774855527,0.00783905931388359,0.0118252212303408,0.0425543337407645,0.000525045778842057
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,39597,0.00970948579385376,0.00280011018692647,0.00422126982747787,0.0151977017602296,0.000527260207218065
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39575,0.0387308062407208,0.0111738339587792,0.0168300916815136,0.0606315207999279,0.000529879385112321
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42124,0.0103862471458864,0.00300345726770915,0.00449947090117648,0.0162730233905963,0.000545679428763253
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,42236,-0.0189138361187459,0.00547988897136443,-0.0296544185026202,-0.00817325373487159,0.000559169642634247
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39675,0.0222904771132082,0.00646366726428868,0.0096216892752024,0.034959264951214,0.000565638194931502
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,42222,0.0139716744762106,0.00405541043339308,0.00602307002676021,0.0219202789256611,0.000572369877127188
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,39858,0.0123736027697989,0.00359330734602297,0.00533072037159388,0.0194164851680039,0.000576297918454043
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41929,0.0135719082473215,0.00394192262311752,0.00584573990601116,0.0212980765886318,0.000577137878895455
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39500,0.0113581290104006,0.00330278735065726,0.0048846658031124,0.0178315922176889,0.000586154416944919
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39850,0.0215270937480374,0.00626010441025838,0.00925728910393098,0.0337968983921438,0.000586469369862676
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39575,0.0162155579850854,0.00472033411140626,0.00696370312672909,0.0254674128434416,0.000594184346982
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39526,0.0279048957309409,0.00812719363174425,0.0119755962127222,0.0438341952491597,0.00059800523138163
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,42222,0.0113976104320989,0.00331981741915327,0.00489076829055848,0.0179044525736393,0.000598267374694284
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39590,0.0162370307069674,0.00473173482399755,0.0069628304519322,0.0255112309620026,0.000602423807243288
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,41766,0.0144899242123505,0.00422467749881759,0.00620955631466805,0.022770292110033,0.00060581221282338
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39575,0.0288315827601587,0.00840993961311584,0.0123481011184517,0.0453150644018658,0.000609661689091548
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,41995,0.00996353678290965,0.00290774063601618,0.00426436513631793,0.0156627084295014,0.000613122993054535
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41771,0.0186477076492592,0.00544685569593634,0.00797187048522393,0.0293235448132944,0.000619918239916808
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,39675,0.0275707045109946,0.00805536971763476,0.0117821798644305,0.0433592291575587,0.000622384012213143
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41771,0.0265475711577661,0.00777249713595156,0.011313476771301,0.0417816655442311,0.000638388580796461
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39597,0.0181309623358959,0.00530935781524447,0.00772462101801677,0.0285373036537751,0.000640343325090944
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,41995,0.0708305412648361,0.0207563442976987,0.0301481064413466,0.111512976088326,0.000645658205851681
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39590,0.0226285087640923,0.00664263551248995,0.00960894315961203,0.0356480743685726,0.000660237587175717
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39696,0.0390101570775123,0.0114559463641323,0.016556502203813,0.0614638119512116,0.000663420324735367
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39597,0.0164347364271013,0.00483150165360183,0.00696499318604168,0.0259044796681609,0.000672362115159951
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,41990,0.0167482063440229,0.00492983513448147,0.0070857294804392,0.0264106832076065,0.000682484339003346
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39901,0.00941589980685769,0.00277272396806055,0.00398136082945902,0.0148504387842564,0.000686382822600029
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39526,0.0177656757721273,0.00523531827264156,0.00750445195774988,0.0280268995865048,0.000692688526716754
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39858,0.0263876281742264,0.00778012153415446,0.0111385899672836,0.0416366663811691,0.000697062824238731
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39872,0.0281808326208461,0.00831020337260862,0.0118928340105332,0.044468831231159,0.000698486152548154
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39696,0.0189638827543588,0.00559272862015517,0.00800213465885463,0.0299256308498629,0.000699292929377783
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39858,-0.0146810006116364,0.00433041919023536,-0.0231686222244977,-0.00619337899877508,0.00070080746308316
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39858,0.0263232583706416,0.00776512195164427,0.0111036193454188,0.0415428973958644,0.000701492608136242
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,39590,0.0101499745199396,0.00299694925947805,0.00427595397136267,0.0160239950685166,0.000709688410303461
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39868,0.016632422716482,0.00491998037773761,0.00698926117611628,0.0262755842568477,0.000725767323996053
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,41576,-0.0224704738504504,0.00666140421670216,-0.0355268261151866,-0.00941412158571415,0.000745081102835768
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41771,0.0169385194818672,0.00502290401642344,0.0070936276096772,0.0267834113540571,0.000747696240684292
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,42074,0.0170703934919173,0.00506403071476561,0.0071448932909767,0.0269958936928579,0.000751307011550574
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41747,0.0172121120319692,0.00511138746279936,0.00719379260488246,0.0272304314590559,0.000760967675813201
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42108,0.01086566589423,0.00322723255983224,0.00454029007695884,0.0171910417115012,0.000762391692275066
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,41924,0.0167562361696645,0.0049886838560575,0.00697841581179179,0.0265340565275372,0.00078487204069786
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42048,0.0214274630119751,0.00638045632167391,0.00892176862149427,0.033933157402456,0.000786421740377256
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39575,0.0157211038717148,0.00468514740582303,0.00653821495630167,0.0249039927871279,0.000794846965680788
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39032,0.0205313546786619,0.00612304801954553,0.00853018056035262,0.0325325287969711,0.000801885212503333
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42111,0.0456042794668496,0.013613555506678,0.0189217106737607,0.0722868482599385,0.000810570778109533
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,39590,0.00812588704473365,0.0024275528898787,0.0033678833805714,0.0128838907088959,0.000818597814830002
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42142,0.0116640197879528,0.00348768500707704,0.00482815717408184,0.0184998824018238,0.000827011379307387
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,41943,0.0156032039656639,0.00466757866052949,0.00645474979102612,0.0247516581403017,0.000831386555940705
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39872,0.0166680218254726,0.0049891303127747,0.00688932641243415,0.026446717238511,0.000837884806844081
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,42070,0.0120489379004936,0.00361312272115939,0.00496721736702117,0.019130658433966,0.000856000626929818
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDK,Midkine,42056,0.0185678046209514,0.00556970100488843,0.00765119065137011,0.0294844185905328,0.000859252496644786
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,39869,0.0284175158830326,0.00852885425707111,0.0117009615391732,0.045134070226892,0.000865245091177806
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39917,0.00696403152978875,0.00209179500505409,0.00286411331988273,0.0110639497396948,0.000873698881469301
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,39904,0.0179143310411626,0.00538424267638199,0.00736121539545393,0.0284674466868713,0.000880103789541095
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,41747,0.0172296790031268,0.00517886048860065,0.0070791124454695,0.0273802455607841,0.000880508747330772
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,41995,0.0171108003501678,0.00514485266363465,0.00702688912944391,0.0271947115708917,0.00088399106334563
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,41995,0.02053193121186,0.00617573225257634,0.00842749599681034,0.0326363664269096,0.000887784302740218
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39597,0.015949331574825,0.00480401494377871,0.00653346228501876,0.0253652008646313,0.000903101874039286
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41890,-0.042263628018932,0.012760207406148,-0.0672736345349822,-0.0172536215028819,0.000928313311992655
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41771,0.0108429610376701,0.00327609591446551,0.00442181304531775,0.0172641090300225,0.000936400034382332
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39872,0.0124372718649916,0.00376565742624173,0.00505658330955783,0.0198179604204254,0.000960173585758861
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42072,-0.0121516790907014,0.00368075461295834,-0.0193659581320998,-0.00493740004930311,0.000964504655004232
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),39713,-0.0650681693985275,0.0197368270669206,-0.103752350449692,-0.026383988347363,0.000981034518134904
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39597,0.0122683519815527,0.00372593922137877,0.00496551110765027,0.019571192855455,0.000995479741057472
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LXN,Latexin,41889,0.0244920701988898,0.00743871619835592,0.0099121864501122,0.0390719539476674,0.000995554745795441
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41771,0.0208101556859526,0.00632059803848511,0.0084217835305218,0.0331985278413834,0.000995855556434674
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,42155,-0.0247836162072552,0.00753043026600004,-0.0395432595286153,-0.0100239728858952,0.00100041153762489
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,42063,-0.0138069387351601,0.00419675808290618,-0.0220325845776562,-0.00558129289266393,0.00100478390850118
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,41794,0.0266231651210184,0.00809864907056962,0.0107498129427019,0.0424965172993348,0.00101396240991766
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42063,0.0131912122409989,0.00401642065360529,0.00531902775993254,0.0210633967220653,0.00102489607025151
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39869,0.0174597174125137,0.00531966905850092,0.00703316605785189,0.0278862687671755,0.00103348389206428
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42048,0.0294526159255009,0.00898101441537565,0.0118498276713646,0.0470554041796371,0.0010428106097721
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39858,0.0298559969691636,0.00910521950856341,0.0120097667323793,0.0477022272059479,0.00104492532185032
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,41828,-0.049921519461917,0.0152261849257893,-0.0797648419164641,-0.02007819700737,0.00104569614514505
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42111,0.0231231299457689,0.00705534334806475,0.00929465698356197,0.0369516029079758,0.00105035021936539
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,39696,-0.0119453518585343,0.00364686282446182,-0.0190932029944795,-0.00479750072258913,0.00105793223069411
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,39526,0.0148491157742313,0.00454169643226791,0.00594739076698618,0.0237508407814764,0.0010806776654781
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,41771,0.0228442680264391,0.00699182301217281,0.00914029492258042,0.0365482411302979,0.00108862826671226
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,41924,0.012665820253385,0.00387913831071559,0.00506270916438248,0.0202689313423876,0.00109697068295144
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39590,0.0191061259537191,0.00585273498640022,0.00763476538037466,0.0305774865270635,0.00110001295315771
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42111,0.0138250530106572,0.00424022916428182,0.00551420384866486,0.0221359021726496,0.00111511198688947
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39590,0.0247520517751702,0.00760405020435063,0.00984811337464293,0.0396559901756974,0.00113689778993953
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39868,0.0145763748570805,0.00447951851370514,0.00579651857021841,0.0233562311439426,0.00114125762873384
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41771,0.0188674667693518,0.00579922110548449,0.00750099340260222,0.0302339401361014,0.00114300718346572
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,42187,0.0143665308998651,0.00441791949742472,0.00570740868491264,0.0230256531148176,0.00114925154089136
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39696,0.0130793626768476,0.00402269056657971,0.00519488916635133,0.0209638361873438,0.00115182257119136
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39525,0.0121602795717097,0.00374179540109685,0.00482636058555982,0.0194941985578595,0.00115814661066326
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,41828,0.0298066131730255,0.00917668598593488,0.0118203086405931,0.0477929177054578,0.00116476204553517
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41828,0.0182052697065194,0.00560499035735185,0.0072194886061098,0.029191050806929,0.00116490011070494
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42048,-0.0171590033747723,0.00529085062806939,-0.0275290706057883,-0.00678893614375629,0.00118505784779428
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,41754,0.0198730760471216,0.00612842869006039,0.00786135581460325,0.03188479627964,0.00118669380468286
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,41842,0.0213118074683554,0.00657947709730856,0.00841603235763059,0.0342075825790801,0.00120188899753616
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41771,0.0111704229040293,0.00345105775305687,0.00440634970803787,0.0179344961000208,0.0012117215703677
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41766,0.0278172700649357,0.00860406781695836,0.0109532971436973,0.0446812429861741,0.00122783331877873
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41766,0.0299077829098639,0.00925894273187378,0.0117602551553913,0.0480553106643365,0.00124028579763179
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,39872,0.0121643000074988,0.00377009403399538,0.00477491570086784,0.0195536843141297,0.0012566142188782
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41771,0.0297546169761135,0.00925334708648521,0.0116180566866024,0.0478911772656245,0.00130508166450966
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42009,0.0118090286623012,0.00367358458514613,0.00460880287541477,0.0190092544491876,0.00130945160561064
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,42010,0.0147023555437657,0.00457467640776254,0.00573598978455108,0.0236687213029802,0.00131274700718942
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39590,0.0109023615140762,0.00339585169748924,0.00424649218699731,0.0175582308411551,0.00132888079744757
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42063,0.0123758427885553,0.00386025868871734,0.00480973575866928,0.0199419498184412,0.00134926051815657
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,42108,0.0148727162839226,0.00464165094223971,0.00577508043713275,0.0239703521307124,0.00135759157020946
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,39927,0.0185396314950882,0.00579400594519306,0.00718337984250979,0.0298958831476666,0.00137904352964877
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39575,0.0109063141244341,0.00341388244105069,0.00421510453997473,0.0175975237088934,0.00140374363145197
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41842,0.0228612358947941,0.00715780417802133,0.00883193970587228,0.0368905320837159,0.00140698432693391
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39639,0.0188313437320008,0.00589981168222572,0.00726771283483839,0.0303949746291632,0.00141758357789452
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,39927,-0.00935978751611774,0.00293371428685879,-0.015109867518361,-0.00360970751387451,0.00142452334551195
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,42003,0.00872169077172728,0.00273401229749898,0.00336302666862929,0.0140803548748253,0.00142565847771387
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41828,0.0178282403369378,0.00558882960133697,0.00687413431831729,0.0287823463555582,0.00142615848158462
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,39526,0.0189163496983977,0.00593040034414989,0.00729276502386394,0.0305399343729315,0.00142810122801631
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39872,0.0299582832021743,0.00940264742098341,0.0115290942570468,0.0483874721473017,0.00144570840744613
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39364,0.0374582169698789,0.0117665850684024,0.0143957102358101,0.0605207237039476,0.00145950476065679
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,42048,0.0190802023136057,0.00601419555209566,0.0072923790314982,0.0308680255957132,0.0015145796093408
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,39512,0.0135572182238036,0.00427376154031676,0.00518064560478278,0.0219337908428245,0.00151708976868148
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39895,0.0166516762282305,0.00525203915084208,0.00635767949257997,0.0269456729638809,0.00152574783957795
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,39904,0.0391639589157126,0.0123705935897112,0.0149175954798786,0.0634103223515466,0.00155018887942318
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,39869,-0.0260877826184417,0.00824317310555119,-0.042244401905322,-0.00993116333156136,0.00155616116014054
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42048,0.0388236541990783,0.0122706907713467,0.0147731002872387,0.0628742081109178,0.00155998719933968
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,42063,0.0219258731862407,0.00693034610191205,0.00834239482649311,0.0355093515459883,0.00156097561978986
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39849,-0.0296865433982862,0.0093849653627081,-0.0480810755091941,-0.0112920112873783,0.00156458944173356
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,39839,0.0155703307004776,0.00492459474374106,0.00591812500274511,0.0252225363982101,0.00157241669557744
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,39897,-0.00997528417111757,0.00315781217345833,-0.0161645960310959,-0.00378597231113924,0.0015877087154262
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39895,0.0248918985810078,0.00788118505235336,0.00944477587839526,0.0403390212836204,0.00159058122916551
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39869,0.0163636321386504,0.00518230685603556,0.00620631070082067,0.0265209535764801,0.00159495387150989
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,39872,0.00872642125926092,0.00277149880528318,0.00329428360090589,0.0141585589176159,0.00164466442740159
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,39590,0.0137191330396753,0.00435822995786994,0.00517700232225022,0.0222612637571004,0.00164905721972431
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,41828,0.0248857652604517,0.00791531955240803,0.00937173893773197,0.0403997915831714,0.00167023962890124
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,39564,0.0229114479886018,0.00728849005823015,0.00862600747447071,0.0371968885027329,0.00167379413310125
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39869,0.0262831110994504,0.008361300704596,0.00989496171844221,0.0426712604804585,0.00167417166298851
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,39868,0.0131719526520801,0.00419044277606273,0.00495868481099711,0.021385220493163,0.00167469670463592
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39674,0.0225343322021637,0.00717452068267339,0.00847227166412388,0.0365963927402036,0.0016888253540988
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42108,0.0271752484036441,0.00865285535172056,0.0102156519142718,0.0441348448930164,0.00168959768476135
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,39597,0.0173691503054647,0.00553701538010208,0.00651660016046466,0.0282217004504648,0.00171185722661295
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39597,0.0101570899974506,0.00323796621731715,0.00381067621150896,0.0165035037833922,0.00171210398837839
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41771,0.0184635316423681,0.00588741931322012,0.00692418978845668,0.0300028734962795,0.00171587994606899
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39575,0.0107618610415871,0.00343543857502038,0.00402840143454715,0.017495320648627,0.00173720107441808
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39512,0.0131003696354189,0.00418798756864807,0.00489191400086868,0.0213088252699691,0.00176413976511755
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39696,0.0242530747132537,0.00776537389236383,0.00903294188422056,0.0394732075422868,0.00179336169703261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,42032,0.00969056678812562,0.00310611833728753,0.00360257484704206,0.0157785587292092,0.00181337413854935
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,42091,-0.0287069300557249,0.00921682761424731,-0.0467719121796497,-0.0106419479318002,0.00184566875105875
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42174,0.0156897048777442,0.00504105184006293,0.00580924327122085,0.0255701664842675,0.0018596633042858
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,41757,0.0166410814046873,0.00534708548681191,0.00616079385053598,0.0271213689588387,0.00186110308106027
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42063,0.0179203048353714,0.00576147430938976,0.0066278151889675,0.0292127944817753,0.00187244726603361
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39895,0.0363392080346839,0.011683232406781,0.0134400725173932,0.0592383435519747,0.00187316609315125
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,41812,0.0299934295542661,0.00965050610757391,0.0110784375834213,0.048908421525111,0.00188780563596122
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,39895,0.0252799652612026,0.00813409558593856,0.00933713791276302,0.0412227926096422,0.00188888842714927
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,41924,0.0233554792668659,0.00752358818502075,0.00860924642422519,0.0381017121095065,0.00191129105485984
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,41842,0.0162705337710868,0.00524681881378862,0.00598676889606111,0.0265542986461125,0.00193254875285832
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39696,0.0249270074768511,0.00805802887940664,0.00913327087321405,0.0407207440804881,0.00198343847111139
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41736,0.0254054843554375,0.00821799791331478,0.00929820844534057,0.0415127602655345,0.00199602176807726
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39675,0.0292075504056362,0.00944919237188461,0.0106871333567423,0.04772796745453,0.00199971822964632
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41741,0.0246200660993774,0.00796643972453606,0.00900584423928674,0.0402342879594681,0.00200255718521605
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39895,0.0333715658776944,0.0107989518351297,0.0122056202808402,0.0545375114745485,0.00200467755367821
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,39758,0.0201882874055093,0.00654771950427568,0.00735475717712894,0.0330218176338896,0.00205249530014612
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41842,0.0198990597476731,0.0064541833203739,0.00724886043974026,0.032549259055606,0.00205259646764865
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42142,0.0106891086544028,0.00346835352476322,0.00389113574586684,0.0174870815629387,0.00206098864849538
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,39575,0.0098213252876288,0.00318775734282661,0.00357332089568865,0.0160693296795689,0.0020685099115756
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39904,0.010977462466479,0.00356969313071163,0.00398086393028416,0.0179740610026738,0.0021087485649969
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39512,0.0163024782696113,0.00530129367894981,0.0059119426588697,0.0266930138803529,0.00210889455747702
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39575,0.0145736499969248,0.00474693915069644,0.00526964926155977,0.0238776507322898,0.00214498956533805
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42048,0.0283478687517683,0.00924019122462375,0.0102370939515058,0.0464586435520308,0.00216006236740023
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41882,0.0199724415084313,0.00651303935244152,0.00720688437764595,0.0327379986392167,0.00216993087697327
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39869,0.0145007653045945,0.00472964688637447,0.00523065740730051,0.0237708732018884,0.00217507949008021
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41771,0.0160703376429971,0.00524539225182264,0.00578936882942475,0.0263513064565695,0.00219055496096628
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42111,0.0355334675892583,0.011601814660401,0.0127939108548723,0.0582730243236442,0.00219743919107033
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41766,0.012301314591197,0.0040191143838645,0.00442385039882263,0.0201787787835715,0.00221262765575909
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,41943,0.0315113909661455,0.0103020265468311,0.0113194189343566,0.0517033629979343,0.00222698224621468
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,39814,0.0241959776694274,0.0079127711116657,0.00868694629056263,0.0397050090482922,0.00223464791361479
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42016,0.0286779023047159,0.00937935471344122,0.0102943670663712,0.0470614375430607,0.00223589193120134
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42088,0.0233202688607567,0.00763354585317329,0.00835851898853706,0.0382820187329763,0.00225520859341891
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,39858,0.0133558302221428,0.00437256265170187,0.00478560742480717,0.0219260530194785,0.00225990906066565
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39575,0.0202520894136414,0.00663251082149114,0.00725236820351878,0.0332518106237641,0.0022676255498303
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41771,0.0209687439264884,0.00686886058867712,0.00750577717268127,0.0344317106802956,0.00227225557942633
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,39858,0.0159305214597366,0.0052208871093176,0.00569758272547407,0.0261634601939991,0.00228379166110933
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39575,0.0189699271815391,0.00622761233514637,0.00676380700465226,0.031176047358426,0.00232381345145547
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,42048,0.0157961059050586,0.00519283249284816,0.00561815421907623,0.025974057591041,0.00235538711262298
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,42063,0.00866054824947649,0.00284732668968499,0.0030797879376939,0.0142413085612591,0.0023574440970832
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39869,0.023812010943597,0.00783435960176671,0.00845666612413431,0.0391673557630598,0.00237567483011409
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39512,0.0141127883950314,0.004648618382379,0.00500149636556853,0.0232240804244942,0.00240376239755942
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41771,-0.0171791386274689,0.00566460630488857,-0.0282817669850505,-0.0060765102698873,0.00242835736481793
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,42077,0.0133021398904425,0.00438676514658315,0.00470408020313956,0.0219001995777455,0.00243131331481678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,41766,-0.0173744890748619,0.00573326397281121,-0.0286116864615719,-0.00613729168815193,0.00244646866181839
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39895,0.00977453616119199,0.00322729343487207,0.00344904102884273,0.0161000312935413,0.00246154950826968
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,41828,0.0146643149734629,0.00484438298594219,0.00516932432101617,0.0241593056259096,0.0024740717849514
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,39696,0.0545762401819072,0.0180293989064968,0.0192386183251735,0.0899138620386409,0.0024750393171099
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39872,0.0256255253126112,0.00847416826155048,0.00901615551997225,0.0422348951052501,0.00250052827406604
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,42048,0.0211517975745903,0.00700945306783307,0.00741326956163744,0.0348903255875431,0.00255253137852873
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42050,0.0129453172753394,0.00429022079880256,0.00453648450968639,0.0213541500409924,0.00255429103491095
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41771,0.0257815016473094,0.00854462242779811,0.00903404168882507,0.0425289616057937,0.00255542927892414
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39597,0.0263336066780273,0.00873301470176895,0.00921689786256019,0.0434503154934945,0.00257219196914142
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41771,0.0157734520378201,0.00523691144450907,0.00550910560658228,0.0260377984690578,0.00260045637495545
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39872,0.0215363342489889,0.00715350224826353,0.00751546984239234,0.0355571986555854,0.00261309312211166
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39597,0.0145096628896215,0.00482144417752499,0.00505963230167256,0.0239596934775705,0.00262355865626371
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,39675,0.0216861395819053,0.00721609930317404,0.00754258494768416,0.0358296942161264,0.00265961945804612
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39858,0.0115351855571737,0.00384242767848217,0.00400402730734864,0.0190663438069987,0.00268750599647059
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42072,0.00928092649098158,0.00309215413129067,0.00322030439365186,0.0153415485883113,0.00269194955188766
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,41995,0.0260886812042977,0.00869512044170044,0.00904624513856479,0.0431311172700305,0.00270137514509081
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,39575,0.00755327454106968,0.00252189102456796,0.00261036813291649,0.0124961809492229,0.00274981856888908
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42121,0.00768851084667688,0.00256824632968277,0.00265474804049865,0.0127222736528551,0.00276132102697411
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,42092,0.00685203523748634,0.00228901376036897,0.00236556826716315,0.0113385022078095,0.00276347504176599
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39597,0.00714224661639704,0.00238609247461797,0.00246550536614582,0.0118189878666483,0.00276608299052125
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,42222,0.0115567827544738,0.00386204445248052,0.00398717562761195,0.0191263898813356,0.00277289072377655
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,41766,0.0221521966251451,0.00740730366884107,0.00763388143421662,0.0366705118160736,0.00278955558806243
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39696,0.0128494399016488,0.00429702020912672,0.0044272802917604,0.0212715995115372,0.00279302301304772
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39773,0.00972095836310513,0.00325806279722684,0.00333515528054051,0.0161067614456697,0.00285436821295829
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39696,0.0216189070491853,0.00724831675867081,0.00741220620219053,0.0358256078961801,0.00286422553789006
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,39927,0.022575661994029,0.00758184452742569,0.00771524672027467,0.0374360772677834,0.00291134496597542
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42072,0.0202906088787803,0.00681489504752175,0.00693341458563764,0.0336478031719229,0.00291229888067412
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41924,0.0241000728920255,0.00810418718801183,0.00821586600352232,0.0399842797805287,0.00294682255719148
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C2,Complement C2,42124,0.00729254504740749,0.00245267170277025,0.0024853085099778,0.0120997815848372,0.0029512940744901
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41771,0.0153326086816523,0.00515727046806966,0.00522435856423581,0.0254408587990689,0.00295430021666057
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,42093,0.0104136902501936,0.00350282152710451,0.0035481600570688,0.0172792204433185,0.00295479823307414
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,42213,0.0189338648903511,0.00637814153391811,0.00643270748387158,0.0314350222968306,0.00299724445296816
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39675,0.0137987000943695,0.00464906981211536,0.00468652326262335,0.0229108769261155,0.00300330768284963
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41771,0.0157321288038923,0.00530069283811371,0.00534277084118945,0.0261214867665952,0.00300343800174976
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39538,0.0165122068283347,0.00556386398937686,0.00560703340915601,0.0274173802475133,0.00300629121757916
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,41995,0.0106554255537161,0.00359055525153177,0.00361793726071384,0.0176929138467184,0.00300639652079722
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,41924,0.0258409543442175,0.00871616794545663,0.00875726517112248,0.0429246435173125,0.00303499901090477
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41771,0.0158926476605156,0.00536276556990905,0.00538162714349381,0.0264036681775373,0.00304689175684452
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41842,0.00910150487222253,0.0030731435979424,0.00307814342025543,0.0151248663241896,0.00306561516531635
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42063,0.016052857887094,0.00543419513855479,0.0054018354155266,0.0267038803586614,0.00314180588684451
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39575,0.0310703547559068,0.0105195595725919,0.0104520179936268,0.0516886915181868,0.00314777924292572
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39869,0.0248579239757398,0.00842332309835571,0.00834821070296261,0.041367637248517,0.003173140370043
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39513,0.0202358993379994,0.00686373261803938,0.0067829834066422,0.0336888152693566,0.00320270781520424
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39917,0.00811135407188445,0.00275151952099224,0.00271837581073966,0.0135043323330292,0.00320537587937973
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42072,-0.0353320818297642,0.0119930842382792,-0.0588385269367914,-0.011825636722737,0.00322423750380356
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39869,0.0185059291111673,0.00628837836648721,0.00618070751285236,0.0308311507094822,0.00325839549919374
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,42222,0.0302982726210674,0.0102974450186888,0.0101152803844374,0.0504812648576974,0.00326322804988085
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39597,0.0289616260412903,0.00985309064497266,0.00964956837714389,0.0482736837054367,0.00329591459133862
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39872,0.0237506339192046,0.00808360590843094,0.00790676633867997,0.0395945014997293,0.00330874195591039
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,41842,0.0363321554978762,0.0123752216211025,0.0120767211205153,0.0605875898752372,0.00333175750864759
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41766,0.0187559036889114,0.00639096271167946,0.00622961677401964,0.0312821906038031,0.00334388666273077
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42198,0.00623631658693272,0.00212894248484544,0.00206358931663565,0.0104090438572298,0.00340287836652406
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,39597,0.0176911031387376,0.00603969019956695,0.00585331034758636,0.0295288959298888,0.00340598363653766
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41766,0.00885755361961611,0.00302765842506066,0.00292334310649722,0.014791764132735,0.00344439561774044
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39696,-0.00966259843532199,0.00330503037027452,-0.01614045796106,-0.00318473890958393,0.003467044876581
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42174,0.0197937840662788,0.00677386781556055,0.00651700314778012,0.0330705649847775,0.0034827548587294
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42222,0.0309878640699207,0.0106209929557314,0.0101707178766872,0.0518050102631542,0.0035330701749829
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39868,0.0284160590258102,0.0097400082239369,0.00932564290689386,0.0475064751447265,0.00353594878327028
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39575,0.00684133782489601,0.00234544922553184,0.0022442573428536,0.0114384183069384,0.00354295368329205
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42056,-0.0241429864558347,0.00828084969650711,-0.0403734518609887,-0.0079125210506808,0.00355681714644872
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39526,0.0233850320748599,0.00802203870046073,0.00766183622195685,0.0391082279277629,0.00356298608614673
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39872,0.0200397941020953,0.00687504318880907,0.00656470945202957,0.0335148787521611,0.00356547514175478
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,41702,0.020194921266731,0.0069321070729367,0.00660799140377511,0.033781851129687,0.00358299046312361
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,39872,0.00924209860441112,0.00318399420038076,0.00300146997166483,0.0154827272371574,0.00370708195586499
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,39512,-0.0175636164425869,0.00605126277714853,-0.029424091485798,-0.00570314139937577,0.00370972227868482
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39869,0.00931510671771455,0.00321139274169358,0.00302077694399513,0.015609436491434,0.00373117011699125
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42048,0.0245368760297425,0.00846891463470737,0.00793780334571611,0.041135948713769,0.00377012654896043
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,39858,-0.0122693350189768,0.0042364281304822,-0.0205727341547219,-0.00396593588323167,0.0037849791987538
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39675,0.0069287212305941,0.00239525885417431,0.00223401387641245,0.0116234285847758,0.00382712465251972
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41828,0.0106607413804297,0.00369358931467894,0.00342130632365898,0.0179001764372004,0.00390453080313321
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39868,0.0340632832505804,0.0118229928551809,0.0108902172544258,0.057236349246735,0.00397031534828928
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39597,0.0183108473411368,0.00636035747094858,0.00584454669807756,0.030777147984196,0.00399831568401144
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,39815,0.0147402744919852,0.00512315925015599,0.00469888236167943,0.0247816666222909,0.00401997954613195
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,42222,0.0141881182450382,0.00493479865380872,0.00451591288357306,0.0238603236065033,0.004045048694935
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39575,0.0179501098464019,0.00624387836455505,0.00571210825187401,0.0301881114409298,0.00405017879588821
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39895,0.0240554001365526,0.00836916651379769,0.00765183376950913,0.0404589665035961,0.00405694575536454
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,39575,0.0160676068906266,0.00559024105202465,0.0051107344286583,0.0270244793525949,0.00405799162267806
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39575,0.0160900182721794,0.00559843096120012,0.00511709358822721,0.0270629429561317,0.00406057994777875
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,42141,0.0183087059740151,0.00637316310880224,0.00581730628076276,0.0308001056672675,0.00407507481419492
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,42051,-0.0138973357200024,0.00484000979540632,-0.0233837549189988,-0.00441091652100604,0.00409367985451041
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",41943,0.0180763802124288,0.00629777645539339,0.00573273835985772,0.0304200220649998,0.00410753489129343
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42083,0.0298296349528022,0.0104072338364668,0.0094314566333273,0.0502278132722772,0.00416021476575787
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42070,0.0102403846661634,0.00357412396926236,0.00323510168640916,0.0172456676459176,0.00417462737224906
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41766,0.0120783482883908,0.00422142375746334,0.0038043577237627,0.020352338853019,0.00422702059191953
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39597,0.00762110628708623,0.00266377471697007,0.00240010784182489,0.0128421047323476,0.00423079773531675
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,42149,-0.0151152311334233,0.00528426982367326,-0.0254723999878229,-0.00475806227902372,0.00423727122907218
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,39479,0.0127809869818074,0.00447149872812036,0.00401684947469147,0.0215451244889233,0.00426695710921514
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39696,0.0138505981943017,0.00484968796504008,0.00434520978282315,0.0233559866057803,0.00429842518410302
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,39883,0.014769324820984,0.005172112273466,0.00463198476499067,0.0249066648769774,0.00430381469406618
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39858,0.0161019246353339,0.00564085686884091,0.00504584517240573,0.0271580040982621,0.00431809821169247
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,41724,0.0146815078208146,0.00514707886549802,0.00459323324443844,0.0247697823971907,0.00434587878510622
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,42175,0.0156699138092367,0.00550128102539033,0.00488740299947167,0.0264524246190018,0.00440040646835929
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,41995,0.0179902905960301,0.00632066370494149,0.00560178973434478,0.0303787914577154,0.00443024097902414
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,39869,0.0192307225943873,0.00676379923485337,0.00597367609407467,0.0324877690946999,0.00447456765380179
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39927,-0.0199179404393534,0.00701162894957037,-0.0336607331805113,-0.00617514769819543,0.00450948077505861
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,39575,0.0120396036574247,0.00424827169476442,0.00371299113568643,0.020366216179163,0.00460531828005181
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39848,0.0241192086222917,0.00851085818991936,0.00743792657004971,0.0408004906745336,0.00460607371315608
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,42187,0.00681063327232345,0.00240483294420978,0.00209716070167229,0.0115241058429746,0.00463170589303044
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,41809,0.0159454181531748,0.00563333020085559,0.00490409095949784,0.0269867453468518,0.0046538325262501
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,39696,0.0396240510709703,0.0140007916418368,0.0121824994529701,0.0670656026889705,0.004661278014891
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,41771,0.0273712163476854,0.00967208650423688,0.00841392679938114,0.0463285058959897,0.004663030804298
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39575,0.0103814857236739,0.00366937373350956,0.00318951320599516,0.0175734582413526,0.00467454610978636
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,41995,0.031476908902045,0.011138178624316,0.0096460787983857,0.0533077390057043,0.00471975290094407
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,41766,0.0152702430850358,0.00542553837981112,0.00463618786060599,0.0259042983094656,0.00489238406492139
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,39858,0.0137123510127938,0.00487740086355727,0.00415264532022159,0.0232720567053661,0.00494108628460672
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,39590,0.0199283395898369,0.00709361850867616,0.00602484731283166,0.0338318318668422,0.00497318785594928
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39500,0.0152903763089475,0.0054457121393303,0.00461678051586011,0.0259639721020349,0.0049972525947575
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,42072,0.0154970220812543,0.00552077938204704,0.00467629449244213,0.0263177496700665,0.00500715947916039
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,41995,0.00583290926763662,0.00207815012243917,0.00175973502765585,0.00990608350761739,0.00501117374019958
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39597,0.0157063875851577,0.00559880393734899,0.00473273186795369,0.0266800433023617,0.00503562792396277
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPART,Spartin,39675,0.0236801467045331,0.00845210925617029,0.00711401256243933,0.0402462808466269,0.00509247234154661
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,42046,0.0204303137102788,0.00729442468696746,0.00613324132382254,0.034727386096735,0.00510469463546678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,39597,0.0101055829288713,0.00360843425728651,0.00303305178458972,0.0171781140731528,0.00511054055896441
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39512,0.0111332899476073,0.00397643982340618,0.00333946789373123,0.0189271120014835,0.00512219792865432
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39869,0.0132821220257558,0.00474739684485366,0.0039772242098426,0.0225870198416689,0.00515441387731663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,41995,0.0162942192134422,0.00582909529987829,0.00486919242568073,0.0277192460012036,0.00519212484650798
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39597,0.0164135078128404,0.00587290676139349,0.00490261056050916,0.0279244050651716,0.00520243088984777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39872,0.0150120532350126,0.00537266420410267,0.00448163139497138,0.0255424750750538,0.00521234946966459
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,42072,0.011793365669822,0.00422475587015114,0.00351284416432576,0.0200738871753183,0.0052539770177154
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39519,0.0169111452863775,0.00605932498106349,0.00503486832349304,0.0287874222492619,0.00526482478867316
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,39917,0.0090604857835423,0.00324721903538081,0.00269593647419591,0.0154250350928887,0.00527588549085792
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,39597,0.0128926405535752,0.00462108261291123,0.00383531863226917,0.0219499624748812,0.00528051252254347
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,39597,0.00931094170344622,0.00334395460283025,0.00275679068189893,0.0158650927249935,0.00537167995543498
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39526,0.0151151040769497,0.0054346013487225,0.00446328543345355,0.0257669227204458,0.00542391303562068
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41766,0.0125835330661838,0.00452686827035018,0.00371087125629743,0.0214561948760701,0.00544790227317601
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39872,0.0220760229663738,0.00794248765275404,0.00650874716697592,0.0376432987657718,0.00545354212972309
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39927,-0.00818425501316478,0.00294477889132144,-0.0139560216401548,-0.00241248838617476,0.00545756167754278
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,42181,-0.00736453256290155,0.00265332920196392,-0.0125650577987508,-0.00216400732705226,0.00551784000857798
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',39512,0.0129794810548622,0.00467792096018241,0.00381075597290463,0.0221482061368197,0.00553592140947653
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,41771,0.0172123710540236,0.00620616486143017,0.00504828792562042,0.0293764541824267,0.00555466030851294
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,42187,0.0132775104625951,0.00478837626284544,0.00389229298741804,0.0226627279377722,0.00556412564985994
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39895,0.0274963945405296,0.00992098495708589,0.00805126402464127,0.046941525056418,0.00558833265213178
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39696,0.0262338514326767,0.00946548699588136,0.00768149692074923,0.0447862059446042,0.00558870096105032
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39512,0.0200099340165245,0.00722093709132065,0.00585689731753605,0.034162970715513,0.00559619591538392
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39597,0.0193487252886419,0.00698880941000758,0.00565065884502706,0.0330467917322568,0.00564041570739632
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42108,0.021657740043179,0.00782532318490858,0.00632010660075819,0.0369953734855998,0.00565392679321922
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,39858,0.00665805732466904,0.00240990098384913,0.00193465139632475,0.0113814632530133,0.00574021428653162
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42111,0.0089239338311969,0.00323039554737439,0.0025923585583431,0.0152555091040507,0.00574399541991527
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,39575,0.0262963368400979,0.00952630579433839,0.00762477748319469,0.0449678961970012,0.00578278995064297
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,42072,0.0228561330403908,0.00828721416987286,0.00661319326744001,0.0390990728133416,0.00582346667351632
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,39575,-0.0154515383371929,0.00560285108542359,-0.0264331264646231,-0.00446995020976264,0.00582881952818122
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39575,0.0187648587711191,0.00680579506155155,0.0054255004504781,0.0321042170917602,0.00583971306975528
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39526,0.00950121969172436,0.00344742308227163,0.00274427045047197,0.0162581689329767,0.00586036811351086
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,39500,0.022407818880741,0.00813925208922677,0.00645488478585655,0.0383607529756255,0.00591394871355751
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,39410,0.012592515693576,0.00457404187369073,0.00362739362114222,0.0215576377660099,0.00591434151581836
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39872,0.0139752174734431,0.00509418131614269,0.00399062209380345,0.0239598128530828,0.00609084841987636
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,39526,0.0142773915226496,0.00520432793671337,0.00407690876669138,0.0244778742786078,0.00609114842832533
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39696,0.0220631512592921,0.00804980746949695,0.00628552861907807,0.0378407738995061,0.00613823392796841
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,39895,0.00902950066238783,0.00329520900274764,0.00257089101700246,0.0154881103077732,0.00615000202509933
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39500,0.0191415813951558,0.00699208186274848,0.0054371009441688,0.0328460618461428,0.00619881333867544
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,41995,0.0252362203047251,0.00922669204849178,0.00715190388968123,0.043320536719769,0.00624373127372285
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39869,0.0149062848284551,0.0054520540225835,0.00422025894419141,0.0255923107127187,0.00626548816234139
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42187,-0.0109141091939845,0.00399882725951818,-0.0187518106226402,-0.00307640776532891,0.00635453344536733
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,42142,0.029774285221895,0.0109451889389744,0.00832171490150507,0.0512268555422849,0.0065304369461981
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,41943,0.0180634092708448,0.00664458602065326,0.00504002067036445,0.0310867978713252,0.00656603451669117
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,39904,0.012713716193718,0.00467752766234663,0.00354576197551857,0.0218816704119174,0.00657696289495509
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,39575,0.00878577344627669,0.00323327007567342,0.00244856409795678,0.0151229827945966,0.00659196268764054
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,39652,-0.0115603536639108,0.00426012321586359,-0.0199101951670034,-0.00321051216081812,0.00666557124216669
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39597,0.023136911074278,0.00853187890202172,0.00641442842631548,0.0398593937222406,0.00670191224819637
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39895,-0.00826719433434044,0.00305061903462394,-0.0142464076422034,-0.00228798102647752,0.00673836572905379
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,39597,0.0136730658998992,0.00504984065078196,0.00377537822436652,0.0235707535754318,0.00678716420121925
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39575,0.0154512669089607,0.00570678425786428,0.00426596976354675,0.0266365640543747,0.00678917193400418
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,41995,0.026154460952225,0.00967794126411058,0.00718569607456822,0.0451232258298817,0.00689106636209798
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42072,0.0169306785942886,0.00626859275061686,0.00464423680307959,0.0292171203854977,0.00692440186603249
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,41943,0.0204436807160729,0.00757049902284503,0.00560550263129661,0.0352818588008491,0.00693351282808031
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41766,0.02162944748684,0.00801310597930362,0.00592375976740491,0.0373351352062751,0.00695828102469056
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39734,0.00238790656749121,0.000885085998524756,0.000653138010382694,0.00412267512459974,0.00698757172000185
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42222,0.0193468719480209,0.00717382526990792,0.00528617441900141,0.0334075694770405,0.00700807444063692
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,41766,0.0180004830886534,0.00667883552475821,0.00490996546012729,0.0310910007171795,0.00704456614246511
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,41771,0.0281134542867131,0.0104421633863928,0.00764681404938326,0.048580094524043,0.00710504402042373
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,41842,0.0136408933669361,0.00506838491561501,0.00370685893233069,0.0235749278015415,0.00712488457178049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41828,0.016457103024876,0.00611676269847701,0.00446824813586102,0.0284459579138909,0.007143628229945
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,41766,0.0193455366130076,0.00719775280492282,0.00523794111535883,0.0334531321106563,0.00720323621556152
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39696,0.0205931766268229,0.00766177394550654,0.0055760996936301,0.0356102535600157,0.00720356886126351
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39872,0.0122478183038615,0.00456040569657579,0.00330942313857293,0.02118621346915,0.00724870491052991
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,39869,0.0181791333523459,0.00677017794856796,0.00490958457315274,0.0314486821315392,0.00725972912890515
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41766,0.0116584073830021,0.00434223865637819,0.00314761961650089,0.0201691951495034,0.00726458371335152
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39597,0.0118547886180886,0.00442052762232585,0.00319055447832996,0.0205190227578473,0.00733456153424377
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39868,0.0257135645476323,0.0095910597446989,0.00691508744802246,0.0445120416472422,0.0073510905275647
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,41766,0.0150104776420401,0.00560143663399857,0.0040316618394029,0.0259892934446773,0.00737677129847695
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39696,0.022970224328129,0.00857381375129383,0.0061655493755931,0.0397748992806649,0.00739261204930419
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39500,0.0140182605359335,0.00524125557906154,0.00374539960097293,0.0242911214708942,0.00749301736799754
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,41995,0.023973339072264,0.00897780077987551,0.006376849543708,0.04156982860082,0.00758770628487262
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39590,0.014688614910774,0.00550930331150703,0.00389038042022026,0.0254868494013278,0.00768383101218328
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,39872,0.0309388796732338,0.0116050384732146,0.00819300426573322,0.0536847550807344,0.00768721946044452
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41882,0.010198516121481,0.0038298420302763,0.00269202574213949,0.0177050065008226,0.00775620296945441
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39512,0.0127629692573358,0.00479578592900129,0.0033632288364933,0.0221627096781784,0.00779562369214506
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,42222,0.00978676610930963,0.00368755411319356,0.00255916004745025,0.017014372171169,0.00796363682796453
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39675,0.0239475618135319,0.00902906198311037,0.00625060032663559,0.0416445233004282,0.00800651759483106
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42072,0.00799566249239492,0.00301809711782496,0.00208019214145799,0.0139111328433319,0.0080767237837477
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,41943,0.0228036781428612,0.00861224148637539,0.00592368482956539,0.0396836714561569,0.00811075463336624
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42048,-0.0189512155497937,0.00716308670733675,-0.0329908654961737,-0.00491156560341367,0.00816224016396121
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,39575,0.0127636631642959,0.0048250511148209,0.00330656297924697,0.0222207633493449,0.00817370361270319
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39575,0.0152214281220224,0.00575916960240448,0.00393345570130959,0.0265094005427352,0.0082294161931744
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42222,0.00947999263657262,0.00358774637365355,0.00244800974421165,0.0165119755289336,0.00824330891306642
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,39590,0.0173788544812967,0.00658059099888082,0.00448089612349027,0.0302768128391031,0.00827966983047984
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39872,0.017099950893264,0.00647740205441633,0.00440424286660802,0.02979565891992,0.00830349759661283
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41747,0.0139132040988658,0.00527121251419093,0.00358162757105162,0.0242447806266801,0.00831339018735202
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39858,0.0101825731251253,0.00386122289650865,0.00261457624796835,0.0177505700022822,0.00837239510954099
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39590,0.0235033483329071,0.0089139784277042,0.00603195061460688,0.0409747460512073,0.00838384096241588
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,39590,0.0142546031354555,0.00540730813730613,0.00365627918633546,0.0248529270845755,0.00839646505139002
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,41828,0.0161565033775425,0.00613062920266466,0.00414047014031979,0.0281725366147652,0.00841425376195054
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39869,0.0293139346556523,0.0111343463996922,0.0074906157122557,0.051137253599049,0.00848125642861964
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,42010,0.008923191515878,0.00339279311338938,0.00227331701363482,0.0155730660181212,0.00854715990173137
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39904,0.0157168845295728,0.00597893551026314,0.0039981709294571,0.0274355981296886,0.00858254729664615
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39858,0.0131355242587103,0.00500198783966917,0.00333162809295876,0.0229394204244619,0.00864962727683424
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,41828,0.0173460279100535,0.00660630155708391,0.00439767685816901,0.0302943789619379,0.00865758395487471
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42149,0.020814337777502,0.00792995844478968,0.0052716192257142,0.0363570563292898,0.00868041677470403
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,42072,-0.0122176250990296,0.0046564162933602,-0.0213442010340156,-0.00309104916404357,0.00870462692502292
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41771,0.0220534080407065,0.00840553635262245,0.00557855678956654,0.0385282592918466,0.00870866515403026
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,41995,0.0390698851795787,0.0149039694313767,0.00985810509408032,0.0682816652650772,0.00876577224600801
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39858,0.010000258966494,0.00381708413943755,0.00251877405319642,0.0174817438797916,0.00880816831107969
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,41747,0.0100408799233577,0.00384044850434551,0.00251360085484046,0.0175681589918749,0.00894582254147861
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39512,0.0172504749747591,0.00660190551018646,0.00431074017479363,0.0301902097747246,0.00898865060603855
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,39760,0.00889834847125296,0.00340821176483744,0.00221825341217157,0.0155784435303343,0.00904368077162439
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39575,0.0210186396561138,0.00806690128505298,0.00520751313740999,0.0368297661748177,0.00918531935108487
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39512,0.00987394762799597,0.0037917107089566,0.00244219463844104,0.0173057006175509,0.00922439686004587
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39512,-0.0114616942039721,0.00440951447977486,-0.0201043425843308,-0.00281904582361333,0.00935371698122981
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42213,0.0170337526340952,0.00655473654752056,0.00418646900095491,0.0298810362672355,0.00936801130712872
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42236,0.008752080633954,0.00337575666804637,0.00213559756458312,0.0153685637033249,0.00953474400728118
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39917,0.00745931848102031,0.00287957048002042,0.00181536034018029,0.0131032766218603,0.00959797262336678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,39904,-0.0238203644164985,0.0092102512578628,-0.0418724568819096,-0.00576827195108742,0.00971395968662206
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,41995,0.0156359853955121,0.00605546359399676,0.00376727675127848,0.0275046940397458,0.009829816415472
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41766,0.0156238395133913,0.0060568884638203,0.00375233812430348,0.0274953409024791,0.00990463469531136
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,39597,0.0130242552343263,0.00504957694867993,0.0031270844149136,0.0229214260537389,0.00991361532044394
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,39868,0.0212195160936954,0.00824595476502336,0.0050574447542496,0.0373815874331412,0.0100853459235983
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39868,0.012195591545137,0.00474002513870109,0.00290514227328287,0.0214860408169912,0.0100978295433701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,42185,0.00747680835422045,0.00290881792049535,0.00177552523004957,0.0131780914783913,0.0101688433160506
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41765,0.0221652344226298,0.00863094278532396,0.00524858656339485,0.0390818822818648,0.0102363172753022
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39675,0.0201300303687559,0.00783921341318199,0.00476517207891922,0.0354948886585926,0.0102457394277289
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39895,0.0183988789478484,0.00716548039929924,0.00435453736522192,0.032443220530475,0.010250008997642
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,39500,0.0181925785521968,0.00709234125891438,0.00429158968472461,0.032093567419669,0.0103278089184854
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,42155,-0.00758315086732515,0.00295643177386487,-0.0133777571441003,-0.00178854459055001,0.0103292170641821
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,41903,0.0181572370298011,0.00708424366017275,0.00427211945586251,0.0320423546037397,0.0103867505624601
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39872,0.0103778140330768,0.00404983409092604,0.00244013921486178,0.0183154888512918,0.0104041870719935
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,39597,0.00728662555601893,0.0028439958129799,0.00171239376257831,0.0128608573494595,0.0104170863620041
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42111,0.0237738425614687,0.00930170806733193,0.00554249474949812,0.0420051903734393,0.010603487200421
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,39904,0.0235653727046003,0.00923078726324368,0.00547302966864272,0.0416577157405579,0.010695718233884
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,39500,0.0154566741019168,0.00605626532343083,0.00358639406799235,0.0273269541358412,0.0107186636212729
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42172,0.0154526171940223,0.00606306409529504,0.00356901156724404,0.0273362228208006,0.0108250466631851
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,39500,0.0171289120743135,0.00672098119078652,0.00395578894037192,0.0303020352082551,0.0108300507393148
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,39904,0.0313469928628956,0.0123092138953329,0.0072209336280431,0.0554730520977481,0.010890062904402
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41828,0.00814698441352061,0.00320163866160199,0.00187177263678071,0.0144221961902605,0.0109506349409714
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39597,0.00956669421977323,0.00376060976572347,0.00219589907895523,0.0169374893605912,0.0109751495866118
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,39839,0.0145085985189805,0.00570533182563952,0.00332614814072705,0.025691048897234,0.0110041443217284
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41771,0.0209909133875224,0.00826688693726786,0.00478781499047744,0.0371940117845675,0.0111234377530675
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39858,0.00954579552384182,0.00376245119537118,0.00217139118091431,0.0169201998667693,0.0111901990512553
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39868,-0.0239150124150137,0.00942762802990023,-0.0423931633536181,-0.0054368614764092,0.0112038326414283
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,39590,0.00864960800855138,0.00341232434845473,0.00196145228558011,0.0153377637315226,0.0112644536034526
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39904,0.0173144470879522,0.00683395284638661,0.00391989950903441,0.0307089946668699,0.0113034106648562
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41916,0.00764386182291177,0.00302135100178605,0.00172201385941112,0.0135657097864124,0.0114193647607499
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39872,0.0192163393966072,0.00761658908233228,0.00428782479523596,0.0341448539979785,0.0116508497136968
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,41766,0.0151569562484869,0.0060104400925852,0.00337649366701995,0.0269374188299539,0.0116882533393285
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42163,-0.00688019317954111,0.00273060936442464,-0.0122321875338134,-0.00152819882526881,0.0117583861673096
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41771,0.0230378800536293,0.00915829563246363,0.00508762061400056,0.040988139493258,0.0118974776024147
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42222,0.0105978484646459,0.00421346436716327,0.00233945830500593,0.018856238624286,0.0119067569790947
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41771,0.0202627432998295,0.0080639534957425,0.00445739444817424,0.0360680921514849,0.0119910799549327
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39526,0.02039317510045,0.00811898902656309,0.00447995660838633,0.0363063935925136,0.0120264408125814
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39500,0.0156401763455344,0.00623021211096095,0.00342896060805097,0.0278513920830179,0.0120746233712728
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,41771,0.0178913366666705,0.00713140823490007,0.00391377652626635,0.0318688968070746,0.0121258315281708
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39526,0.0152566564404463,0.00608205356850666,0.00333583144617326,0.0271774814347194,0.0121398525793425
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39904,0.0376621983379092,0.0150175625427777,0.00822777575406485,0.0670966209217535,0.0121597967115662
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,42070,0.00887881882249406,0.00354131013817249,0.00193785095167597,0.0158197866933121,0.0121804109886815
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,41995,0.00707002738247469,0.00282129368590008,0.00154029175811052,0.0125997630068389,0.0122239712564336
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42048,0.0228965598685927,0.0091376842897589,0.00498669866066529,0.0408064210765202,0.0122316453652169
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,39869,0.031432073006253,0.0125505068933088,0.0068330794953677,0.0560310665171384,0.0122783263018685
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39597,0.00802371831189861,0.00320408124469719,0.00174371907229211,0.0143037175515051,0.0122865973113635
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39675,0.0142526589292064,0.00569375443357194,0.00309290023940538,0.0254124176190074,0.0123215559963772
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,39872,-0.0142643645649858,0.00570249523709123,-0.0254412552296846,-0.00308747390028699,0.0123835285402622
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,41842,0.0130309338208354,0.00521368706180982,0.0028121071796882,0.0232497604619827,0.0124534372017468
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42072,0.0133852286451897,0.0053658336244238,0.00286819474131904,0.0239022625490603,0.0126243193162394
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,39597,0.0103099712929406,0.00414095767752396,0.00219369424499368,0.0184262483408876,0.0127977647774696
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42072,0.0181568494053089,0.00729518838759859,0.0038582801656157,0.0324554186450022,0.0128265950639137
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39590,0.011329705382835,0.00455224843024626,0.00240729845955228,0.0202521123061176,0.012831640260033
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,39597,0.00796632153182917,0.00320538267001697,0.0016837714985959,0.0142488715650624,0.0129591601912241
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39652,0.0132532100045435,0.00533385008937235,0.00279886382937374,0.0237075561797133,0.012979436110438
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,41995,-0.0105661849383844,0.00425675455879541,-0.0189094238736235,-0.00222294600314543,0.0130689640861523
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39575,0.0114381463632579,0.00460820007111416,0.00240607422387413,0.0204702185026416,0.0130748471450836
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39575,0.0152923599862933,0.00616866794745686,0.0032017708092778,0.0273829491633087,0.0131886474066494
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,42048,-0.00924414493011544,0.00372913357502,-0.0165532467371546,-0.00193504312307623,0.0131910347821784
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39675,0.0182321428526153,0.00736398875017313,0.00379872490227593,0.0326655608029546,0.0133067209919706
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39858,0.0130081722205558,0.00525636234017858,0.00270570203380575,0.0233106424073058,0.0133476395675043
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39895,0.0190797872001688,0.00770985720754717,0.00396846707337636,0.0341911073269613,0.0133483985253768
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39696,0.0140967453348633,0.00569768276281356,0.00292928711974867,0.0252642035499778,0.0133713634062605
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,42236,0.00463354372748744,0.00187482666580033,0.000958883462518783,0.00830820399245609,0.013468692451778
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39696,0.00997412219232371,0.0040363444196642,0.00206288712978187,0.0178853572548655,0.0134855471815789
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,41842,0.0121270076031976,0.00490778787867555,0.0025077433609935,0.0217462718454017,0.0134871200666903
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39869,0.01720255908121,0.00696490694462919,0.00355134146973679,0.0308537766926832,0.0135301345618526
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42063,0.00780938173127456,0.0031643363311556,0.00160728252220959,0.0140114809403395,0.0136017734582556
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,42063,-0.00846917175875745,0.00343251100440884,-0.0151968933273988,-0.00174145019011613,0.013624451627145
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41766,0.00778751712861952,0.00316120127820247,0.00159156262334268,0.0139834716338964,0.013772724386914
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,42072,0.00941952002194187,0.00382886633911465,0.00191494199727716,0.0169240980466066,0.0139010194651042
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39526,0.0130844227497687,0.00531868034671204,0.0026598092702131,0.0235090362293243,0.0139056545966393
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,42063,0.0326168191229524,0.0132664979361477,0.00661448316810291,0.0586191550778019,0.0139610529917719
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,42187,0.00789277470569102,0.0032156170098302,0.00159016536642382,0.0141953840449582,0.0141199951125467
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39800,-0.00777008905765894,0.00316661311415286,-0.0139766507613985,-0.00156352735391934,0.0141524923064304
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,39590,0.0156866013723972,0.00639546785144852,0.00315148438355811,0.0282217183612363,0.0141915875357027
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39675,0.0319090441100682,0.0130114959305923,0.00640651208610735,0.0574115761340291,0.0142070571086064
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39696,0.0109187379816846,0.00445333928213419,0.00219019298870161,0.0196472829746676,0.0142293045849502
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39904,0.00754148059191842,0.00307808165385591,0.00150844055036084,0.013574520633476,0.0142983498918232
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41929,0.0124954459339873,0.00510474956262304,0.00249013679124618,0.0225007550767285,0.0143856354517188
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,39575,-0.0167560832438181,0.00684517233945355,-0.0301726210291471,-0.00333954545848915,0.0143859528155649
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,39500,-0.0106265504491898,0.00435022701719449,-0.019152995402891,-0.00210010549548865,0.0145912868303495
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,41828,0.0304456773754565,0.0124739959722556,0.00599664526983549,0.0548947094810774,0.0146705664108498
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42072,0.0174649919924738,0.00715968652065535,0.00343200641198931,0.0314979775729583,0.0147264629138667
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39675,0.0298609549648817,0.0122688482805267,0.00581401233504929,0.053907897594714,0.0149534775534516
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39872,0.0174767432577623,0.00718336233293547,0.00339735308520875,0.0315561334303158,0.0149919188021297
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,41766,0.0120374300749652,0.00494863733846307,0.00233810089157755,0.0217367592583528,0.015009312954983
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42128,0.0300616460067478,0.0123594020761504,0.00583721793749302,0.0542860740760027,0.015016583288345
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42072,-0.0103392565380235,0.00426016542086,-0.0186891807629091,-0.00198933231313785,0.0152389055817494
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39590,0.0155466573164615,0.00640600915822971,0.00299087936633129,0.0281024352665918,0.0152449869079742
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39597,0.0112370701498963,0.00463222825705177,0.0021579027660748,0.0203162375337177,0.0152887501643114
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39590,0.0209030746063154,0.0086175933202494,0.00401259169862661,0.0377935575140042,0.015297925775823
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,41995,0.0119199269844551,0.00492046385351726,0.00227581783156128,0.0215640361373489,0.0154264112553061
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,41943,0.0275534324992353,0.0113809319039883,0.0052468059674182,0.0498600590310524,0.0154903960818177
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,42236,-0.0149992242106608,0.00619935219730476,-0.0271499545173781,-0.00284849390394346,0.0155556026773538
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,41766,0.0101437526083209,0.00419265954352384,0.00192613990301416,0.0183613653136276,0.0155592669766585
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39858,0.00949690848307561,0.00392801938240585,0.00179799049356015,0.0171958264725911,0.0156332373730275
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42108,0.00615515703508045,0.00254801349063721,0.00116105059343152,0.0111492634767294,0.0157195174205065
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39575,0.00860551403620963,0.00356439684006063,0.0016192962296908,0.0155917318427285,0.0157818425466898
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39590,0.00949085928720477,0.00393153931548967,0.00178504222884502,0.0171966763455645,0.0157933414060535
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,41995,0.0140509304418897,0.00583253348763155,0.00261916480613188,0.0254826960776476,0.016007021095793
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,41943,-0.00792773886396293,0.00329132320120146,-0.0143787323383178,-0.00147674538960806,0.016023869023602
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39696,0.0138720922043212,0.00575997806051262,0.00258253520571648,0.0251616492029259,0.0160406369750962
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39696,0.0298462361779199,0.0123953111058714,0.00555142641041192,0.0541410459454279,0.0160623229846153
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42210,0.0101544381000379,0.00422410709100944,0.00187518820165937,0.0184336879984164,0.0162333683508318
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,42111,0.0241792123230921,0.0100624068003762,0.00445689499435475,0.0439015296518295,0.0162779049981852
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,42142,0.0145321659189217,0.00605543395841379,0.00266351536043071,0.0264008164774128,0.0164149684628301
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42187,0.0108061329788154,0.00450759084186131,0.00197125492876723,0.0196410110288636,0.0165289582140223
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41828,0.0124299686910001,0.00518736534749888,0.00226273260990226,0.0225972047720979,0.016579816583609
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,39895,0.0138726858656015,0.00579060726463686,0.00252309562691329,0.0252222761042898,0.0166038347606989
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39597,0.0117836216173497,0.00492054458547391,0.00213935422982088,0.0214278890048786,0.0166469738079495
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,39895,0.0186919666849932,0.00781454718012254,0.00337545421195305,0.0340084791580334,0.0167756071528191
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39791,-0.0175045541296679,0.00732108825189406,-0.0318538871033802,-0.00315522115595552,0.0168200248119892
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,41960,0.0175985459079056,0.0073876975440783,0.00311865872151214,0.0320784330942991,0.0172261597586375
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42048,0.0213982842514181,0.00898775011437992,0.00378229402723347,0.0390142744756028,0.0172876311327979
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39512,0.0103940972332266,0.00436768846382505,0.00183342784412949,0.0189547666223237,0.0173404923107439
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39869,0.0222471186937794,0.00935207593004037,0.00391704987090025,0.0405771875166585,0.0173836379127409
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39895,0.0231173667577522,0.00972429122159888,0.00405775596341836,0.042176977552086,0.0174573776804548
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,42187,-0.0155334556429391,0.00653621937485429,-0.0283444456176535,-0.00272246566822472,0.017490589798651
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,41945,0.015121024416222,0.00636449297639081,0.00264661818249605,0.027595430649948,0.0175230322568485
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39597,0.00939836913085139,0.00395786649668618,0.00164095079734647,0.0171557874643563,0.0175848016040931
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42088,-0.0169399331608012,0.00713800934738033,-0.0309304314816666,-0.00294943483993573,0.0176485804592865
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,42049,0.0332753153843715,0.0140256395312734,0.00578506190307564,0.0607655688656674,0.0176839014630726
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39868,0.027557359145105,0.011622565783751,0.00477713020895311,0.050337588081257,0.0177556963002922
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41842,0.0114018713011377,0.00482019274253078,0.00195429352577737,0.020849449076498,0.0180230417994344
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,41995,-0.0225810589167252,0.00955265573061436,-0.0413042641487294,-0.00385785368472105,0.0181002538436933
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39675,0.0228697602639652,0.0096952965554948,0.00386697901519542,0.041872541512735,0.018348880897109
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,39917,-0.0175314192326027,0.00743355006129092,-0.0321011773527329,-0.00296166111247247,0.0183699150524597
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41752,0.015147724078613,0.00642532743410426,0.00255408230776865,0.0277413658494573,0.0184129066558049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39597,0.0149111930327211,0.00633436143448901,0.00249584462112265,0.0273265414443196,0.0185892658672248
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41828,-0.00802537440873695,0.00341083192207395,-0.0147106049760019,-0.00134014384147201,0.0186417933897604
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39858,-0.00947381009743367,0.00403215127839403,-0.017376826603086,-0.00157079359178137,0.0188124336301446
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39512,0.0122197486508765,0.00520734952428128,0.00201334358328519,0.0224261537184678,0.0189615884092579
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42048,0.0112893010710743,0.00481218359545987,0.00185742122397294,0.0207211809181756,0.0189914142672474
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39868,0.0212452031180856,0.0090561656676,0.00349511840958961,0.0389952878265816,0.0189965031773301
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42111,0.0278391351159475,0.0118673886538251,0.00457905335445038,0.0510992168774446,0.0189980315499276
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42108,0.0233727876593669,0.00996359920716576,0.00384413321332199,0.0429014421054118,0.0189997710142225
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42222,0.0187291759516798,0.00800219325065136,0.0030448771804031,0.0344134747229564,0.0192720156115987
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39872,0.0079681108627496,0.00340951511477819,0.00128546123778435,0.0146507604877149,0.0194554715175019
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,39868,0.00967952726494284,0.00414220960098611,0.00156079644701007,0.0177982580828756,0.0194668640267096
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,39869,0.017658348019714,0.00756630015147937,0.00282839972281439,0.0324882963166135,0.0196228760471595
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41771,0.0165316088788444,0.00708768287561667,0.00263975044263572,0.0304234673150531,0.0196924393580977
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39512,0.01255725462593,0.00538438423144953,0.00200386153228894,0.0231106477195711,0.0197102816096073
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39858,0.0157878060048073,0.00677325203724972,0.00251223201179782,0.0290633799978167,0.0197759422879553
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,41943,0.0030850129309285,0.00132399638974684,0.000489980007024686,0.00568004585483231,0.0198169400339964
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39597,0.0221225536954644,0.00949639026713359,0.0035096287718826,0.0407354786190463,0.0198466325896466
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39872,0.0215792067386369,0.00926529135252619,0.0034192356876856,0.0397391777895883,0.0198746849803228
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,41995,0.0228021543084855,0.00979959550047628,0.00359494712755196,0.042009361489419,0.0199882701145052
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39526,0.0191409316410724,0.00822706394448354,0.00301588630988469,0.0352659769722602,0.0200057609317766
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,39597,0.016124968877364,0.00693162966004096,0.00253897474368376,0.0297109630110443,0.0200212558166456
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42149,0.0172987802276264,0.00744883732982343,0.00269905906117243,0.0318985013940803,0.0202290346539191
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,41842,0.00994689328197529,0.00428537786511251,0.00154755266635477,0.0183462338975958,0.0202952586269055
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,42108,0.0141396226092502,0.00609349045835026,0.00219638131088372,0.0260828639076167,0.0203315191400587
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42092,-0.0190954283971778,0.00826603579619912,-0.0352968585577281,-0.0028939982366275,0.0208972372547439
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,39590,0.0171929329641877,0.00744255728249744,0.00260552069049273,0.0317803452378827,0.0209019343637573
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39868,0.0155013016624386,0.0067377076889275,0.00229539459214074,0.0287072087327365,0.0214279626253654
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42219,0.0150081420702308,0.00652758921420654,0.00221406721038596,0.0278022169300756,0.0215094376452812
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41842,0.0174518561922263,0.00759247063826165,0.00257061374123343,0.0323330986432191,0.0215446374337967
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,39868,0.0156594635489322,0.00682319232994597,0.00228600658223806,0.0290329205156262,0.0217494217466899
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39597,0.01779495599187,0.00776460605128155,0.00257632813135818,0.0330135838523818,0.0219357581080341
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42089,0.0127712162701477,0.00557432099178993,0.00184554712623947,0.023696885414056,0.0219741230680606
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41842,0.013626195841431,0.00595214352801521,0.00195999452652115,0.0252923971563408,0.0220780429142871
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41766,0.0125357425779988,0.0054767083394979,0.00180139423258289,0.0232700909234147,0.0220998107708129
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39590,0.0170203785828687,0.00743620573428677,0.00244541534366666,0.0315953418220708,0.0221068024932432
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41828,0.0236222840126125,0.010334026970559,0.00336759115031681,0.0438769768749081,0.0222773680859738
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39872,0.0317754351744996,0.0139031467606363,0.00452526752365249,0.0590256028253468,0.0223028766983524
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39597,0.0141621480550255,0.0061976607989313,0.00201473288912018,0.0263095632209309,0.0223271126995546
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,39698,0.0060615152136257,0.00265414171380813,0.000859397454561779,0.0112636329726896,0.0224023940550682
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39868,0.00829926489704278,0.00363474047018408,0.00117517357548198,0.0154233562186036,0.0224302297295891
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41842,0.0161270877035866,0.00707021305884011,0.00226947010826001,0.0299847052989133,0.0225648269242682
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",41995,-0.0258553535077644,0.011342887693209,-0.0480874133864539,-0.00362329362907482,0.0226569882529041
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,41950,-0.0179278402226858,0.00787360963918281,-0.0333601151154841,-0.00249556532988751,0.0228047745015899
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39526,0.0244725614701138,0.0107697400309069,0.00336387100953622,0.0455812519306915,0.0230850432470026
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39696,0.0116403851366616,0.00512660618898135,0.00159223700625818,0.0216885332670651,0.0231913137273072
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,41682,0.0265595790669428,0.0117386441588816,0.00355183651553479,0.0495673216183507,0.0236781426945144
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39675,0.0205417146837948,0.00908102747959025,0.00274290082379795,0.0383405285437917,0.0237137720253642
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,42063,0.00572648988418253,0.00253246565213345,0.000762857206000956,0.0106901225623641,0.0237608437489708
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39872,0.0112520628695237,0.00497998861381449,0.00149128518644727,0.0210128405526001,0.0238740762932347
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39868,0.0145241223567506,0.00643145256553841,0.00191847532829535,0.0271297693852059,0.0239462675249444
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,41842,0.0101408255640988,0.00449085899977255,0.00133874192454457,0.018942909203653,0.0239553997982813
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42236,0.00759073652517588,0.00336257994373483,0.00100007983545562,0.0141813932148961,0.0239979415808053
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,39868,0.01764542191101,0.00782482798241346,0.00230875906547963,0.0329820847565404,0.0241489513157824
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39590,0.00885635507585127,0.0039324892041218,0.00114867623577254,0.01656403391593,0.0243356710020968
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39597,0.0135327451730488,0.00601456608654544,0.00174419564341976,0.0253212947026779,0.0244689335232741
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39597,0.0255269850360753,0.0113651061600429,0.0032513769623912,0.0478025931097594,0.024718386089449
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,39858,0.00858500690571512,0.00382739861988699,0.00108330561073662,0.0160867082006936,0.0249136297724797
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39858,0.0131409312889323,0.00585933659305272,0.00165663156654902,0.0246252310113157,0.0249333749397373
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39868,0.0130354894681846,0.00582171187695695,0.00162493418934892,0.0244460447470202,0.0251677909142094
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,39512,0.0158557804519053,0.00709940348737213,0.00194094961665589,0.0297706112871547,0.0255430212956529
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39858,0.0229639208440099,0.0102870114548191,0.00280137839256456,0.0431264632954552,0.0256132872407224
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,39590,0.0119241682377057,0.00534375586034703,0.00145040675142551,0.0223979297239859,0.0256733527133347
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39512,0.0142963420962416,0.00640714237133693,0.00173834304842126,0.026854341144062,0.0256806156481716
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,41943,0.0194070479986501,0.00873275318704068,0.00229085175205034,0.0365232442452498,0.0262778008418732
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,42072,0.0164043137034181,0.00738408834337291,0.00193150055040724,0.030877126856429,0.0263285243494198
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,41766,-0.0177293260013864,0.00798226332861962,-0.0333745621254809,-0.00208408987729198,0.0263618064826962
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42057,0.0136817457164522,0.00616036295448648,0.00160743432565876,0.0257560571072457,0.0263721667264443
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,39512,0.0151926773646183,0.00684469466841731,0.00177707581452041,0.0286082789147163,0.026464493807859
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEP,Leptin,42072,0.0167460976160519,0.00754499138051446,0.00195791451024357,0.0315342807218603,0.0264694126319297
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42069,0.015008098927342,0.00676241116626336,0.00175377304146579,0.0282624248132182,0.0264801033829216
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42072,0.00422571085559044,0.00190424957470863,0.000493381689161532,0.00795804002201934,0.0264968523249518
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,41842,-0.0170609733039062,0.00769046884860572,-0.0321342922471734,-0.001987654360639,0.0265405931550875
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,39417,0.00954433577418786,0.0043033825918038,0.00110970589425241,0.0179789656541233,0.0265845093531667
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,39597,0.0178289016274491,0.00803932031874823,0.00207183380270258,0.0335859694521956,0.0265947968470281
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41766,0.0103883111364302,0.00468946087110481,0.0011969678290648,0.0195796544437957,0.0267602068978472
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,42039,0.00576994629755562,0.00260480137291444,0.000664535606643312,0.0108753569884679,0.0267685672631374
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,39597,0.00938168524642686,0.00423756192783004,0.00107606386787998,0.0176873066249737,0.0268537112482725
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39858,0.0128210436854877,0.00579346385620334,0.00146585452732918,0.0241762328436463,0.0269163406026567
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,39590,0.0118611364844524,0.00536065242695586,0.00135425772761889,0.0223680152412859,0.0269436926899259
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39603,-0.00654062438143673,0.00295741336873419,-0.0123371545841557,-0.000744094178717717,0.0270145801137639
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42050,0.00656038994833433,0.00297100383295739,0.000737222435737849,0.0123835574609308,0.0272513806975278
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,39512,0.0106976145336318,0.00484697378324057,0.00119754591848029,0.0201976831487833,0.0273298497039004
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,41995,0.0200893677684413,0.00910495969357049,0.00224364676904315,0.0379350887678395,0.0273714918026625
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCN,Decorin,41828,0.00550834102221933,0.00249830197866657,0.000611669144032851,0.0104050129004058,0.027482895140086
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,41766,0.0126736683977365,0.00575430571000499,0.00139522920612674,0.0239521075893463,0.0276496060413452
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42072,0.0161554714449761,0.00734068433882739,0.00176773014087441,0.0305432127490778,0.0277661883675641
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,39526,0.0253356883444382,0.0115339963450748,0.00272905550809152,0.0479423211807849,0.0280692618784446
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39858,0.0115271008149293,0.00525190394149138,0.00123336908960618,0.0218208325402524,0.0281952612456475
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,39590,0.0313161947141963,0.0142863830224665,0.00331488399016201,0.0593175054382306,0.0283981686417819
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,39696,0.0128368591204481,0.00585741121053307,0.00135633314780331,0.0243173850930929,0.0284321153382289
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39500,0.020303672335639,0.00926511399206544,0.00214404891119072,0.0384632957600872,0.0284431538055523
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,41943,0.0187744111092384,0.00858073518015103,0.00195617015614236,0.0355926520623344,0.0286889020355272
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39868,0.00933280009111355,0.0042670581005098,0.00096936621411434,0.0176962339681128,0.0287502803536162
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,42187,0.00956503853634895,0.00437393751790287,0.000992121001259335,0.0181379560714386,0.0287722502537714
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39597,0.00903285913241926,0.00413112769401501,0.000935848852149828,0.0171298694126887,0.0287974196858424
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39895,0.0210291549321438,0.00962957422663032,0.00215518944794837,0.0399031204163392,0.0289967556434312
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39590,0.0182808826040593,0.00837196488781771,0.0018718314239366,0.034689933784182,0.0290139571405257
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39590,0.0191807901060632,0.00879255857944937,0.00194737529034242,0.036414204921784,0.0291690543038885
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39526,-0.0107469576125458,0.00493352834034378,-0.0204166731596196,-0.00107724206547198,0.0294012015901068
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42020,0.0212219331883181,0.00975252807037971,0.00210697817037385,0.0403368882062623,0.0295693314582623
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42108,0.0224828927144971,0.0103330757611731,0.00223006422259781,0.0427357212063964,0.0295861430074193
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,39500,0.015637985645223,0.00719181380019158,0.00154203059684751,0.0297339406935985,0.0296954416421197
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41842,0.00852494271834285,0.00392293632753497,0.000835987516374303,0.0162138979203114,0.0297902710884063
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,42187,0.0150797373875596,0.00695170259702076,0.00145440029739895,0.0287050744777203,0.0300836487782599
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,42048,-0.00775266796643809,0.00357414756307473,-0.0147579971900646,-0.000747338742811608,0.0300928849209773
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42023,-0.0159503286432402,0.00735887727212585,-0.0303737280966068,-0.00152692918987351,0.0302146632192724
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,42063,-0.00666417083806636,0.00307963278351289,-0.0127002510937516,-0.000628090582381093,0.030485728251592
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42063,-0.00993560029191674,0.0045914210967523,-0.0189347856415512,-0.000936414942282231,0.0304858053249521
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39675,0.020506060557331,0.00949995822222665,0.00188614244176679,0.0391259786728952,0.0309071185699509
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42032,0.0156994617559803,0.00728575212502391,0.00141938759093342,0.0299795359210271,0.0311938848861026
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42165,0.00742139841915879,0.00344839395948448,0.0006625462585692,0.0141802505797484,0.0314045614368476
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,41771,0.00732286338946664,0.00340583904971932,0.00064741885201677,0.0139983079269165,0.0315661782361919
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42072,0.0188141045988526,0.00875123941938532,0.00166167533685734,0.0359665338608478,0.0315825456708711
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41771,0.0107775778185725,0.00501804205096633,0.000942215398678463,0.0206129402384665,0.031750573542685
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39675,0.0193595973694238,0.0090144546786328,0.00169126619930347,0.0370279285395441,0.0317658161986521
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,41671,-0.0213807376589984,0.0099594876310111,-0.0409013334157801,-0.00186014190221661,0.0318298735743765
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39696,0.0171641853426593,0.00800071133942817,0.00148279111738005,0.0328455795679385,0.0319479166248078
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41662,0.00481992179774992,0.00224778549286348,0.000414262231737512,0.00922558136376234,0.0320274200068327
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42072,0.0072129607028287,0.00336468817853107,0.000618171872907795,0.0138077495327496,0.0320729054682029
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39590,0.0240594468289019,0.0112330060094159,0.0020427550504467,0.046076138607357,0.0322272343656188
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39858,0.0175832907441565,0.0082165576551278,0.00147883774010599,0.0336877437482069,0.032377600003631
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39895,0.0133066093385671,0.00622027417246926,0.00111487196052733,0.0254983467166068,0.0324382612398981
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39526,0.0223412027022231,0.0104545486841734,0.00185028728124314,0.042832118123203,0.032621438806878
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,42236,0.0056213843453349,0.00263228154886532,0.000462112509558878,0.0107806561811109,0.0327333942849083
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39872,0.0111667447458671,0.00523544213367531,0.000905278163863484,0.0214282113278707,0.0329533702174125
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,42222,0.0147051203643209,0.00689979599692112,0.00118152021035555,0.0282287205182863,0.0330872361986464
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39512,0.0145786224410229,0.00684429221138112,0.00116380970671595,0.0279934351753299,0.0331905438194947
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41771,0.0150679001611648,0.00707449396604098,0.00120189198772452,0.0289339083346052,0.0331991077180512
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42048,-0.00553335122124715,0.00260259296602403,-0.0106344334346542,-0.000432269007840056,0.0335137921994886
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39872,0.00558155845349609,0.00262551847709292,0.000435542238393969,0.0107275746685982,0.033534254454233
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,39868,0.0225737209879519,0.0106352879595803,0.00172855658717452,0.0434188853887293,0.0338149781371435
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,39858,0.0196324756704041,0.00926684059853583,0.00146946809727388,0.0377954832435343,0.0341484359000341
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42108,0.0252991888366909,0.0119524661576526,0.00187235516769176,0.0487260225056901,0.0343077882918312
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42048,0.0279139502730098,0.0131905004598659,0.00206056937167263,0.0537673311743469,0.0343447500294037
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39917,0.00716185260099269,0.00338427110792029,0.000528681229468923,0.0137950239725165,0.0343481155076092
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,39868,0.0217649533141316,0.0102872159661375,0.00160201002050199,0.0419278966077612,0.0343898047597185
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,41943,0.0220458296963847,0.0104900375977392,0.00148535600481581,0.0426063033879535,0.0356073091108471
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39675,-0.00934733150747179,0.00445017882122035,-0.0180696819970637,-0.000624981017879894,0.0357127476452576
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39868,0.0225578173998746,0.0107431180658121,0.0015013059908829,0.0436143288088662,0.0357733849241433
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,39526,0.0170945668575671,0.0081456081515228,0.00112917488058239,0.0330599588345518,0.0358729751746693
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,41842,0.0182005480836244,0.00867962615598403,0.00118848081789573,0.0352126153493531,0.0360188984034437
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39872,0.0149778961746291,0.00714740107475328,0.000968990068112675,0.0289868022811455,0.0361423926890811
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39575,-0.0082366730408449,0.00393140117426985,-0.0159422193424138,-0.000531126739275987,0.0361850907680415
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39512,0.0142583869036272,0.00682122475858079,0.000888786376808838,0.0276279874304456,0.0366141977711817
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,42069,0.0238741574991011,0.011445129486149,0.00144170370624912,0.046306611291953,0.0370004214615345
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],41995,0.0128335100645692,0.00615525738044252,0.00076920559890188,0.0248978145302366,0.0370911626621855
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39512,-0.0104746874419271,0.00502880725745232,-0.0203311496665336,-0.000618225217320538,0.0372802160472817
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39868,0.0126428632391409,0.00607037560910073,0.00074492704530347,0.0245407994329783,0.0372996927651614
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41747,0.0151132124775369,0.00726501894517755,0.000873775344988881,0.0293526496100849,0.0375199496873155
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,39675,-0.00774060320193367,0.00372127962876767,-0.0150343112743183,-0.000446895129549033,0.037540052879637
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39526,0.0134659007781555,0.00647514447953492,0.000774617598267106,0.026157183958044,0.0375827988796409
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,41766,0.0161167479894882,0.00775741295664253,0.000912218594468873,0.0313212773845076,0.0377661825157007
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,39744,0.0080342158233944,0.00387067314233353,0.000447696464420674,0.0156207351823681,0.0379479420845156
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41828,0.0252068850251742,0.0121503094946504,0.00139227841565932,0.0490214916346891,0.0380440356609999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39500,0.0116642074940545,0.00563320314716726,0.000623129325606691,0.0227052856625023,0.0384180671758607
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42236,0.00513300866601502,0.00248062775016109,0.000270978275699284,0.00999503905633076,0.0385425733894005
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39526,0.0146212993635372,0.00707838898317137,0.000747656956521296,0.0284949417705531,0.0388873980341483
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41766,0.0114370641716848,0.00554957400200217,0.000559899127760527,0.022314229215609,0.0393330860358025
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39895,0.00665059066900937,0.00322751964238643,0.000324652169931973,0.0129765291680868,0.0393651377191796
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39597,0.00997059237681345,0.00483875624361027,0.000486630139337333,0.0194545546142896,0.0393676182463321
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,41842,0.00706510974510198,0.00342935227130213,0.000343579293349798,0.0137866401968542,0.0394000834910833
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,39840,0.0163302612226776,0.00792908992038167,0.0007892449787295,0.0318712774666256,0.0394657157065275
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,42041,0.0207116116087553,0.0100647607344755,0.0009846805691834,0.0404385426483273,0.0396252662292401
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,41725,0.0157298779904801,0.00764691745305972,0.000741919782483096,0.0307178361984772,0.0397038191754302
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39895,0.0162434557229271,0.00789978983502377,0.000759867646280561,0.0317270437995737,0.0397872921030374
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,41995,-0.0078587850324619,0.00382217589806245,-0.0153502497926643,-0.000367320272259502,0.039791980057237
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42111,0.00615286978109912,0.00299657215200369,0.000279588363171884,0.0120261511990263,0.0400624351671931
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,41806,0.00956614321568603,0.00465912428527636,0.000434259616544365,0.0186980268148277,0.0400722302185284
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39575,0.0202553502096197,0.00986660025137511,0.000916813716924533,0.039593886702315,0.0401039011238799
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39512,0.0103786260945914,0.00506113151572845,0.000458808323763694,0.0202984438654192,0.0403245541924446
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39868,0.0107377138388833,0.00523694211286363,0.000473307297670589,0.021002120380096,0.0403505887373875
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39597,-0.0153538803758447,0.00749698807504745,-0.0300479770029377,-0.00065978374875165,0.0405830591382261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42222,0.0148530929516134,0.00726117463792642,0.000621190661277636,0.0290849952419492,0.040819870382855
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39868,0.0104404734623665,0.00510470909705624,0.000435243632136279,0.0204457032925967,0.0408520969428002
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39512,0.0154369409308316,0.00754966664618415,0.000639594304310657,0.0302342875573525,0.0409065890472701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,39590,0.0163480117088367,0.00800213291465574,0.000663831196111478,0.032032192221562,0.0410805212042981
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42198,-0.0105710124505847,0.00517497145699184,-0.0207139565062887,-0.000428068394880752,0.0410995065842418
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39872,0.0123600103512024,0.00605134655675956,0.000499371099953627,0.0242206496024511,0.0411229654392436
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39512,0.0102938840161432,0.00504306776421888,0.000409471198274234,0.0201782968340122,0.0412554691279678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39696,0.0140159354946551,0.00687201687138773,0.000546782426735181,0.0274850885625751,0.0414171582578998
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,41879,0.0155033842031071,0.00760145982061681,0.000604522954698131,0.030402245451516,0.0414171901649313
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,41981,-0.0138791512883701,0.00680833910106767,-0.0272234959264628,-0.000534806650277497,0.0415144058402327
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39872,0.0236007971233526,0.0115810450431902,0.000901948838699849,0.0462996454080053,0.0415850866826566
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39512,0.0152912600514438,0.00750402591396009,0.000583369260082013,0.0299991508428056,0.0415999278256433
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,42048,0.00873193419122756,0.00428713395877621,0.000329151632026198,0.0171347167504289,0.0416919777635552
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,41766,0.0112276994664848,0.00552262063982245,0.000403363012432776,0.0220520359205368,0.0420686700176103
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39590,0.00663931790122438,0.00326799042716098,0.000234056663988866,0.0130445791384599,0.0422160508019867
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39872,0.0171087850614623,0.00843549478582824,0.00057521528123897,0.0336423548416857,0.0425643419888127
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39895,0.007132766544774,0.00351755150797582,0.000238365589141394,0.0140271675004066,0.0426077035507176
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,41995,-0.00457151425908368,0.00225486711057461,-0.00899105379580991,-0.000151974722357447,0.0426414327762689
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,41943,0.0205633051503464,0.010160409143677,0.000648903228739405,0.0404777070719533,0.0430038450183788
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39858,0.0158567270415755,0.00784103891333781,0.000488290771433369,0.0312251633117176,0.0431716809357916
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41771,0.0147616630013521,0.00730106730716843,0.000451571079301964,0.0290717549234022,0.0432120282731942
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41919,0.01039235418392,0.00514061230910821,0.000316754058067867,0.0204679543097721,0.0432357927347705
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42050,0.0118327199141016,0.00585329081803958,0.000360269910744072,0.0233051699174592,0.0432426288425934
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,41771,0.0161167631687678,0.00797440068160784,0.000486937832816399,0.0317465885047191,0.0432934730955
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39575,0.0223706967672243,0.0110688093149242,0.000675830509972816,0.0440655630244759,0.04329807467738
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41828,0.00809777513181906,0.00400913591803883,0.00023986873246295,0.0159556815311752,0.0434210904501113
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,41943,0.0219240015136615,0.0108621160036987,0.000634254146411963,0.043213748880911,0.0435704833776875
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41828,0.0166384830409586,0.00825272587479503,0.000463140326360391,0.0328138257555569,0.0438076384681811
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,42108,0.0134514521545832,0.00667336076893984,0.000371665047461096,0.0265312392617053,0.0438517643704649
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39512,0.0218134496281223,0.0108246803680425,0.000597076106759013,0.0430298231494856,0.0439124906036782
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39526,-0.0184049604572342,0.00913965491589367,-0.0363186840923858,-0.000491236822082661,0.0440604818518325
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,39804,0.0208075565147057,0.0103544346192374,0.000512864661000461,0.0411022483684109,0.0445047928269701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41741,0.0117701327221893,0.00585980737134902,0.000284910274345232,0.0232553551700334,0.044597750981162
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39869,0.0111849158910465,0.00558163574005285,0.000244909840542928,0.0221249219415501,0.0451070445957218
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39590,0.0158269214763602,0.00791311051243233,0.000317224871992863,0.0313366180807276,0.0455152696329494
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,41759,0.0235916405067879,0.0118067200758844,0.000450469158054419,0.0467328118555213,0.0457205496692609
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,39597,0.0133902919644599,0.00670253947801224,0.000253314587555916,0.0265272693413639,0.0457636042989296
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39512,0.010910661525965,0.00548068816258282,0.000168512727302636,0.0216528103246273,0.046533648202026
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,39526,0.0133121673720344,0.00668834468172129,0.000203011795860665,0.0264213229482081,0.0465769299972094
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,41766,0.0149313657382597,0.00750367314067348,0.000224166382539656,0.0296385650939797,0.0466254417932726
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,42187,0.00566117703745115,0.00284597685647774,8.30623987547689e-05,0.0112392916761475,0.0467007060345229
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,41995,-0.0180977461994127,0.00910388978912329,-0.0359413701860944,-0.000254122212731078,0.0468415709842335
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,42236,0.00634546758159284,0.00319386369995202,8.54947296868832e-05,0.0126054404334988,0.0469680436518291
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39895,0.00721459042859332,0.00364172702152027,7.68054664136023e-05,0.014352375390773,0.0476053503989227
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,39500,0.0131463406985983,0.00665137845539865,0.000109638926016923,0.0261830424711796,0.0481251950393606
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39512,0.0106772943176641,0.00540510542089583,8.32876927082497e-05,0.0212713009426199,0.04824690180915
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,42063,-0.00852232401523437,0.0043149411951112,-0.0169796087576523,-6.50392728164095e-05,0.0482802557743171
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,39869,0.0221378376527395,0.0112095755102239,0.00016706965270067,0.0441086056527784,0.0483033912482453
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,39597,0.00785114918594615,0.00398705082351375,3.65295718592045e-05,0.0156657688000331,0.048959551736559
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,42092,0.0122540831737285,0.00622644979021115,5.02415849146214e-05,0.0244579247625423,0.0490805382505039
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39895,0.0159331030034951,0.00812333038276853,1.13754532687707e-05,0.0318548305537214,0.0498568684567811
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39869,0.013706750614457,0.00698859959329475,9.0954115992848e-06,0.0274044058173147,0.0498684532553411
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,39575,0.0188252526804181,0.00959846056481184,1.22699733868872e-05,0.0376382353874493,0.0498718097383398
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39858,0.0084427735942898,0.00430843426263089,-1.75756046673706e-06,0.0168873047490463,0.0500681271951616
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42048,0.0147507008240756,0.00752953634800455,-7.19041801328611e-06,0.0295085920661645,0.0501281450255481
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42027,-0.00425463911148284,0.00217294353370292,-0.00851360843754056,4.3302145748738e-06,0.0502498448327817
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39512,0.0143715761751544,0.00734808949650733,-3.06792379999969e-05,0.0287738315883087,0.0505112681600023
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,39836,0.018657004171359,0.00954134003119843,-4.40222897899016e-05,0.0373580306325079,0.0505622613626199
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39858,0.0189387776953658,0.00968614548594547,-4.6067457087285e-05,0.037923622847819,0.0505789851453021
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,39869,0.022216285559963,0.0113732864582492,-7.53558982054051e-05,0.0445079270181314,0.0507999692398106
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,39512,0.00833485706620674,0.00426753941616368,-2.95201894740717e-05,0.0166992343218875,0.0508353300451488
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,39927,-0.015853116923084,0.00811768487447879,-0.0317637792770625,5.75454308944165e-05,0.0508547213656908
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39696,0.0105656110448366,0.0054119320737741,-4.17758197606803e-05,0.0211729979094338,0.0509299899068225
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41842,0.0135372063168058,0.00693774464667208,-6.07731906714475e-05,0.0271351858242831,0.0510495350687491
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41828,0.0102912619197981,0.00527424960255266,-4.62673012050843e-05,0.0206287911408013,0.0510510449506352
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39500,0.0144447026590417,0.00740682125858084,-7.26670077767187e-05,0.0289620723258602,0.0511791738338744
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,39675,0.0147524055886084,0.0075738871038666,-9.24131349701821e-05,0.0295972243121869,0.0514643155770159
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,41842,0.0198939866121703,0.0102212916303051,-0.000139744983227705,0.0399277182075682,0.0516364679477398
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39927,0.0111938527360254,0.00575972266261066,-9.52036826915286e-05,0.0224829091547423,0.0519840381147142
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,41995,0.0197669090227653,0.0101944521349245,-0.000214217161686767,0.0397480352072175,0.0525239095564992
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,41676,0.0141999569684631,0.00732756173419742,-0.000162064030563852,0.02856197796749,0.0526590051862206
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39512,0.0107010402884798,0.0055245424353944,-0.000127062884893238,0.0215291434618528,0.0527710869456979
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HLA_A,,39872,0.00690829755528545,0.00356988942799238,-8.86857235796032e-05,0.0139052808341505,0.0529959801283062
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42168,0.0192400786495927,0.00994315061838407,-0.000248496562440109,0.0387286538616254,0.0530100384778198
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,42048,0.0181777233603299,0.00940460627181427,-0.000255304932426086,0.0366107516530859,0.0532752537239591
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,39597,0.0114686985467455,0.00593706743180402,-0.000167953619590402,0.0231053507130814,0.0534208456396817
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41766,0.00804911423182349,0.00416701577315552,-0.000118236683561326,0.0162164651472083,0.0534271715949318
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39512,-0.00826742354062489,0.00428286149920455,-0.0166618320790658,0.000126984997816035,0.0535893142375064
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,41943,0.00876428090635139,0.00454563060205666,-0.000145155073679664,0.0176737168863824,0.0538679729869018
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,39689,0.0207721519017565,0.0107824770361573,-0.000361503089111891,0.0419058068926249,0.0540708555622477
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41842,0.0112456086577826,0.00585226385603139,-0.000224828500038944,0.0227160458156041,0.0546797322121923
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,39853,0.00512236212092697,0.00266857838521594,-0.00010805151409627,0.0103527757559502,0.0549451164979346
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,42026,0.010024303310439,0.0052281651586811,-0.000222900400575961,0.0202715070214539,0.0552127146304348
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39597,0.0117850778098936,0.00614796583933873,-0.000264935235210271,0.0238350908549975,0.0552756517635498
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39597,0.0179767037750158,0.00938525072295979,-0.000418387641985346,0.036371795192017,0.0554647764733015
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,39858,0.0129594144296455,0.00676925009660735,-0.000308315759704893,0.0262271446189959,0.0555875573972938
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41719,0.0120647980998671,0.00631610196443078,-0.000314761750417246,0.0244443579501514,0.0561337289811473
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,39526,0.0153151453380658,0.00802957025058807,-0.000422812353086782,0.0310531030292185,0.0565023683014083
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,39590,0.0138896091808494,0.00728349174005255,-0.000386034629653632,0.0281652529913524,0.0565468047401961
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,42236,-0.00940971088613681,0.00496316467727531,-0.0191375136535964,0.000318091881322797,0.057993138694293
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42063,-0.00783479926597538,0.00413392406673454,-0.0159372904367751,0.000267691904824308,0.0580813404331118
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,39597,0.01173999787127,0.00620500730510429,-0.000421816446734405,0.0239018121892744,0.0585145624812655
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42175,0.00639054700445661,0.0033793974609164,-0.000233072018939547,0.0130141660278528,0.0586414135066636
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41924,0.0229391411899455,0.0121371834013608,-0.000849738276721541,0.0467280206566126,0.0587811376411186
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,39512,0.015462130176786,0.00818694319055002,-0.000584278476692039,0.031508538830264,0.0589675344054669
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,39868,0.0140992671311406,0.00747039561084684,-0.000542708266119194,0.0287412425284004,0.0591386559806075
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41766,0.0135232035625248,0.00716896155390521,-0.000527961083129401,0.027574368208179,0.0592691747000756
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,41998,-0.0136133466477988,0.00722224041609457,-0.0277689378633442,0.000542244567746519,0.0594622395932196
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39597,0.0164889965033428,0.00875763373820953,-0.000675965623547835,0.0336539586302335,0.0597519358333836
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,42063,0.0091663035913554,0.00487025643372628,-0.000379399018748113,0.0187120062014589,0.0598441586138816
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,41995,0.0238854575203326,0.0127002542661293,-0.00100704084128075,0.048777955881946,0.0600334583556372
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39575,-0.00768948296582639,0.00410473202115382,-0.0157347577272879,0.000355791795635099,0.0610505515745233
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,39597,0.020377648759372,0.0108870000586229,-0.000960871355528966,0.041716168874273,0.0612689129586251
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,39846,0.0173808222833312,0.00929113408643783,-0.000829800526086982,0.0355914450927493,0.0614141519786489
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42063,0.0156373205106095,0.0083627163361257,-0.000753603508196903,0.0320282445294159,0.0615214309740353
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39526,0.015320998746987,0.00819786355794474,-0.000746813826584695,0.0313888113205587,0.0616632673411897
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39512,-0.00730511737347402,0.00390910177836208,-0.0149669568590637,0.00035672211211565,0.0616849656563956
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39512,0.00796442624415517,0.00426192237365086,-0.000388941608200516,0.0163177940965109,0.0616857208481315
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,42030,-0.0101034585786598,0.00541281128150159,-0.0207125686904029,0.000505651533083334,0.0619816947938702
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,41766,0.00943047606072499,0.00505750331062461,-0.000482230428099232,0.0193431825495492,0.0622526432092192
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39500,-0.00735671368044338,0.00394853362902028,-0.0150958395933231,0.000382412232436371,0.0624679249669378
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42063,0.0107656732656447,0.00578761687496983,-0.0005780558092962,0.0221094023405855,0.0628900637998667
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,41995,0.0113742880812275,0.00611859392841422,-0.000618156018464412,0.0233667321809193,0.0630531770941369
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39512,0.00966676851982358,0.00520783100530348,-0.000540580250571245,0.0198741172902184,0.0634521954275476
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39869,0.0218937984618471,0.0117973257861361,-0.0012289600789796,0.0450165570026739,0.063504276023208
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41771,0.015779435939641,0.00851169717862337,-0.000903490530460817,0.0324623624097428,0.0637825257474185
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41842,0.0114524553792529,0.00618834660716736,-0.000676703970795127,0.0235816147293009,0.064242370178065
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42222,0.015208876906637,0.00823388604871833,-0.000929539748850955,0.0313472935621249,0.0647531587390296
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39872,0.0054722081105484,0.0029625629445261,-0.000334415260722743,0.0112788314818196,0.0647559964928263
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39590,0.0139673175840528,0.00756253883320517,-0.000855258529029347,0.0287898936971349,0.0647872604518775
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,42008,0.00574978499842805,0.00311379828259558,-0.000353259635459292,0.0118528296323154,0.0648343732611866
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,39512,0.00953658333547427,0.00516896495586071,-0.000594587978012717,0.0196677546489613,0.0650690380238096
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39500,0.00842704520461186,0.0045676663499575,-0.000525580841304839,0.0173796712505286,0.0650741791710683
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,39512,0.00789814128230098,0.00429648973217185,-0.000522978592755855,0.0163192611573578,0.0660486588595914
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39675,0.0115002146522729,0.00625653091789989,-0.000762585946810852,0.0237630152513567,0.0660724319517327
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,39680,-0.00434475369855894,0.00236599142086823,-0.00898209688346067,0.000292589486342797,0.0663348495726678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39500,0.0113274432457975,0.00617220611542543,-0.000770080740436318,0.0234249672320314,0.066498239471078
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39927,0.00490961447227897,0.00268228118956254,-0.000347656659263616,0.0101668856038216,0.0672182486947114
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41842,-0.00846457640638807,0.0046288721478709,-0.017537165816215,0.000608013003438893,0.0674748830593977
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39895,0.0124213545250811,0.00679415921715317,-0.000895197540539112,0.0257379065907013,0.0675398818398042
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39675,0.0152950886795834,0.00836861487514932,-0.00110739647570926,0.0316975738348761,0.0676255837935308
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,39897,0.00285317303963155,0.00156520112890659,-0.000214621173025367,0.00592096725228846,0.068348062406512
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,39898,-0.00738362185047755,0.00405284595785016,-0.0153271999278639,0.000559956226908758,0.068506256674479
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42039,-0.00473059388744898,0.00259816976372173,-0.00982300662434357,0.000361818849445603,0.0686684832795981
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42164,0.0128071912990429,0.00703415201399589,-0.000979746648388992,0.0265941292464749,0.0686721010274192
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,39869,0.0512771649786666,0.0281667588829198,-0.00392968243185612,0.106484012389189,0.0687116733730574
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,39895,0.00536463960292983,0.00294771848388893,-0.000412888625492477,0.0111421678313521,0.0687962092940226
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39696,0.0124773974681185,0.00685931812463223,-0.000966866056160656,0.0259216609923977,0.0689317473230793
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42156,0.00442078046659953,0.00243153558926488,-0.000345029288359642,0.0091865902215587,0.0690705577887599
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41828,-0.00542774655474523,0.00298942995851146,-0.0112870292734277,0.00043153616393723,0.0694473229474157
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,39652,0.020438613526558,0.0112759918417943,-0.00166233048335887,0.0425395575364749,0.069924071510215
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39868,0.00599396213947673,0.00331272239532485,-0.000498973755359983,0.0124868980343134,0.0704191640467751
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,39696,0.00757599004304426,0.00419393664705014,-0.000644125785174018,0.0157961058712625,0.0708806233993795
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41863,0.033147700256568,0.0183762052917158,-0.00286966211519489,0.0691650626283309,0.0712793632497633
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39696,0.0141444156064319,0.00784455054852916,-0.00123090346868521,0.0295197346815491,0.0714015009604246
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,39744,0.00524761331772042,0.00291371888458912,-0.000463275696074262,0.0109585023315151,0.0717296007934917
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,41980,0.0134939691039861,0.0074977428366567,-0.00120160685586101,0.0281895450638332,0.0719246127924331
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39858,0.00730725161250889,0.00406215554613621,-0.000654573257918073,0.0152690764829359,0.0720675056077305
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39512,0.0235160603137599,0.0130759368430824,-0.00211277589868162,0.0491448965262015,0.0721376910694791
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,42015,0.0141266927137975,0.0078655143196162,-0.00128971535265023,0.0295431007802453,0.0725123800121172
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41771,0.0112307115095553,0.00625996954146313,-0.00103882879171247,0.023500251810823,0.0728277806335224
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39526,0.0114575605942699,0.00639628082071571,-0.00107914981433288,0.0239942710028727,0.0732752722290492
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39500,0.0147747808180215,0.00825827842284387,-0.00141144489075249,0.0309610065267955,0.0736285185289881
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42072,0.00892356772003091,0.00500041090496925,-0.000877237653708819,0.0187243730937706,0.0743540923182543
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42111,0.00763811199180232,0.00428040576531321,-0.000751483308211566,0.0160277072918162,0.0743752074555123
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39512,0.0114125956486074,0.00639986165342148,-0.00113113319209869,0.0239563244893135,0.0745723266355512
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,41741,0.00709127233980117,0.00398105416413489,-0.000711593821903204,0.0148941385015056,0.0748939049649957
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39675,-0.00636146638411717,0.00358047595982484,-0.0133791992653739,0.00065626649713952,0.0756434580406471
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39858,0.00864005912715643,0.004865079070289,-0.000895495850610011,0.0181756141049229,0.0757708077867157
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,41686,0.0135271218660031,0.00762126751684608,-0.00141056246701523,0.0284648061990214,0.0759347341834634
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,41771,0.01535934946331,0.00867231590446255,-0.00163838970943657,0.0323570886360566,0.0765708241223001
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41766,0.00582321119417115,0.00328879650980496,-0.000622829965046563,0.0122692523533889,0.0766469311161597
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39872,0.0191926928837738,0.0108558072470152,-0.00208468932037602,0.0404700750879237,0.0770937151516208
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,39639,0.00853468881376278,0.00482768693952754,-0.000927577587711205,0.0179969552152368,0.0771114387191401
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39872,0.00912192330698893,0.00517397602773284,-0.00101906970736744,0.0192629163213453,0.0779209462567761
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41771,0.0140167747071117,0.00795849868356665,-0.00158188271267895,0.0296154321269023,0.0782220857559647
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39526,0.0175693099928841,0.0099963490727437,-0.00202353418969355,0.0371621541754617,0.0788482470276905
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41766,0.0164414614340762,0.00936022083911329,-0.00190457141058584,0.0347874942787383,0.0790220603435968
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39526,0.00667454002260733,0.00380615583876352,-0.000785525421369173,0.0141346054665838,0.079524173561536
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42174,0.00968247244675013,0.00552659115733284,-0.00114964622162223,0.0205145911151225,0.0797999737995661
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39895,0.0187389457738494,0.0106968350054283,-0.00222685083679005,0.0397047423844889,0.0798316392954736
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39696,0.0124102020415397,0.00708903995243049,-0.00148431626522407,0.0263047203483035,0.0800393401376914
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,39858,0.0213111470267229,0.0121736903820276,-0.00254928612205125,0.0451715801754971,0.0800437054994102
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39869,0.0205389752743173,0.0117409611165411,-0.00247330851410322,0.0435512590627377,0.0802588633582946
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39858,0.00548142684824497,0.00313963557376191,-0.000672258876328375,0.0116351125728183,0.0808590889537134
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,42236,-0.0082486129141394,0.00472568839072108,-0.0175109621599527,0.00101373633167392,0.0809231988188298
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39872,0.0189783024194731,0.0108917265754897,-0.00236948166848664,0.0403260865074328,0.08145678945872
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,39597,0.00752411454473941,0.00431884670119445,-0.0009408249896017,0.0159890540790805,0.0815087083014616
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39512,0.0112033686033822,0.00643192313465493,-0.00140320074054145,0.0238099379473059,0.0815649594288885
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,42187,-0.00884490288748228,0.00508035523438152,-0.01880239914687,0.00111259337190549,0.0817060611617922
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39526,0.0159230068615187,0.00918028706444025,-0.00207035578478417,0.0339163695078216,0.0828614910369368
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39858,0.00837321339390567,0.00483673987863392,-0.00110679676821682,0.0178532235560282,0.0834490514340038
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,41943,0.00686463133626927,0.0039702040012779,-0.000916968506235416,0.014646231178774,0.0838255259127854
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39575,0.00887172030343335,0.00514020173612299,-0.00120307509936771,0.0189465157062344,0.0843849346222085
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42063,-0.00978251324699518,0.00567087661926622,-0.020897431420757,0.00133240492676661,0.0845424435440114
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39858,-0.011612282954137,0.00673305420734591,-0.024809069200535,0.001584503292261,0.0846147734789274
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39590,0.019702372022538,0.0114337672455227,-0.00270781177868653,0.0421125558237625,0.0848851674825304
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42072,0.0154181892414439,0.0089574877447072,-0.00213848673818218,0.0329748652210701,0.085226129050639
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39696,0.0123372070521405,0.0071687773065137,-0.00171359646862631,0.0263880105729074,0.0852852489006865
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41771,0.0113934944379285,0.00662264291269518,-0.00158688567095405,0.0243738745468111,0.085386000169455
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,39500,0.00995390353871861,0.00579209964278812,-0.0013986117611461,0.0213064188385833,0.0857281779796268
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40452,-0.00582601381084662,0.00339034566698144,-0.0124710913181303,0.000819063696437005,0.0857474410173631
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39512,0.00722283887544299,0.0042094809980618,-0.00102774388075814,0.0154734216316441,0.0862178460799305
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41771,0.00663015919239394,0.00387637219908826,-0.000967530317819055,0.0142278487026069,0.0872149003079299
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39590,0.00937053832290012,0.00547871026524569,-0.00136773379698143,0.0201088104427817,0.0872285105204787
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41828,0.00614296614658178,0.00359526752626104,-0.000903758204889856,0.0131896904980534,0.087543782004067
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41771,0.0074378783869107,0.00436531853733347,-0.00111814594626291,0.0159939027200843,0.0884314013623275
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39590,0.0114867381857734,0.00675227549091516,-0.00174772177642028,0.0247211981479671,0.0889402002052623
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39500,0.0146859267640627,0.00863984202726771,-0.00224816360938196,0.0316200171375074,0.0891987532387651
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39526,0.0114700595977143,0.00674960136632229,-0.00175915908027741,0.024699278275706,0.0892782490232069
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39696,0.00634507204260413,0.00373562546551378,-0.000976753869802875,0.0136668979550111,0.0894358047515836
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42039,0.0079833062771204,0.00470078292848073,-0.00123022826270183,0.0171968408169426,0.0894756427772017
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,39858,-0.0143210846066992,0.0084338288382631,-0.0308513891296948,0.00220921991629649,0.0895254781787255
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39597,0.0156844826001063,0.00923717310756418,-0.00242037669071948,0.0337893418909321,0.0895409027510767
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AFM,Afamin,39917,-0.00370366838496953,0.0021899034279033,-0.00799587910365999,0.000588542333720925,0.0908171035235523
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39927,0.00396991203003944,0.00235023245642713,-0.000636543584557734,0.00857636764463662,0.0912168346191804
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42048,0.0175659401191419,0.0104004999855174,-0.00281903985247229,0.0379509200907561,0.0912519060824867
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39872,0.0114606874865008,0.00678574808084821,-0.00183937875196165,0.0247607537249633,0.0912595435499793
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39512,0.0115011107428138,0.00682125196099197,-0.00186854310073043,0.0248707645863581,0.0918108365751159
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,42108,0.0128168222913253,0.00760902569765189,-0.0020968680760724,0.027730512658723,0.0921229395195567
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39696,0.00646689585248475,0.00383931853379495,-0.00105816847375335,0.0139919601787228,0.0921351452928357
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,39696,0.00610949295181409,0.00363060374880223,-0.00100649039583829,0.0132254762994665,0.0924465914261621
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,42222,0.00732111563487236,0.00435432677771119,-0.00121336484944157,0.0158555961191863,0.0927192880018455
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42236,0.00775628404056476,0.00461565452817463,-0.00129039883465751,0.016802966915787,0.0928966003021147
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39917,-0.00598663852947651,0.0035638533838768,-0.012971791161875,0.00099851410292203,0.093019597930833
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,41771,0.0087106650178338,0.00520081344096623,-0.00148292932646001,0.0189042593621276,0.093984287837074
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39597,0.0176177655091115,0.0105243748281379,-0.00301000915403868,0.0382455401722617,0.0941597459031401
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",41995,0.0154184010040167,0.00923606615146261,-0.00268428865284997,0.0335210906608835,0.095067673375927
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,39526,0.0116630662795399,0.006987230166887,-0.00203190484755859,0.0253580374066385,0.095106918436535
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39590,0.00739366444347042,0.00443222269621282,-0.0012934920411067,0.0160808209280475,0.0953121061068812
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39872,0.00708977224887548,0.00425189295765573,-0.00124393794812976,0.0154234824458807,0.0954549181204877
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39869,0.0158742299742625,0.00953563751805567,-0.00281561956112665,0.0345640795096516,0.0959951020149391
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42063,0.00803711066271083,0.00483109704904198,-0.00143183955341146,0.0175060608788331,0.0962116257424205
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,39895,0.0116982182601594,0.00703958047880362,-0.00209935947829566,0.0254957959986145,0.0965850942033622
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39917,0.00329851287998809,0.00198872461099451,-0.000599387357561151,0.00719641311753733,0.0972226898719432
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39895,0.00723611451921262,0.00436366503984395,-0.00131666895888152,0.0157888979973068,0.0972916877718359
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39696,0.00723616896760281,0.00436470325845561,-0.00131864941897019,0.0157909873541758,0.0973692757954437
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,41828,0.00873282281868937,0.00529106708661272,-0.00163766867107156,0.0191033143084503,0.0988676751250323
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39597,0.011835511837999,0.00717168921452044,-0.00222099902246108,0.025892022698459,0.0989080650755326
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",41972,0.0135744692998311,0.00822783269717082,-0.00255208278662371,0.0297010213862859,0.0990025884989322
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39526,0.0136266862211889,0.00826584473398955,-0.00257436945743056,0.0298277418998085,0.0992679183833456
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41771,0.00941579766957989,0.00571239921134263,-0.00178050478465167,0.0206121001238114,0.0993131788221671
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39590,0.00963760341622054,0.00584697595305541,-0.00182246945176806,0.0210976762842091,0.0993185532046299
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,41842,0.00886802179071961,0.00538607286413315,-0.00168868102298137,0.0194247246044206,0.0996902114205295
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39927,0.0108515267364454,0.00659133183134734,-0.00206748365299539,0.0237705371258862,0.099722972833308
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39858,0.00784162779856585,0.00476695737861674,-0.00150160866352297,0.0171848642606547,0.0999984683417962
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,39597,0.0084267466922885,0.00512473321893216,-0.00161773041681853,0.0184712238013955,0.100136876062441
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,39869,0.0121103415329744,0.00736951179355332,-0.00233390158239016,0.0265545846483389,0.100348136149335
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,39696,0.00631554119862175,0.00385641071730336,-0.00124302380729284,0.0138741062045363,0.101518200519258
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,39526,0.00861421111663611,0.00526783764500214,-0.00171075066756809,0.0189391729008403,0.102026267585989
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,39858,0.00822651182182298,0.00503216993090487,-0.00163654124275055,0.0180895648863965,0.102122255327152
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,39500,0.00934873973140027,0.00572810776159304,-0.00187835148132209,0.0205758309441226,0.10269116742369
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39868,0.00735285372138534,0.00451199577224392,-0.00149065799221275,0.0161963654349834,0.10320907557377
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39696,0.0100687672850064,0.0061901568745422,-0.00206394018909634,0.0222014747591091,0.103855346492286
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42111,0.0212630953310655,0.0130755189316885,-0.00436492177504396,0.046891112437175,0.10393553732968
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41766,0.0150536615792702,0.00925859365834756,-0.00309318199109098,0.0332005051496315,0.103992240162767
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39675,-0.00723239767471514,0.0044509489103825,-0.0159562575390648,0.00149146218963456,0.104209891583339
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,39675,0.00896779749328148,0.00552946294066455,-0.00186994987042103,0.019805544856984,0.104870208687961
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,41686,0.0129578348134953,0.00799322128088799,-0.0027088788970452,0.0286245485240357,0.105019648437303
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,39597,0.0077090080224022,0.00475960345622671,-0.00161981475180215,0.0170378307966065,0.105330905293237
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39500,-0.00458625194895566,0.00283174714561736,-0.0101364763543657,0.000963972456454362,0.10535063010503
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41710,0.00963563402568495,0.0059539018068,-0.00203401351564305,0.021305281567013,0.105606289389782
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39597,0.0072599197945174,0.00449014047456629,-0.00154075553563253,0.0160605951246673,0.105937606775709
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,42063,-0.00350278955317443,0.00216708137967704,-0.00775026905734143,0.000744689950992567,0.106039343569815
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39696,0.0115088957243883,0.00712796053648975,-0.00246190692713158,0.0254796983759082,0.106423022897758
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,42236,-0.0113290203389257,0.00701962913564786,-0.0250874934447955,0.0024294527669441,0.10657099381361
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42236,0.00443378564823568,0.00274733083160369,-0.000950982781707541,0.00981855407817891,0.106582647841182
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39677,0.00925457618430946,0.00574394913667389,-0.00200356412357136,0.0205127164921903,0.10716746141558
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39869,0.0172819412532105,0.0107315260475873,-0.0037518498000607,0.0383157323064817,0.107340770136408
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39500,0.00762199913359541,0.00474107388349459,-0.00167050567805399,0.0169145039452448,0.107940277245148
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,41895,0.0183651433734332,0.0114322522287769,-0.00404207099496946,0.0407723577418358,0.108202627728183
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39512,0.0045924585483599,0.00286047424039672,-0.00101407096281767,0.0101989880595375,0.108415274952754
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HLA_DRA,,41989,0.00634280761839042,0.00395363578663095,-0.00140631852340624,0.0140919337601871,0.108672099529305
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,39858,0.0070542166607697,0.00439762868464285,-0.00156513556113028,0.0156735688826697,0.108721040591558
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39500,-0.00839370434438376,0.00523849949361505,-0.0186611633518693,0.00187375466310175,0.109115873676476
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41828,0.0154889198518923,0.00966775909408218,-0.00345988797250879,0.0344377276762934,0.109152732588211
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39652,0.014992883858035,0.00936112878514546,-0.0033549285608501,0.0333406962769201,0.109270306575156
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42138,0.00575230596102745,0.00359244758498761,-0.00128889130554826,0.0127935032276032,0.109351098863598
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41828,-0.00996043348512357,0.00622142443831186,-0.0221544253842148,0.00223355841396767,0.109403185154235
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39597,0.00959543011836381,0.00601771746120622,-0.00219929610560039,0.021390156342328,0.110846147732855
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,41828,0.00563033033783544,0.00353228404637703,-0.00129294639306354,0.0125536070687344,0.110968197048137
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,39858,0.0145092103895499,0.00911859531374986,-0.0033632364253998,0.0323816572044996,0.111600014179025
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,41599,0.00632499519507728,0.00398423417945425,-0.00148410379665305,0.0141340941868076,0.112422437659625
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39590,0.0132734157358813,0.00838975144745044,-0.00317049710112162,0.0297173285728841,0.113655792280705
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39526,0.0141473381577732,0.00894458149375097,-0.00338404156997873,0.0316787178855251,0.113754841393454
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,39868,0.00654413803110443,0.00413763970776012,-0.0015656357961054,0.0146539118583143,0.113766381941048
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39512,0.0119201517220203,0.00754992158389757,-0.00287769458241898,0.0267179980264595,0.114400727909979
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39597,0.0151652956895802,0.00961143025787001,-0.00367310761584497,0.0340036989950055,0.11463121661678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39872,0.00918777255310055,0.00582973838163759,-0.00223851467490913,0.0206140597811102,0.115049720843215
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41766,0.0129712284089706,0.00824069538476203,-0.00318053454516294,0.0291229913631042,0.115500988771945
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42048,0.00848231452298635,0.00538957736716972,-0.0020812571166663,0.019045886162639,0.115548736903924
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,41748,-0.0201795600142852,0.0128234540006187,-0.0453135298554979,0.00495440982692746,0.115593681376443
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41766,0.0106451599897994,0.00676542979873581,-0.00261508241572279,0.0239054023953216,0.115635454308728
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,39590,0.00584338707372612,0.00371407269141823,-0.00143619540145361,0.0131229695489059,0.11567588013987
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41842,0.0053389715808226,0.00341263951304401,-0.00134980186474366,0.0120277450263889,0.117731166943554
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,39526,0.0073306337640165,0.00468845849490611,-0.00185874488599948,0.0165200124140325,0.117952522522795
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,39500,0.00620998941896813,0.00397248897418751,-0.00157608897043938,0.0139960678083756,0.118023069176903
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39597,0.0106143875995389,0.00679280137576615,-0.00269950309696279,0.0239282782960405,0.118177001604419
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39675,0.0162583029175664,0.010407139248744,-0.00413969000997182,0.0366562958451046,0.118263343426145
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42063,0.00656887486328835,0.00420523498284398,-0.00167338570308586,0.0148111354296626,0.118294810133038
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,39512,0.00591672858983774,0.00378850320357288,-0.0015087376891651,0.0133421948688406,0.118373796914679
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39858,0.0103984636244028,0.00666481280430383,-0.00266456947203267,0.0234614967208383,0.118739929897146
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,42072,0.011391249622266,0.00730719945111142,-0.00293086130191233,0.0257133605464444,0.119041712722424
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,39852,0.01647617709958,0.0105700201274015,-0.00424106235012694,0.037193416549287,0.119080142003752
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39500,0.0160586174907351,0.0103133555060211,-0.00415555930106636,0.0362727942825365,0.119482875321289
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39895,0.00481957701937719,0.00310151844606296,-0.00125939913490621,0.0108985531736606,0.120226481544584
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,42009,-0.0147824918286357,0.00952426961667864,-0.0334500602773258,0.00388507662005448,0.120665089417659
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39597,0.00612114448808684,0.00394513943325635,-0.0016113288010956,0.0138536177772693,0.120794863267414
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,41766,-0.0138045743715819,0.00890566697634252,-0.0312596816452132,0.00365053290204947,0.121144246584927
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39575,0.0130118416789356,0.00840017772231929,-0.00345250665681017,0.0294761900146814,0.121411515618759
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39675,0.00629449124477244,0.00406697822306271,-0.00167678607243047,0.0142657685619754,0.121721394585598
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39675,0.00839014458523926,0.00542328559532103,-0.00223949518158995,0.0190197843520685,0.121877512228264
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,42135,0.00710765724137685,0.00459524944223081,-0.00189903166539554,0.0161143461481492,0.121949274372245
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,41943,0.0068319653652123,0.00441842378741357,-0.00182814525811831,0.0154920759885429,0.122069142953024
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,39597,0.00822128950518466,0.00532077507822077,-0.00220742964812804,0.0186500086584974,0.122343582497925
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41842,0.0102494096697625,0.00665090601170053,-0.00278636611317058,0.0232851854526955,0.123327379280535
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,39526,0.0152810428274506,0.00992173078009688,-0.00416554950153926,0.0347276351564405,0.123550563300645
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,41995,0.00573383944702275,0.003724363475466,-0.0015659129648906,0.0130335918589361,0.123693986526864
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39895,-0.0128661277345459,0.00836099767420168,-0.0292536831759812,0.00352142770688943,0.123874584565037
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39500,0.0244281939981446,0.0159037784880124,-0.00674321183835968,0.0555995998346489,0.124567555791315
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39895,0.00905464979627446,0.00589553288441375,-0.00250059465717649,0.0206098942497254,0.1246033657006
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39833,0.00639101094841117,0.00416309294566816,-0.00176865122509843,0.0145506731219208,0.124772861111721
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,39597,0.00999578464377884,0.00653722341587767,-0.00281717325134139,0.0228087425388991,0.12627917370879
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39858,0.00983137766917863,0.00643129121394619,-0.0027739531101559,0.0224367084485131,0.126372218427716
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,42222,0.0101557032607569,0.00664588355958979,-0.00287022851603909,0.0231816350375529,0.126506126701354
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,42142,0.00491377095632784,0.00321843013156325,-0.00139435210153613,0.0112218940141918,0.126844011829086
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,42048,0.00987853759812217,0.00647128500179403,-0.00280518100539413,0.0225622562016385,0.12690425310153
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41771,0.009935738337389,0.00651571624030553,-0.00283506549360985,0.0227065421683878,0.127311013675181
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39858,0.010762921947301,0.00706495666907284,-0.00308439312408174,0.0246102370186838,0.127680841242176
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41828,0.0157423601056367,0.010335421451744,-0.00451506593978144,0.0359997861510549,0.127745983872505
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,39597,0.00712002970436597,0.00468207965390425,-0.00205684641728636,0.0162969058260183,0.128364362254236
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39675,-0.00506267934277596,0.003338073427157,-0.0116053032600037,0.00147994457445175,0.129384351043286
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39904,-0.0105529796400542,0.00696518471015835,-0.0242047416719646,0.00309878239185617,0.129774013566727
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41766,0.00840439895724834,0.00555047491072304,-0.00247453186776881,0.0192833297822655,0.130005071785885
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42108,0.00753288588803877,0.00497542621462709,-0.00221894949263032,0.0172847212687079,0.130044617675861
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,39858,0.016509959167849,0.0109162794623869,-0.00488594857842922,0.0379058669141273,0.130456056145892
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39575,0.00405592744114604,0.00268558622558234,-0.00120782156099534,0.00931967644328742,0.131006453790834
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,39917,-0.00674680532961527,0.00446793750517481,-0.0155039628397579,0.00201035218052736,0.131058795995176
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39872,0.0132579120144738,0.00881916479843267,-0.00402765099045422,0.0305434750194018,0.132787915513583
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39590,0.00972770599457333,0.00647100040675232,-0.00295545480266122,0.0224108667918079,0.132796365649096
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41771,0.00846832564697562,0.00564717693835745,-0.00260014115220498,0.0195367924461562,0.13375031823464
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42236,0.00531597588424421,0.00355491843265272,-0.00165166424375512,0.0122836160122435,0.134836827557949
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42187,0.00863104383085893,0.00577939909174269,-0.00269657838895674,0.0199586660506746,0.135351694576777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39575,0.00652707094161946,0.0043721504611827,-0.00204234396229863,0.0150964858455376,0.135498845787638
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,39917,0.00415550083104774,0.00279880768967097,-0.00133016224070735,0.00964116390280284,0.137640648236432
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39904,0.00655043785634855,0.00441884591319136,-0.00211050013350651,0.0152113758462036,0.138265340371588
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,42092,-0.0140072688519426,0.00947440239476094,-0.0325770975456741,0.0045625598417888,0.139315270841365
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39564,0.0126500378728559,0.00859594629240668,-0.00419801686026122,0.0294980926059729,0.141149978617491
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39927,0.00764329074769077,0.0051969395193107,-0.00254271071015821,0.0178292922055397,0.141392141389444
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42048,0.0063006789225306,0.00428546442399824,-0.00209883134850595,0.0147001891935671,0.141519041168898
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39590,0.00535057364658187,0.00364691466503716,-0.00179737909689096,0.0124985263900547,0.142363661421897
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41842,0.00889449688802285,0.00606540845806797,-0.00299370368979037,0.0207826974658361,0.142554926116778
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42056,0.00520461731135511,0.00355314369322226,-0.00175954432736052,0.0121687789500707,0.143000972302876
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41766,0.00664611778777046,0.00453938326862479,-0.00225107341873414,0.0155433089942751,0.143190096295757
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,39869,0.0191420076241486,0.0130795702155254,-0.00649394999828112,0.0447779652465784,0.143357321451341
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42039,-0.00824184690524391,0.00563531588664489,-0.0192870660430679,0.00280337223258007,0.143618035863336
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,39696,0.00687196641180392,0.00470095884268234,-0.00234191291985346,0.0160858457434613,0.143818233702488
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39872,0.0188704355146674,0.0129090629631443,-0.00643132789309538,0.0441721989224301,0.143824595645542
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42108,0.0113110150630299,0.00773878429272081,-0.00385700215070286,0.0264790322767627,0.143873834599187
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39858,0.00953247381313322,0.0065272837827414,-0.00326100240103992,0.0223259500273064,0.14420687552882
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39597,0.0145066258388985,0.00995235893220772,-0.00499999766822862,0.0340132493460256,0.144977515081018
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,41995,0.0122930005360236,0.00843765350242905,-0.00424480032873738,0.0288308014007845,0.14516143393834
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41696,-0.0132831033659414,0.00913000060678021,-0.0311779045552306,0.0046116978233478,0.145724994856007
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,39696,0.004352680010357,0.00299351025412889,-0.00151460008773563,0.0102199601084496,0.145963837188804
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,41828,0.0169955619480568,0.0116927155808327,-0.00592216059037539,0.039913284486489,0.146103960544507
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39597,0.0051124186562428,0.00351816745496988,-0.00178318955549817,0.0120080268679838,0.146211148387825
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39481,0.00418424463726878,0.00288617092846613,-0.00147265038252483,0.00984113965706238,0.147155296275653
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42072,0.020325646349323,0.0140213758789738,-0.0071562503734657,0.0478075430721118,0.147188202297794
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,41995,0.0179909147889013,0.012412461206513,-0.00633750917586411,0.0423193387536668,0.14724271954982
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42236,0.0110199009791011,0.00760427363146935,-0.00388447533857879,0.025924277296781,0.14731253052281
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41766,0.0107600758362575,0.00743388737497334,-0.00381034341869023,0.0253304950912053,0.147798672561632
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,39872,-0.00955717112801056,0.00660360806226708,-0.022500242930054,0.00338590067403292,0.147850513997705
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,42056,-0.00477015176304517,0.0032977281578447,-0.0112336989524208,0.00169339542633045,0.148061325805307
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39895,-0.00933607620316974,0.0064579447069261,-0.0219936478287449,0.00332149542240542,0.148296689504643
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,41943,-0.017688176091716,0.0122366955787761,-0.0416720994261171,0.00629574724268514,0.148340229940347
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39872,0.00426856895816335,0.00295392063747066,-0.00152111549127915,0.0100582534076059,0.148471074976975
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39597,0.0108556073159451,0.00751385532127588,-0.00387154911375564,0.0255827637456458,0.148557926405872
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42187,0.00841194805129092,0.00583291606992099,-0.00302056744575423,0.0198444635483361,0.149282718084329
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39872,0.0103751554235972,0.00720173288723949,-0.00374024103539219,0.0244905518825866,0.149712188958307
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,41943,0.00829696632753245,0.00576134262559652,-0.00299526521863673,0.0195891978737016,0.149859781487836
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39575,0.00644148218381659,0.00447961765697488,-0.00233856842385418,0.0152215327914874,0.150475741603235
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41766,0.00946270905064986,0.00658513099536664,-0.00344414770026876,0.0223695658015685,0.150747115113061
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42111,0.00434303572027241,0.00302661055075923,-0.00158912095921569,0.0102751923997605,0.15132440712487
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNST,Consortin,42072,-0.0169676642913087,0.0118317974412686,-0.0401579872761951,0.00622265869357765,0.151574568270194
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39858,0.00902292110586506,0.00629332265477472,-0.00331199129749339,0.0213578335092235,0.151677298493439
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39526,0.00809541418717747,0.00566892198641872,-0.00301567290620323,0.0192065012805582,0.153310611652944
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39744,0.00869615205339012,0.00609467909480685,-0.00324941897243131,0.0206417230792115,0.153653082072282
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,42038,0.0102424138513092,0.00720410108997168,-0.00387762428503532,0.0243624519876537,0.155122727110194
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,39917,-0.00315469961612212,0.00222055746330762,-0.00750699224420506,0.00119759301196082,0.155437616621356
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,39597,0.015614576984956,0.0110041687625171,-0.00595359378957746,0.0371827477594894,0.155936325207834
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39526,0.00949861851243366,0.0067085352959145,-0.00365011066755875,0.0226473476924261,0.156833142240943
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39696,0.00851876704148295,0.00602520915096701,-0.00329064289441239,0.0203281769773783,0.157432781596222
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39500,0.00862327546575866,0.00609948138478626,-0.00333170804842242,0.0205782589799397,0.157457441656662
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",41995,0.0068082898390459,0.00482042867423208,-0.00263975036244898,0.0162563300405408,0.15786055321298
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39512,0.00592711723459258,0.00421570375667645,-0.00233566212849327,0.0141898965976784,0.159764026713797
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39512,0.0114254449085966,0.00813071748595797,-0.00451076136388098,0.0273616511810742,0.159984406760277
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42034,0.016714831935919,0.011897605856776,-0.00660447554336205,0.0400341394152001,0.160077001387382
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,39512,0.0170349588285311,0.0121292856683516,-0.00673844108143805,0.0408083587385002,0.160213756311141
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39869,-0.00462129144698606,0.00329122960384306,-0.0110721014705185,0.00182951857654634,0.160309760598031
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42222,0.00604208885130863,0.00431372765815821,-0.00241281735868145,0.0144969950612987,0.161336947633272
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,42133,0.0170277742385218,0.0121737665080339,-0.00683280811722468,0.0408883565942682,0.161917821810545
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,39904,0.00657209695485523,0.00470582743632611,-0.00265132482034394,0.0157955187300544,0.162565251171353
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41766,0.00678949651845303,0.00488023938120651,-0.00277577266871174,0.0163547657056178,0.164181617714474
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39512,0.00846220109232654,0.00609012084946719,-0.00347443577262915,0.0203988379572822,0.164710199764685
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,39868,-0.00581252934583755,0.00419396770621343,-0.0140327060500159,0.00240764735834076,0.165796893784789
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42013,0.0288890185288645,0.0208480922798683,-0.0119732423396773,0.0697512793974063,0.165864247797175
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,39512,0.00508677004867526,0.00367200936353674,-0.00211036830385674,0.0122839084012073,0.165994440536694
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41828,-0.00916312170258185,0.00662021534820592,-0.0221387437850655,0.00381250037990175,0.166347412127852
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39696,0.0114582611483167,0.00828669126062495,-0.00478365372250818,0.0277001760191416,0.166775327518797
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42108,0.0124998078563952,0.00904985847967625,-0.00523791476377022,0.0302375304765607,0.167235454087344
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39500,0.00500894744445514,0.00362888022786492,-0.00210365780216011,0.0121215526910704,0.167522256407926
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39869,0.0126099841936853,0.00913951961792043,-0.00530347425743875,0.0305234426448093,0.167700038755218
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39872,0.0101272586086327,0.00734009142147777,-0.00425932057746375,0.0245138377947291,0.167700757244345
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,39872,0.0103963306102625,0.00753526244871341,-0.00437278378921578,0.0251654450097408,0.167709302049684
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,39927,-0.00433984846180604,0.00315285121649989,-0.0105194368461458,0.00183973992253376,0.168699123540554
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41771,0.0115384798712007,0.00838793262304603,-0.00490186806996948,0.027978827812371,0.168967431402176
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39526,0.00724256112038225,0.00527468561041672,-0.00309582267603453,0.017580944916799,0.169755902871635
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39590,0.00814581649137741,0.00593519276837561,-0.00348716133463879,0.0197787943173936,0.169948195465763
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,42236,0.0110137178803228,0.00803630983169469,-0.00473744938979881,0.0267648851504444,0.170555171960644
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39500,0.00939487741736384,0.00687675482805861,-0.00408356204563104,0.0228733168803587,0.171910999203753
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FURIN,Furin,42108,-0.00491078275385424,0.00359796167461606,-0.0119627876361017,0.00214122212839324,0.172313779846504
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39590,0.00580217054106903,0.00426494688072613,-0.00255712534515419,0.0141614664272923,0.173721134752212
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,41842,0.0107839343335213,0.00794941891625956,-0.00479692674234749,0.02636479540939,0.174941361253696
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39868,0.00818871726131321,0.00604339066174648,-0.00365632843570989,0.0200337629583363,0.175448784310379
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39512,0.0071285991834849,0.00526227294460484,-0.00318545578794059,0.0174426541549104,0.175553438171633
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39667,-0.00713506241408402,0.00526739451201751,-0.0174591556576383,0.0031890308294703,0.175581775900434
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42108,0.00547425650313158,0.00405227668166424,-0.00246820579293033,0.0134167187991935,0.176747254674936
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,39696,0.0126656054793958,0.00937615974057615,-0.00571166761213341,0.0310428785709251,0.176777180572458
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39696,0.0108941655744531,0.00806669911029318,-0.00491656468172156,0.0267048958306277,0.176879682003044
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39868,0.00533972354107374,0.00396014088681893,-0.00242215259709136,0.0131015996792388,0.177567453261231
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39597,0.00612610175431558,0.00454885104737103,-0.00278964629853162,0.0150418498071628,0.178093006324039
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39575,0.0128506655806227,0.00955402919878767,-0.00587523164900109,0.0315765628102466,0.178636251905955
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,39675,0.0093792947942685,0.00698416072618583,-0.00430966022905572,0.0230682498175927,0.179319573208019
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39590,0.00909497140230788,0.0067738561497809,-0.00418178665126268,0.0223717294558784,0.179410506850351
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,42187,-0.00544889015250594,0.00406228814481764,-0.0134109749163485,0.00251319461133664,0.179834060120607
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42047,0.0106630495989623,0.00795305537755442,-0.00492493894104438,0.0262510381389689,0.180024666939379
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,39500,0.00497871895345856,0.00371580994669726,-0.00230426854206806,0.0122617064489852,0.180314084728708
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39512,0.0073916116367212,0.00551774373470947,-0.00342316608330936,0.0182063893567518,0.180400838220999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,39512,0.00740912296645987,0.00553450834447905,-0.00343851338871907,0.0182567593216388,0.180691735028988
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39872,0.017086483457131,0.0127943127503239,-0.00799036953350384,0.0421633364477658,0.181747932960397
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39500,0.00972988353039035,0.00728880693883001,-0.00455617806971646,0.0240159451304972,0.181934481403463
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39575,0.0106584662108488,0.00798726358979927,-0.00499657042515779,0.0263135028468553,0.182089753858055
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,39590,0.0118715042936693,0.00891892178764723,-0.0056095824101193,0.0293525909974578,0.183201150592743
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39526,-0.005421163130093,0.00407372353696131,-0.0134056612625372,0.00256333500235117,0.183294568407893
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39858,0.0063764154668394,0.00479494490255022,-0.00302167654215904,0.0157745074758378,0.18360440024521
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42179,0.00816530157894118,0.00615700584556064,-0.00390242987835768,0.02023303303624,0.184802195942785
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,42124,0.00368382026517848,0.00278089121557718,-0.0017667265173528,0.00913436704770975,0.185296197697535
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39696,0.00880226161765952,0.00664806970725894,-0.00422795500856801,0.021832478243887,0.185519461969958
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41842,0.00895777877064144,0.00676694177335399,-0.00430542710513238,0.0222209846464153,0.185606994093137
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42048,0.0172532471765402,0.0130347737824905,-0.00829490943714128,0.0428014037902216,0.185647703575963
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,41842,-0.00489544908908197,0.0037012611161477,-0.0121499208767315,0.00235902269856751,0.185976790462481
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39868,0.00686482804413027,0.0051919710918839,-0.00331143529596218,0.0170410913842227,0.186128151247468
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39510,0.0145960499330562,0.0110512771592164,-0.00706445329900799,0.0362565531651204,0.186610156696892
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39675,0.00963561629898295,0.00730575170483801,-0.00468365704249956,0.0239548896404655,0.187227052888274
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39904,0.00488761324464441,0.00370670617144619,-0.00237753085139013,0.0121527573406789,0.187334055783768
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42111,0.0126092943120325,0.00958186409218605,-0.00617115930865217,0.0313897479327171,0.188211741402985
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42048,0.0141758173039158,0.0107829529513409,-0.00695877048071227,0.0353104050885439,0.188649721132622
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41771,0.0176200290469965,0.0134483179724852,-0.00873867417907445,0.0439787322730675,0.190149957038052
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,42187,0.00236286029520265,0.00180981191290621,-0.00118437105409352,0.00591009164449882,0.191716392395622
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39895,0.00568032836354889,0.00435214888846488,-0.00284988345784227,0.0142105401849401,0.191858879047335
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39512,0.00467437795867914,0.0035834308702594,-0.00234914654702929,0.0116979024643876,0.192110412800423
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41766,0.00744782897980557,0.00571164241600209,-0.00374699015555853,0.0186426481151697,0.192265496930035
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,38447,0.0151224912217684,0.0115994583580865,-0.00761244716008105,0.0378574296036179,0.192358211186913
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,41943,0.00817003685949007,0.0062712530233233,-0.00412161906622359,0.0204616927852037,0.192673788055543
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41409,0.004238698863338,0.00325360752112862,-0.0021383718780741,0.0106157696047501,0.192677073668261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,39590,0.00913749376458147,0.00702247894859922,-0.00462656497467299,0.0229015525038359,0.193224877493841
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,39858,0.0074700459100289,0.00574585115226786,-0.0037918223484161,0.0187319141684739,0.193601375586933
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39872,0.0082553460712924,0.00635926923116696,-0.00420882162179483,0.0207195137643796,0.19425907582741
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39575,0.0106747189140711,0.00822723338623885,-0.00545065852295703,0.0268000963510992,0.194491341376997
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,39590,0.00532002880817185,0.00411441333669271,-0.00274422133174585,0.0133842789480896,0.196030475007991
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41828,-0.00715668810350738,0.00553949558693099,-0.0180140994538921,0.00370072324687735,0.196400983784623
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,42017,-0.0144566067304677,0.0112076622979546,-0.0364236248344586,0.00751041137352331,0.197112473126623
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39696,0.0095654708431127,0.00743021792251274,-0.00499775628501227,0.0241286979712377,0.197990744447087
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39868,-0.00353930823095725,0.00275274209734976,-0.00893468274176278,0.00185606627984829,0.198560541612928
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,42072,0.0171506712494249,0.013343586079003,-0.00900275746542103,0.0433040999642708,0.198705375010566
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39590,0.00474196298730703,0.00368980559201369,-0.00249005597303979,0.0119739819476539,0.198766071336825
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39512,0.0049530898178511,0.00387753591859944,-0.0026468805826038,0.012553060218306,0.201495027504564
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,39575,0.00569331212569365,0.00445732881975599,-0.00304305236102809,0.0144296766124154,0.201526063630077
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,39869,-0.00606312697845498,0.00474708755072537,-0.0153674185778767,0.00324116462096674,0.201547049642756
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39904,0.00544488767802663,0.00426751293829431,-0.00291943768103021,0.0138092130370835,0.202019744768825
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39526,0.0114741575317629,0.00905913474901011,-0.00628174657629689,0.0292300616398227,0.205330981722017
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39512,0.0102767369920486,0.00812719419546794,-0.00565256363106856,0.0262060376151658,0.206082043994029
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41856,0.00626344100544452,0.0049603197808,-0.00345878576492347,0.0159856677758125,0.206715948217857
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,39895,-0.00378468488873553,0.00299850868193748,-0.00966176190533299,0.00209239212786193,0.206906821119952
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41842,0.0081585821247829,0.00647009078886886,-0.00452279582140007,0.0208399600709659,0.207342331289749
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39575,0.00669756771426245,0.00531792334411194,-0.00372556204019695,0.0171206974687218,0.20790078919334
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42048,0.0138519290730672,0.011048381512666,-0.00780289869175814,0.0355067568378926,0.209953999557796
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39500,0.00635495722566728,0.00508108214284036,-0.00360396377429983,0.0163138782256344,0.211067364119839
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42108,0.00827101257850679,0.00661650966911554,-0.00469734637295966,0.0212393715299732,0.211300472934221
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,42236,-0.00841346411576925,0.006734242788051,-0.0216125799803492,0.00478565174881072,0.211556475327955
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39696,0.0092399570937922,0.00740141391817203,-0.00526681418582499,0.0237467283734094,0.211909368771652
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,39590,0.0123035012255013,0.00989374556551527,-0.00708824008290864,0.0316952425339112,0.21368676897099
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39597,0.00671089779004283,0.00539949983472053,-0.0038721218860094,0.0172939174660951,0.213940778506051
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,42187,0.0052685131493049,0.00425901003271639,-0.00307914651481923,0.013616172813429,0.216098199396783
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39858,0.0065675401702649,0.00531243469337891,-0.00384483182875775,0.0169799121692876,0.216388449543283
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,39696,0.00754042842695272,0.0061028252647881,-0.00442110909203195,0.0195019659459374,0.216647000072661
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42198,0.00685128708887351,0.00555182687438861,-0.00403029358492817,0.0177328677626752,0.217201900480685
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39590,-0.00863903191425262,0.00700156028188494,-0.0223620900667471,0.00508402623824187,0.217276845271268
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39500,0.00357058892597572,0.00289449021044828,-0.00210261188650291,0.00924378973845436,0.217385573120053
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,39868,0.0112820811978586,0.00917853102579492,-0.00670783961269946,0.0292720020084166,0.21902940378324
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39597,0.00542939987613815,0.00442968532888512,-0.00325278336847668,0.014111583120753,0.220343398722701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39512,-0.00567316507469259,0.00464863128595822,-0.0147844823951707,0.00343815224578552,0.222341650092462
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,42009,-0.00466589418360196,0.00382725915747232,-0.0121673221322477,0.00283553376504378,0.222819500325804
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39500,0.00777511330446756,0.00638313761971819,-0.00473583643018009,0.0202860630391152,0.22322344885076
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39590,0.00889892830083232,0.00731260864825063,-0.00543378464973891,0.0232316412514036,0.223657218508721
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41766,0.00907128402169878,0.00745782218043003,-0.00554604745194409,0.0236886154953416,0.223875367367248
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,41766,0.00478815809343244,0.00394009227906632,-0.00293442277353755,0.0125107389604024,0.224296325884716
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,39660,-0.00765211715225546,0.00630091935036659,-0.020001919078974,0.00469768477446305,0.22460394152841
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,42056,0.0233777637421579,0.0192796524457042,-0.0144103550514223,0.061165882535738,0.225318814980878
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,39872,0.00493144477165251,0.00407347387871129,-0.00305256403062161,0.0129154535739266,0.226064969338631
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42063,0.00422425451791259,0.00349325484074074,-0.00262252496993925,0.0110710340057644,0.226584079664928
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,41943,0.0137680962512843,0.0114248874603076,-0.00862468317091867,0.0361608756734873,0.228187275850007
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,39526,-0.00684764342588789,0.00568506310424409,-0.0179903671102063,0.00429508025843053,0.228423497506885
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39500,0.00343975334302098,0.00285642431743362,-0.00215883831914891,0.00903834500519086,0.228532051928762
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42063,0.00546978082581202,0.00454421794596538,-0.00343688634828013,0.0143764479999042,0.228734740889999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39872,0.0051937725712016,0.00432014380484907,-0.00327370928630258,0.0136612544287058,0.229302724538204
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42236,0.0093722786982065,0.00780201216430289,-0.00591966514382717,0.0246642225402402,0.22966955735254
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41919,0.0044011397728011,0.00366643144224839,-0.00278506585400575,0.0115873453996079,0.230010092855239
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,42011,0.010143614454813,0.00847686464357239,-0.00647104024658891,0.0267582691562148,0.231474535260727
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39512,0.00424637657556184,0.00355053153788598,-0.00271266523869467,0.0112054183898184,0.231729046917787
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41766,0.00822798786355493,0.00689927839173278,-0.00529459778424131,0.0217505735113512,0.233052757587743
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39590,-0.00614703581283386,0.00515695351451382,-0.0162546647012809,0.00396059307561322,0.23329099636399
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,39658,0.00470407919690858,0.00395203032778669,-0.00304190024555333,0.0124500586393705,0.233956290438653
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39500,0.00516604086675958,0.00435057388171115,-0.00336108394139428,0.0136931656749134,0.235080401171942
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,39526,0.00754679115251051,0.00635910361106677,-0.00491705192518036,0.0200106342302014,0.23534429731803
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,42129,-0.00884297759878012,0.00747487638683541,-0.0234937353169775,0.00580778011941728,0.23681939384366
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,39500,0.00512262814758161,0.00434119358929819,-0.00338611128744283,0.0136313675826061,0.238024160540789
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41766,0.0143141834528283,0.0121351464259986,-0.00947070354212893,0.0380990704477855,0.238194929327079
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39852,0.0140780819759493,0.011941636173385,-0.00932752492388528,0.0374836888757839,0.238460021445894
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42048,-0.00678110361297031,0.00575232501145494,-0.018055660635422,0.00449345340948137,0.238480479127023
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39575,-0.0341153217387789,0.0289461364037429,-0.090849749090115,0.0226191056125571,0.238591227296679
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39858,0.014539952145998,0.012396089510018,-0.00975638329363727,0.0388362875856332,0.240842001701114
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42063,0.00361583262743251,0.00308305444210529,-0.00242695407909385,0.00965861933395887,0.240893336785394
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,42174,0.00939185107369189,0.00801699265289588,-0.00632145452598403,0.0251051566733678,0.241421217485486
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",41995,0.00541815405750632,0.00465003128865006,-0.00369590726824779,0.0145322153832604,0.243964225125654
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41924,0.00911845850959892,0.0078353361923878,-0.00623880042748117,0.024475717446679,0.244541729161879
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,42056,0.00390033956649523,0.00335487810394948,-0.00267522151724574,0.0104759006502362,0.24501749636852
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39500,0.00392849372321095,0.00338974530613546,-0.00271540707681455,0.0105723945232364,0.246508160349547
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39500,-0.00775909067770318,0.00669691411426789,-0.0208850423416682,0.00536686098626189,0.246641851661237
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,39597,-0.00570503579326894,0.0049258110407848,-0.0153596254332072,0.00394955384666927,0.246810773551569
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,39675,0.00459338166367192,0.00397095870930676,-0.00318969740656933,0.0123764607339132,0.247402019483182
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,39500,-0.00654198571303695,0.00565826790430436,-0.0176321908054735,0.0045482193793996,0.247632190277391
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,41828,0.00653377942272449,0.00565393267400979,-0.00454792861833469,0.0176154874637837,0.247858817239237
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41547,0.00478736757873333,0.00414830334152794,-0.00334330697066144,0.0129180421281281,0.248499183164142
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42063,0.00299287717616541,0.00261254523580161,-0.00212771148600575,0.00811346583833656,0.251989718720998
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,39500,-0.0088448944748513,0.00772224079537251,-0.0239804864337814,0.00629069748407883,0.252077231431604
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,39512,0.005320217138665,0.00466092285267162,-0.00381519165257139,0.0144556259299014,0.253707153717062
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,41943,0.0109054396157361,0.00956177037619702,-0.00783563032161003,0.0296465095530823,0.254088050815055
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39904,0.00373803427331615,0.00328027072621566,-0.00269129635006655,0.0101673648966988,0.254497747810965
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39512,0.00815474294737003,0.00715760253204847,-0.00587415801544496,0.022183643910185,0.254598025632836
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39869,0.0212455264484468,0.018657002604078,-0.015322198655546,0.0578132515524396,0.254834673413777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39575,0.00478441925058735,0.00420384449554141,-0.00345511596067381,0.0130239544618485,0.255101205094758
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39575,-0.00291735347278558,0.00256736956451023,-0.00794939781922563,0.00211469087365447,0.255847460058404
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,39872,-0.00579085384167892,0.00509875308300586,-0.0157844098843704,0.00420270220101256,0.25608986893523
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,39904,0.0113908337205773,0.0100557122121738,-0.00831836221528346,0.031100029656438,0.257333851324159
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,42069,0.00443504262496188,0.00391552249368837,-0.00323938146266733,0.0121094667125911,0.2573678988817
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,41766,-0.00396833107937562,0.00350926576511979,-0.0108464919790104,0.00290982982025917,0.258153477781133
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39500,0.0112280079336956,0.00994162725311265,-0.00825758148240514,0.0307135973497964,0.258756781111565
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39512,0.0113428997723333,0.0100491598825327,-0.00835345359743084,0.0310392531420974,0.259031880572929
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39682,0.00655993612559358,0.00582370159387696,-0.00485451899840525,0.0179743912495924,0.260012018170482
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,39575,0.00524297775866353,0.00466524093403979,-0.00390089447205446,0.0143868499893815,0.261106091096037
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39696,0.00893518902771465,0.00795465557431137,-0.00665593589793564,0.0245263139533649,0.261349114768663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41771,0.0102892742006525,0.00916351917939847,-0.00767122339096848,0.0282497717922735,0.261520899367003
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,39590,-0.00456559469044316,0.00406612145833102,-0.012535192748772,0.00340400336788563,0.261530935840394
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39526,0.00697284208456005,0.00621453135690866,-0.00520763937498094,0.019153323544101,0.261877662019732
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,39512,0.00557964121004885,0.00497946468505152,-0.00418010957265213,0.0153393919927498,0.262512495450958
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39500,0.00664053043723528,0.00596113630422977,-0.00504329671905507,0.0183243575935256,0.265316373191379
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39426,0.00370455817979425,0.00333655858799133,-0.00283509665266875,0.0102442130122573,0.266897379279293
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39526,0.00742573941251183,0.00668816304716222,-0.00568306015992612,0.0205345389849498,0.266902452610627
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,42187,0.00568946149940462,0.00512722293643125,-0.00435989545600062,0.0157388184548099,0.267166272870806
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,42111,0.00572018958776339,0.0051566247853499,-0.00438679499152242,0.0158271741670492,0.267325068961463
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39526,0.00650132151909115,0.00586113334550741,-0.00498649983810338,0.0179891428762857,0.267357111024133
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39500,0.00626600479907899,0.0056571281795975,-0.00482196643293211,0.0173539760310901,0.268046089484083
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,39590,0.0072154864711792,0.00651947009844216,-0.00556267492176742,0.0199936478641258,0.268422080437527
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,39590,0.00431358212504032,0.00390002480674432,-0.00333046649617854,0.0119576307462592,0.268733562678348
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39526,0.00353559662348353,0.00319885970808389,-0.00273416840436091,0.00980536165132796,0.26906790467924
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39512,0.00511427317027485,0.00463278114380759,-0.00396597787158803,0.0141945242121377,0.269647183567789
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42236,-0.00795306273600383,0.00720802402525732,-0.0220807898255082,0.00617466435350052,0.269889286512533
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,41842,0.00723469512978682,0.00660187562080425,-0.0057049810869895,0.0201743713465631,0.273162381719154
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39526,0.00410566557234333,0.00374652773051949,-0.00323752877947488,0.0114488599241615,0.273164703491613
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41771,0.00757406316988823,0.00692006078286571,-0.00598925596452856,0.021137382304305,0.273752174525591
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42063,0.00287036802989276,0.00262257300997626,-0.00226987506966071,0.00801061112944624,0.273761701112216
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,41771,0.00732375311966869,0.00669217023726112,-0.00579290054536312,0.0204404067847005,0.273809946493832
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39696,0.010226927600193,0.00936575420041615,-0.00812995063262266,0.0285838058330086,0.274879148468778
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39834,-0.00320273024473073,0.00294080763852392,-0.00896671321623762,0.00256125272677615,0.276148648328611
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,39512,-0.00665034063471568,0.00610749241335705,-0.0186210257648955,0.00532034449546413,0.276229821898833
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,39575,0.00743019917795757,0.00683609922315868,-0.00596855529943344,0.0208289536553486,0.277102100702949
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39597,0.00314571130810291,0.00289421812738975,-0.00252695622158099,0.00881837883778682,0.27710702373793
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39895,0.0126521343038587,0.011656776023744,-0.0101951467026795,0.0354994153103969,0.277772649258621
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42108,0.00988372788642598,0.00911176857257136,-0.00797533851581389,0.0277427942886658,0.278064546104269
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,42048,0.010806609429659,0.0100241490168434,-0.00884072264335404,0.0304539415026721,0.281027415345209
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39696,0.00519744445059706,0.00482816142622573,-0.00426575194480538,0.0146606408459995,0.28173370836305
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39858,0.00337721795053309,0.00313993416652224,-0.0027770530158505,0.00953148891691668,0.282142808132301
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,39696,0.00680174338837655,0.00633388394759124,-0.00561266914890228,0.0192161559256554,0.282906041412724
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39917,0.00178512538864987,0.00166902952975002,-0.00148617248966016,0.0050564232669599,0.284840714669065
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,39590,0.00670745276006809,0.00628225423957039,-0.00560576554948989,0.0190206710696261,0.285687217990195
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39868,0.0115309784045604,0.0108227697675257,-0.00968165033979,0.0327436071489107,0.286701089190314
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,39869,-0.0109834103242665,0.010331375198029,-0.0312329057124033,0.00926608506387029,0.287753883380635
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39500,0.00460815950244876,0.0043401023813209,-0.00389844116494021,0.0131147601698377,0.288366879767856
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39904,0.00964868306036643,0.00909772447682609,-0.00818285691421271,0.0274802230349456,0.288912548682472
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41766,0.0171683928870367,0.0161929606196057,-0.0145698099273905,0.048906595701464,0.289055766776322
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,39872,0.0179483060838596,0.016974710375383,-0.0153221262518911,0.0512187384196104,0.290371959096488
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",41995,0.00701163399434785,0.00663423795166424,-0.00599147239091406,0.0200147403796098,0.290582624823804
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,39858,0.00655587599117891,0.00621394526909377,-0.00562345673624487,0.0187352087186027,0.291435914582914
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42050,0.00336553902311715,0.00319364561049836,-0.00289400637345964,0.00962508441969395,0.291982630002556
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39895,-0.00867760163591972,0.00824455009752082,-0.0248369198270605,0.0074817165552211,0.292580898692124
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,39597,0.00654720088156306,0.00623759104914782,-0.00567847757476666,0.0187728793378928,0.293908508736901
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41766,0.00630489250534883,0.00600782348656128,-0.00547044152831129,0.0180802265390089,0.293991686032276
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39512,0.00415438783228865,0.00396782917060763,-0.00362255734210231,0.0119313330066796,0.295114552083382
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39872,0.00754568489171128,0.00722807154681574,-0.00662133534004757,0.0217127051234701,0.296534777015272
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,41842,-0.00362162531284275,0.00347142747464547,-0.0104256231631479,0.00318237253746238,0.296843750756911
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42088,0.00363890870052057,0.00349566791679027,-0.00321260041638836,0.0104904178174295,0.297905040881939
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39675,-0.00363523246125233,0.00349631651679078,-0.0104880128341623,0.00321754791165759,0.298487087557774
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,39512,0.00390961061113632,0.00376416953217527,-0.00346816167192721,0.0112873828941998,0.298996003929409
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,42048,0.0108636505253706,0.0104764873322136,-0.00967026464576815,0.0313975656965093,0.299775269568072
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42048,0.0117220643423281,0.0113151909996237,-0.0104557100169343,0.0338998387015906,0.300240294307563
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39512,-0.00429909299305555,0.0041531905852644,-0.0124393465401738,0.00384116055406267,0.300631050338803
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42092,-0.0100971485144738,0.00975510008410842,-0.0292171446793263,0.00902284765037867,0.300657785444521
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,39927,0.0103965221478245,0.0100443322589752,-0.00929036907976697,0.030083413375416,0.300661333432182
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39675,0.00855731841663914,0.00828318332655628,-0.00767772090341117,0.0247923577366895,0.301581824189265
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39904,-0.00574610870357454,0.00556431323869044,-0.0166521626514078,0.00515994524425872,0.301779663388811
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,41771,0.0149353936694788,0.0144956916703336,-0.0134761620043751,0.0433469493433327,0.302872497165355
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41592,0.00543905575271346,0.00529587632900995,-0.00494086185214604,0.015818973357573,0.304422623590898
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39597,0.00502758031275782,0.00490129248888449,-0.00457895296545577,0.0146341135909714,0.305024350280031
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,39904,-0.00835540716761859,0.00814802115271782,-0.0243255286269455,0.00761471429170834,0.305171756501616
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42172,-0.00469598781124758,0.0045844256141939,-0.0136814620150676,0.00428948639257248,0.30569530797927
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39858,0.0111354104238897,0.0108723688183672,-0.0101744324601099,0.0324452533078893,0.305765853236865
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,39526,0.00516539821050143,0.00506105884646743,-0.00475427712857473,0.0150850735495776,0.307458949660388
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39597,0.00242861198526359,0.00238125778912376,-0.00223865328141897,0.00709587725194616,0.307804865553858
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39500,0.00486600874938908,0.00477977501317827,-0.00450235027644033,0.0142343677752185,0.308680886953534
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39512,0.0031180058793402,0.00306434946257386,-0.00288811906730456,0.00912413082598496,0.308933489688692
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39895,0.00317630536435342,0.003123301739144,-0.00294536604436882,0.00929797677307567,0.309189301844047
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39868,0.00770727684336335,0.00758047532902525,-0.00715045480152614,0.0225650084882528,0.309304965233922
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,39526,0.0102441363924435,0.0100801735362155,-0.00951300373853883,0.0300012765234258,0.309525296629698
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,41766,0.00738136196917108,0.00726942225815436,-0.00686670565681147,0.0216294295951536,0.309934467543135
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41766,0.00523385520119861,0.00515880479302353,-0.0048774021931275,0.0153451125955247,0.310339970343153
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,41995,-0.00852588298832336,0.00847685369727501,-0.0251405162349824,0.00808875025833567,0.314537700770351
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39597,0.00367347137425079,0.00366931408662775,-0.00351838423553959,0.0108653269840412,0.316784546529461
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,39512,0.00718165242335743,0.00718202626982558,-0.00689511906550071,0.0212584239122156,0.317357872227619
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39858,0.0058143236494729,0.00581750463410763,-0.00558798543337805,0.0172166327323239,0.317596678147548
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39897,0.00200174716771362,0.00200521951969803,-0.00192848309089451,0.00593197742632175,0.318170635367547
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41924,0.0105293979803858,0.0105662948135896,-0.0101805398542498,0.0312393358150214,0.319021447941137
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,41227,0.00540262446028251,0.00543067688256542,-0.00524150222954571,0.0160467511501107,0.319835850456232
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,39500,0.00504438751746448,0.00508749316872959,-0.00492709909324552,0.0150158741281745,0.321450259743675
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,39500,0.00834745209716214,0.00845006202649517,-0.0082146694747684,0.0249095736690927,0.323244662537685
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39512,0.00454566922628488,0.00461190735087519,-0.00449366918143049,0.0135850076340003,0.324332840764032
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39512,0.00419725887645151,0.00428293520698882,-0.00419729412924658,0.0125918118821496,0.327109876487211
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,41943,0.0038777680832634,0.00395948744443245,-0.0038828273078242,0.011638363474351,0.327419333842201
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,39836,0.00984313787560719,0.0100595863435902,-0.00987365135782969,0.0295599271090441,0.327856382458606
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39674,0.0053638292859649,0.00548576957188793,-0.00538827907493545,0.0161159376468652,0.328208695748838
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,39526,0.0070857758675028,0.00725855771663304,-0.00714099725709794,0.0213125489921036,0.328988899054863
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,42236,0.00929888264706836,0.00955873884691483,-0.00943624549288471,0.0280340107870214,0.330662610192255
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,42048,0.00720629764765103,0.0074239383975468,-0.00734462161154069,0.0217572169068427,0.331723158004245
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41771,0.00457385849732276,0.00472014289315262,-0.00467762157325638,0.0138253385679019,0.33255875077933
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,39868,0.0114036672332211,0.0117751710105923,-0.0116756679475397,0.034483002413982,0.332840343007643
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,41943,0.00344543724567503,0.00356042067836589,-0.00353298728392213,0.0104238617752722,0.333209210383362
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,39661,-0.00347482767823091,0.00360856422810913,-0.0105476135653248,0.00359795820886298,0.335599124445904
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,41842,0.00507061870934729,0.00526665485010392,-0.00525202479685638,0.015393262215551,0.335676591949359
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,39597,0.0034676076242401,0.00360228984383543,-0.00359288046967734,0.0105280957181575,0.335763411884599
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39590,0.00380797403662569,0.00396110521016393,-0.00395579217529562,0.011571740248547,0.336401738019058
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39590,0.00326828466848637,0.00340065459685944,-0.00339699834135813,0.00993356767833086,0.336535521254628
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39512,0.00354741411012451,0.00369992985924919,-0.0037044484140039,0.0107992766342529,0.337691461020602
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39597,0.00477541410913126,0.00498392116000197,-0.00499307136447261,0.0145438995827351,0.338001103619995
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42063,0.00482780331694127,0.00504035942868001,-0.00505130116327154,0.0147069077971541,0.338166104277873
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42236,-0.00242423491695115,0.00253292237783738,-0.00738876277751241,0.00254029294361011,0.338538750911489
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,39869,0.00738587295224783,0.00774671672887656,-0.00779769183635023,0.0225694377408459,0.340397873664483
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39512,0.00903512114955156,0.00948902820644158,-0.00956337413507394,0.0276336164341771,0.341034365618288
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39590,-0.00377984579235295,0.00398773329579642,-0.0115958030521139,0.00403611146740803,0.343217369892341
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39696,0.00705171411946852,0.00744120786948989,-0.00753305330473167,0.0216364815436687,0.343324640200138
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39512,0.00354849410678325,0.00374510954467847,-0.00379192060078656,0.0108889088143531,0.343404655365487
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,41741,-0.00943021689104831,0.0100022346464182,-0.0290345967980279,0.0101741630159313,0.345794914364663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,42063,-0.00465039438958179,0.00493769325106249,-0.0143282731616643,0.0050274843825007,0.346304177955479
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,42172,0.00447664482624363,0.00475791956519164,-0.00484887752153198,0.0138021671740192,0.346781653097098
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39512,-0.00686467193738525,0.00730232192779845,-0.0211772229158702,0.00744787904109971,0.347203998369377
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42063,0.00457471763093769,0.00487239485154744,-0.00497517627809529,0.0141246115399707,0.347796182065095
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERVV_1,,39512,0.00442854920899509,0.00474093444888916,-0.00486368231082766,0.0137207807288178,0.350268374883545
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,41828,0.00797023517684034,0.00855345083070441,-0.00879452845134031,0.024734998805021,0.351449063347714
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,41842,-0.00775887080041994,0.00834834909581062,-0.0241216350282088,0.00860389342736888,0.352704034269439
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39597,0.00593052121670139,0.00638834817526921,-0.00659064120682625,0.018451683640229,0.353254684987199
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42063,-0.0062461016302858,0.00673006630223156,-0.0194370315826597,0.00694482832208806,0.353377956601832
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,39512,-0.00651265562405625,0.00702266552718617,-0.0202770800573412,0.00725176880922864,0.353751550899661
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39858,0.00473936162441301,0.00511670139409575,-0.00528937310801467,0.0147680963568407,0.354334206753169
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39500,0.00544957127775745,0.00588681138748793,-0.00608857904171889,0.0169877215972338,0.354609159222831
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42048,0.00413502614739454,0.00446858927121139,-0.00462340882417979,0.0128934611189689,0.354798496902305
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,41995,0.00713619480793269,0.00772034130785903,-0.007995674155471,0.0222680637713364,0.355327691251693
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39597,-0.00279881323530404,0.00303459568304189,-0.00874662077406614,0.00314899430345805,0.356391379196397
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39590,0.00510051495693156,0.00554625279567662,-0.00577014052259461,0.0159711704364577,0.357784961496273
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39512,0.00483363287597905,0.00526451546800248,-0.00548481744130582,0.0151520831932639,0.35855884475669
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39868,0.0240335762456725,0.0261812550001524,-0.0272816835546263,0.0753488360459712,0.358654828043487
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42093,-0.0119254021018682,0.0129996949645628,-0.0374048042324112,0.0135540000286748,0.358970344635583
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,39696,0.00574946533233251,0.00628214467264849,-0.00656353822605853,0.0180624688907235,0.360102645275654
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39696,0.00567849591693065,0.0062147611098358,-0.00650243585834751,0.0178594276922088,0.360888547802845
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,39526,0.0046347287656998,0.00508807593639486,-0.00533790006963412,0.0146073576010337,0.362368120025015
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,41759,-0.00846999752335622,0.00931649694094392,-0.0267303315276063,0.00979033648089386,0.363293023159207
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39526,-0.00298598256373091,0.00330051563569047,-0.00945499320968424,0.00348302808222241,0.36564331455164
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39868,0.00377089187532692,0.00416939227184373,-0.00440111697748679,0.0119429007281406,0.365790786711304
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41828,0.0056956973524793,0.00634029894535623,-0.00673128858041891,0.0181226832853775,0.369024598424472
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,39696,0.0028192367436748,0.00314064756724921,-0.00333643248813366,0.00897490597548325,0.369385799511865
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41842,0.00622628177044447,0.00694070088336052,-0.00737749196094215,0.0198300555018311,0.369698855912355
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39597,0.00434391468161817,0.00484671139763429,-0.00515563965774503,0.0138434690209814,0.37013341172635
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39696,0.00667340361651307,0.00750688405353088,-0.00804008912840746,0.0213868963614336,0.374037836926738
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,39526,0.00943685784335233,0.010620334879662,-0.0113789985207853,0.0302527142074899,0.374256470304648
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39869,0.00802539315319369,0.00906040142388683,-0.0097329936376245,0.0257837799440119,0.375762676460442
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39576,0.00553148399924604,0.00625133947095659,-0.00672114136382887,0.017784109362321,0.376258105958601
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,42222,-0.00471880091460497,0.00534065303596249,-0.0151864808650914,0.00574887903588151,0.376948006064999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39512,0.00303709014912408,0.00345282389874229,-0.00373044469241081,0.00980462499065897,0.379097566975412
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,42174,0.00623046505041623,0.00708415305865736,-0.00765447494455218,0.0201154050453847,0.37914944118508
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,39590,0.00385300375488855,0.00439403437060183,-0.00475930361149104,0.0124653111212681,0.380575574168595
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,42072,0.00336280939485115,0.00383611897574661,-0.00415598379761222,0.0108816025873145,0.380710009122157
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39869,0.00338406168229471,0.00388527258674733,-0.00423107258773005,0.0109991959523195,0.383774216769877
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39575,-0.00744471773598543,0.00856008125352434,-0.0242224769928931,0.00933304152092227,0.384482429894019
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,41842,0.0048250174723856,0.00556956736016268,-0.00609133455353325,0.0157413694983045,0.386331393934998
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,39868,-0.00251457575128744,0.00290419999278033,-0.00820680773713688,0.003177656234562,0.386595734755193
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,41468,-0.00266162371386271,0.00307789916215877,-0.00869430607169391,0.00337105864396848,0.38719028227859
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39512,-0.0040963745323703,0.00475744113979315,-0.0134209591663649,0.00522821010162428,0.389231758479738
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39590,-0.00523840398675037,0.00610233136815206,-0.0171989734683284,0.00672216549482767,0.390675628150323
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,39575,0.00480399886326753,0.0056046218052347,-0.00618105987499248,0.0157890576015275,0.391380974997112
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39491,0.00767613885320463,0.00896519598577422,-0.00989564527891284,0.0252479229853221,0.39189748408097
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,39696,0.00385062641176662,0.00449802562800773,-0.00496550381912853,0.0126667566426618,0.391977348967248
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,42044,-0.00733263380190382,0.0085704982055804,-0.0241308102848414,0.00946554268103377,0.39225268280035
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41828,0.00851138872474,0.00994919985800519,-0.0109890429969502,0.0280118204464302,0.392298339588128
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42174,0.00435371183149442,0.00508979913101661,-0.00562229446529815,0.014329718128287,0.392355969391329
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,42119,0.00286506476984584,0.0033684977682591,-0.00373719085594199,0.00946732039563367,0.395036253820318
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,39500,0.00431454736942495,0.00507417844282054,-0.0056308423785033,0.0142599371173532,0.395179902823131
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,42174,0.00295676006616035,0.00349585025690324,-0.00389510643737,0.0098086265696907,0.397684035466832
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,41766,0.00542804773356964,0.00641840626369131,-0.00715202854326533,0.0180081240104046,0.397735356891222
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39590,0.00783678643302619,0.00928508384819353,-0.0103619779094331,0.0260355507754855,0.398677204727536
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,39500,0.0107112558942864,0.0126948645364727,-0.0141706785972002,0.035593190385773,0.39882922456355
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39512,0.00895232960506065,0.0106134085987052,-0.0118499512484016,0.0297546104585229,0.398971597909057
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,39575,0.010802822007366,0.0128369579672415,-0.0143576156084274,0.0359632596231593,0.400063455433698
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,39590,0.00707816188572464,0.00841860728497658,-0.00942230839282946,0.0235786321642787,0.40049179813902
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39500,-0.00446197883936892,0.00531142037667764,-0.0148723627776571,0.00594840509891926,0.400886095539158
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41766,0.00298032673984088,0.0035492862427073,-0.00397627429586543,0.00993692777554719,0.401093270052799
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,39575,0.00676318294834449,0.00805472359162829,-0.00902407529124696,0.0225504411879359,0.401120558368932
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,41943,0.00557203329575249,0.00668752515915926,-0.00753551601619967,0.0186795826077046,0.404747924507198
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,42213,0.00273065814372991,0.00328269945600515,-0.00370343279004019,0.0091647490775,0.405517735294609
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42072,-0.00784065311547525,0.00943009243126559,-0.0263236342807558,0.0106423280498053,0.405734033745481
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,39872,0.00313813105118092,0.00378529038043431,-0.00428103809447032,0.0105573001968322,0.407103227233432
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,41919,0.00414552932898444,0.0050066782571763,-0.00566756005508111,0.01395861871305,0.40768536595197
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,39863,0.00278054809786715,0.00337083593059914,-0.00382629032610716,0.00938738652184147,0.409455009189485
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39868,-0.00346566159554805,0.00420152052121377,-0.011700641817127,0.00476931862603093,0.409469163519665
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39500,-0.00336985883207562,0.00409596624464402,-0.0113979526715779,0.00465823500742666,0.410681698225511
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39590,0.00360861280995976,0.00439462696847066,-0.00500485604824273,0.0122220816681623,0.411583196433852
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,39858,0.00378927664914363,0.00463698757195973,-0.00529921899189743,0.0128777722901847,0.413840010942878
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41771,0.008049663242231,0.00985249904558991,-0.0112612348871252,0.0273605613715872,0.413933257016763
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39858,0.00374212564515694,0.00458122415416041,-0.00523707369699746,0.0127213249873113,0.414037340611786
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,42142,-0.00505183059736117,0.00619639612462891,-0.0171967670016338,0.00709310580691149,0.414923366490465
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,41620,-0.00798049138527457,0.00980145607700345,-0.0271913452962013,0.0112303625256522,0.41553675339449
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,41708,0.00269242821202891,0.00331201018204343,-0.00379911174477621,0.00918396816883403,0.416273689072686
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,39512,0.00419921368279801,0.00517193828453003,-0.00593778535488084,0.0143362127204769,0.416853744775108
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,39500,0.00267157352472687,0.0032951843541507,-0.00378698780940849,0.00913013485886224,0.417526464831861
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39512,0.0045435149166923,0.00561580320817439,-0.0064634593713295,0.0155504892047141,0.418498973977357
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39597,-0.00404271719371729,0.00501083829276669,-0.01386396024754,0.00577852586010542,0.419802288061777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39858,-0.00453680963824744,0.00567753020443295,-0.015664768838936,0.00659114956244114,0.424259984625822
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,41842,-0.00704983939265073,0.00882558250561729,-0.0243479811036606,0.0102483023183592,0.424423076700879
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39512,0.00592963705994706,0.00742551959829018,-0.00862438135270168,0.0204836554725958,0.424569676264688
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,39597,0.00744348408840843,0.0093324842678431,-0.010848185076564,0.0257351532533809,0.425126425964151
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,39740,-0.00201698731678854,0.00253304550110196,-0.00698175649894839,0.00294778186537131,0.425892275784669
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,42174,0.00527093012824399,0.00662545248777481,-0.00771495674779463,0.0182568170042826,0.426303038466702
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39590,0.00596013471623437,0.00751060501138806,-0.00876065110608623,0.020680920538555,0.427467285905542
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,39872,0.00380433032511259,0.00479634824987442,-0.00559651224464128,0.0132051728948665,0.42769416864358
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,39526,0.00359145463413887,0.00452944756590437,-0.0052862625950337,0.0124691718633114,0.42784614435078
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,39895,0.00258525420873942,0.00326215183648706,-0.00380856339077522,0.00897907180825405,0.428086036788376
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,41774,0.00484268594169121,0.00611188551279309,-0.00713660966338324,0.0168219815467657,0.42817723902809
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39575,0.00287619533577637,0.0036493463418009,-0.0042765234941534,0.0100289141657061,0.43063192087595
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,39500,0.00623911302824642,0.00793808212805107,-0.00931952794273368,0.0217977539992265,0.431900774042509
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39500,-0.00309976334172844,0.00396304936218371,-0.0108673400916085,0.00466781340815164,0.434133883935822
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,41771,0.0137760317397144,0.0176154864398064,-0.0207503216823062,0.048302385161735,0.434204566679495
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39526,0.00468681851984506,0.00599383191825729,-0.00706109203993922,0.0164347290796293,0.434266624393364
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,42063,-0.0028999362112597,0.00371429618668807,-0.0101799567371683,0.00438008431464891,0.434963359095933
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39590,-0.00542478746401437,0.00696580568785706,-0.0190777666122142,0.00822819168418548,0.436129699162854
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42108,0.00232358871494879,0.00298374563116003,-0.00352455272212486,0.00817173015202245,0.43614126869119
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39696,0.00455189133412322,0.00584732651984351,-0.00690886864477006,0.0160126513130165,0.436316339742285
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39512,0.00340919020470366,0.00438501441358511,-0.00518543804592315,0.0120038184553305,0.436902006899745
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39526,0.00916795182402561,0.0117972247890886,-0.0139546087625881,0.0322905124106393,0.43710017461194
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41766,0.0056256715344807,0.00727647706763381,-0.00863622351808156,0.019887566587043,0.439458610647583
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,42092,-0.00485095817301899,0.00633167537229255,-0.0172610419027124,0.00755912555667441,0.443605618433595
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,42236,-0.00346746006025574,0.00453334719136927,-0.0123528205553395,0.00541790043482803,0.44435710008771
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39526,0.00334455646660829,0.00438369970485642,-0.0052474949549103,0.0119366078881269,0.44550794898108
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42046,-0.00698697766752328,0.00920109066038425,-0.0250211153618764,0.0110471600268299,0.447648111701286
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39872,0.00298545628906599,0.00394000411185409,-0.00473695177016802,0.0107078643483,0.448628935565303
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39512,0.00577290569850207,0.00765158935773333,-0.00922420944265526,0.0207700208396594,0.450582465231963
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42111,0.00234901335248071,0.00311394388204405,-0.00375431665632564,0.00845234336128705,0.450650347128927
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,39512,0.00326259426398582,0.00433218987362317,-0.0052284978883156,0.0117536864162872,0.451403010558439
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42142,0.00314903542810397,0.00418711802334202,-0.0050577158976464,0.0113557867538543,0.452017787536822
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42048,0.00560325283943007,0.00745148447078872,-0.00900165672331583,0.020208162402176,0.452085483720857
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42236,0.00240536296190234,0.00324966629295966,-0.0039639829722986,0.00877470889610328,0.459198864279523
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39895,0.00389490267409582,0.00526725827585345,-0.00642892354657694,0.0142187288947686,0.459645868369797
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39500,0.00269122793629769,0.00364158475189716,-0.00444627817742074,0.00982873405001613,0.459906768927886
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39868,0.00668203292138879,0.00905004412579021,-0.01105605356516,0.0244201194079376,0.46032167546244
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TTN,Titin,39512,-0.00550043214224078,0.00750868316382141,-0.0202174511433308,0.00921658685884919,0.463853034609505
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,39597,0.00358726952078817,0.00492437823432498,-0.0060645118184888,0.0132390508600651,0.466340480357163
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,42123,0.00233779830653563,0.00321551460558279,-0.00396461032040664,0.0086402069334779,0.467215834696398
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39526,0.00479031441461796,0.00659895985121735,-0.00814364689376804,0.017724275723004,0.467903598030285
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42207,0.00408880544705837,0.00565797016027082,-0.00700081606707244,0.0151784269611892,0.469899399092434
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41766,-0.0026422717662971,0.00365934116677425,-0.00981458045317464,0.00453003692058044,0.470269088710251
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,41842,-0.00213812434033868,0.00296329298999399,-0.0079461786007269,0.00366992992004953,0.470592171715563
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41766,0.00413318621550905,0.00574423806404259,-0.00712552039001442,0.0153918928210325,0.471823486220956
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,39858,0.00309982586433984,0.00432972059146204,-0.00538642649492575,0.0115860782236054,0.474042433740302
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39847,0.00280615012185478,0.0039355132988118,-0.00490745594381635,0.0105197561875259,0.475840245459269
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,39696,0.00409351985377357,0.00578294321782957,-0.00724104885317239,0.0154280885607195,0.479046461061696
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,41668,0.00640663522636435,0.00905796030153921,-0.0113469669646525,0.0241602374173812,0.479396800110742
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,42164,-0.00154175904868505,0.0021905985924777,-0.00583533228994133,0.00275181419257123,0.481564934383101
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41771,0.00269415219931562,0.00384388249428536,-0.00483985748948369,0.0102281618881149,0.483381872056159
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,39500,0.00455929510403285,0.0065182627514442,-0.00821649988879779,0.0173350900968635,0.484276553294068
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,39500,0.0037805599103298,0.00543482330941064,-0.00687169377611505,0.0144328135967747,0.486683037071486
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41771,0.0073204571570931,0.0106285988605155,-0.0135115966095174,0.0281525109237036,0.490992162993758
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,39696,0.00172736704064883,0.00251347663712957,-0.00319904716812512,0.00665378124942278,0.491944522186245
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42142,-0.00317380523744248,0.0046425692234518,-0.012273240915408,0.00592563044052304,0.494219765351564
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,39500,-0.00310493361009654,0.0045495866992148,-0.0120221235405576,0.00581225632036447,0.494959480233642
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,39696,0.0030733024895862,0.004515932469817,-0.00577792515125512,0.0119245301304275,0.496172625425004
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,41828,0.00519235579197446,0.00764472435948196,-0.00979130395261019,0.0201760155365591,0.497018141074883
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41771,0.00931350340248072,0.0137314052093804,-0.0176000508079049,0.0362270576128664,0.497616901486203
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39526,-0.00865278402578639,0.0127774209324207,-0.0336965290533309,0.0163909610017581,0.498297646876777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41771,-0.00605494058358973,0.00894547587653007,-0.0235880733015887,0.0114781921344092,0.498499168908455
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39512,0.0047950337485972,0.00711209967004801,-0.00914468160469691,0.0187347491018913,0.500193432827454
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39575,-0.00453956821040079,0.00681522109928388,-0.0178974015649972,0.00881826514419562,0.505365926533117
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39927,0.00190593937401891,0.00286249094340802,-0.00370454287506082,0.00751642162309863,0.505531756174047
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,41771,0.00711355858116814,0.0107022803058459,-0.0138629108182898,0.028090027980626,0.506268803560633
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,39915,-0.00400378144288138,0.00605491991215083,-0.015871424470697,0.00786386158493425,0.50846910201556
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,42048,0.00364564309586002,0.00552633438386153,-0.00718597229650857,0.0144772584882286,0.509466920108834
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,41828,0.00195289977349125,0.00296712779806984,-0.00386267071072564,0.00776847025770814,0.510434881732293
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42048,0.00531791335437189,0.00814326495214196,-0.0106428859518263,0.0212787126605701,0.513738836301553
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,42063,0.00166574457255878,0.00255763392136663,-0.00334721791331981,0.00667870705843738,0.514874664081625
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39868,0.00400263688206337,0.00617863882358115,-0.00810749521215568,0.0161127689762824,0.517115510934312
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39597,0.0020419445888582,0.00315574926048392,-0.00414332396169028,0.00822721313940667,0.517609596851074
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42055,0.00354435160605789,0.00549227575171286,-0.00722050886729931,0.0143092120794151,0.518721847259145
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,42048,0.00474424507639408,0.0073676556692155,-0.00969636003526829,0.0191848501880565,0.519632639319563
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39500,0.00411603204319601,0.00645936777080745,-0.00854432878758659,0.0167763928739786,0.523995569284452
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42023,0.00469188201752362,0.00737357351694991,-0.00976032207569819,0.0191440861107454,0.524584932844468
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42139,-0.00575673308184178,0.00907953403508075,-0.0235526197906001,0.0120391536269165,0.526069359507646
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42010,0.00133227793978435,0.00210329066526118,-0.00279017176412755,0.00545472764369626,0.526466620126645
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,39868,-0.0015004560457847,0.00237377343522405,-0.00615305197882383,0.00315213988725443,0.527336050425474
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,41842,0.00326863621444719,0.00523947272798032,-0.00700073033239423,0.0135380027612886,0.532737954539431
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,39590,0.00324781555641243,0.00521205239715955,-0.0069678071420203,0.0134634382548452,0.533208327933291
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,39868,-0.00469748633245388,0.00756236071799036,-0.019519713339715,0.0101247406748072,0.534502539804613
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,42074,0.00635380208694073,0.0102714878190403,-0.0137783140383782,0.0264859182122596,0.536199357853463
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39675,0.00189697771534231,0.00306854580315941,-0.00411737205885013,0.00791132748953474,0.536455642741966
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39481,0.00324591359797531,0.00525358277884607,-0.00705110864856299,0.0135429358445136,0.536688722609492
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,39512,0.00388963510234369,0.00632799428144845,-0.00851323368929526,0.0162925038939826,0.538784776255889
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39869,0.0110596711159115,0.0180161466444111,-0.0242519763071344,0.0463713185389573,0.539309989442359
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42051,-0.0039275714108306,0.00651396623015357,-0.0166949452219316,0.0088398024002704,0.546554622510133
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,39597,0.00376111032938664,0.0062444708376756,-0.00847805251245753,0.0160002731712308,0.546979893758835
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39526,0.0021066897231459,0.00352600745091834,-0.00480428488065405,0.00901766432694585,0.550204866917702
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39858,-0.00344706361827381,0.00578110131633422,-0.0147780221982889,0.00788389496174125,0.551010746758373
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39526,-0.00223405554099309,0.003760212591615,-0.00960407222055849,0.0051359611385723,0.55243739077849
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39696,-0.00457719362114786,0.0077090102873209,-0.0196868537842968,0.0105324665420011,0.552694149424859
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,39597,0.00348122664344466,0.00586954942111935,-0.00802309022194927,0.0149855435088386,0.553126782702392
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39590,0.00302021800204522,0.005100376110301,-0.00697651917414475,0.0130169551782352,0.553758353268961
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39500,0.0051989199661539,0.00886619307087636,-0.0121788184527638,0.0225766583850716,0.557635228082736
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41842,0.00234482549999595,0.0039998641108121,-0.00549490815719577,0.0101845591571877,0.557733448554481
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,41943,0.00274140559875951,0.00468170245394468,-0.00643473121097207,0.0119175424084911,0.558182874174906
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,39512,0.00319442066957855,0.00546122387176803,-0.00750957811908678,0.0138984194582439,0.558608481609804
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39597,0.00563203941687852,0.00963346693249396,-0.0132495557708096,0.0245136346045667,0.558806734468371
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39512,-0.00639723252667479,0.011001122854262,-0.0279594333210282,0.0151649682676787,0.560910655477322
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42174,-0.00442794396881865,0.00763690853337726,-0.0193962846942381,0.0105403967566008,0.562053433264854
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39696,0.00502262303781607,0.00868461131618265,-0.0119992151419019,0.0220444612175341,0.563049056905762
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39590,0.00254652090299135,0.00441117597776385,-0.00609938401342579,0.0111924258194085,0.56375644629419
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41771,-0.00464539318175174,0.0080731247958563,-0.0204687177816301,0.0111779314181266,0.565020820328531
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39917,0.0010291436204023,0.00179197953593096,-0.00248313627002238,0.00454142351082699,0.565772533882067
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,41771,0.00550062047540587,0.0096226429936717,-0.0133597597921907,0.0243610007430024,0.567580374933774
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,39590,0.00381872242827581,0.00668680036233695,-0.00928740628190461,0.0169248511384562,0.567954611255058
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,41766,-0.0025731123868196,0.00450759154886551,-0.011407991822596,0.0062617670489568,0.568118024643109
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42048,-0.00565833337013032,0.00991925195206834,-0.0251000671961843,0.0137834004559236,0.568389158797985
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,39696,0.00320015932395926,0.00561643763987512,-0.00780805845019597,0.0142083770981145,0.568835379231132
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,42077,0.002013625734398,0.00355528142862771,-0.00495472586571232,0.00898197733450832,0.571147702227803
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,42099,0.00160929885885523,0.00284264942451873,-0.00396229401320148,0.00718089173091194,0.571317275111353
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,39512,0.0019123699685842,0.00337842493790288,-0.00470934290970544,0.00853408284687385,0.571368909968027
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39500,-0.00381043469919895,0.00673997732556346,-0.0170207902573033,0.00939992085890543,0.571848520731599
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39590,0.00225257010938394,0.00398658475169748,-0.00556113600394312,0.010066276222711,0.572059752414681
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39479,0.00327267852035501,0.00583410696993673,-0.00816217114072097,0.014707528181431,0.574838944426849
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,39591,0.00430715344392444,0.00769866443526882,-0.0107822288492024,0.0193965357370513,0.575854026054154
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39675,0.00632485314696144,0.011381124417147,-0.0159821507106467,0.0286318570045696,0.578405416640889
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39575,0.00576067742189817,0.010457603879305,-0.0147362261815397,0.026257581025336,0.581740747770068
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39575,0.00237032089398326,0.00434458653749931,-0.00614506871951539,0.0108857105074819,0.585365546329235
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,42048,-0.00408047140789936,0.00750596285233946,-0.0187921585984847,0.010631215782686,0.586704680446431
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39526,0.0029531913709494,0.00544198494576154,-0.00771309912274322,0.013619481864642,0.587369443280875
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,39512,0.00484337375252175,0.00895594597198676,-0.0127102803525723,0.0223970278576158,0.588656622293535
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42048,-0.00502599074492669,0.00942682216322368,-0.0235025621848451,0.0134505806949917,0.593932648902341
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,39575,0.00105558923048685,0.00198189497121597,-0.00282892491309645,0.00494010337407015,0.594310116835777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41590,0.00360158458922204,0.00678416597069591,-0.00969538071334195,0.016898549891786,0.595510343973933
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39512,-0.00150777215103063,0.00287440069534965,-0.00714159751391594,0.00412605321185467,0.599905434327495
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,39450,0.0019533476161621,0.00372992083589961,-0.00535729722220115,0.00926399245452534,0.600500135929536
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39512,0.00186104702620684,0.00356431857624059,-0.00512501738322472,0.0088471114356384,0.601588588786997
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39872,0.00229913398653822,0.0044122146381526,-0.00634880670424088,0.0109470746773173,0.602318566288574
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39696,-0.00222313335236847,0.00428478395803265,-0.0106213099101125,0.00617504320537552,0.60388005721621
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39526,-0.0032785208205989,0.00632834632505388,-0.0156820796177045,0.0091250379765067,0.604420533529787
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39512,0.00323006783577802,0.00623990777822231,-0.00900015140953772,0.0154602870810938,0.604715267380813
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39904,-0.00265277209961768,0.00516123043062855,-0.0127687837436496,0.00746323954441428,0.607275630098365
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39590,-0.00199302049841435,0.00388422040995998,-0.00960609250193592,0.00562005150510721,0.607886821932591
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,39512,0.00333330564609318,0.00652354690672877,-0.00945284629109521,0.0161194575832816,0.609385741203996
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,42187,0.00136123930304459,0.00266972046679295,-0.00387141281186959,0.00659389141795876,0.610143230707495
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,39597,0.00235601195844506,0.00462991647088096,-0.00671862432448163,0.0114306482413718,0.610855622955028
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42108,0.00378574038459553,0.00748846652281474,-0.0108916540001214,0.0184631347693124,0.613185889154103
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42049,0.00243369099761802,0.00481925988938532,-0.00701205838557721,0.0118794403808132,0.613572247385413
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39872,-0.00207451112766005,0.00413413631580359,-0.0101774183066351,0.00602839605131498,0.615817754539585
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39500,0.00425430121141676,0.00849437185325387,-0.0123946676209608,0.0209032700437943,0.61649550103663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,41771,0.00537745956946959,0.0107403080815388,-0.0156735442703465,0.0264284634092857,0.616604577349755
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,42063,-0.00245473758195034,0.0049036303207817,-0.0120658530106825,0.00715637784678179,0.616663681698263
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,42063,0.00393233672928232,0.00794078069628374,-0.0116315934354338,0.0194962668939984,0.62046151037157
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,39526,0.00305825515643617,0.00619267467033239,-0.00907938719741531,0.0151958975102877,0.621421729727841
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,39869,0.00594230462663882,0.0120955410618519,-0.0177649558545909,0.0296495651078686,0.623237569282971
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39858,0.00234315499805666,0.00478416511673339,-0.00703380863074077,0.0117201186268541,0.624304067615921
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39512,0.0035307876665624,0.00723386488569493,-0.0106475875093997,0.0177091628425245,0.625494867633849
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39512,0.00326696618468875,0.00669449685350966,-0.00985424764819019,0.0163881800175677,0.62555417397652
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39512,0.00213668937567837,0.00439353589538864,-0.00647464097928337,0.0107480197306401,0.626746034102591
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,39575,0.00165853989330403,0.00341238653643859,-0.0050297377181156,0.00834681750472367,0.626951929349821
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42072,0.00459680886497966,0.00949647199806272,-0.0140162762512233,0.0232098939811826,0.628355144719333
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42174,0.004980228437427,0.0103930483401884,-0.0153901463093423,0.0253506031841962,0.631812309301781
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,39872,0.00216166092134068,0.00458003669994155,-0.00681521101054475,0.0111385328532261,0.636954065382802
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,39858,0.0036036035680116,0.00764559816285587,-0.0113817688311859,0.0185889759672091,0.637413875076773
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42048,0.00267555471843058,0.00570090966894575,-0.0084982282327031,0.0138493376695643,0.638848054873334
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,39500,-0.00216031043522506,0.00460904791760502,-0.0111940443537309,0.00687342348328079,0.639285755327
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41842,0.0018828777669489,0.00402131562614114,-0.00599890086028774,0.00976465639418554,0.639631889999625
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39869,0.0027091817549734,0.00578700985394455,-0.00863335755875793,0.0140517210687047,0.639687232982043
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,39575,0.0035108113954304,0.00753546889403962,-0.0112587076368872,0.018280330427748,0.641292865635194
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39479,-0.00389857686998891,0.00839523899691952,-0.0203532453039512,0.0125560915639733,0.642385168918021
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39500,0.00200080268625584,0.00432786053016448,-0.00648180395286654,0.0104834093253782,0.643869999211845
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41771,0.00326988825675714,0.00708991742121138,-0.0106263498888172,0.0171661264023314,0.644660881571969
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42111,0.00218801306436775,0.00474975732104277,-0.00712151128487608,0.0114975374136116,0.645051503790488
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42050,-0.0149189268328284,0.0325012503210676,-0.0786213774621208,0.048783523796464,0.646222738499381
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,42050,0.00177634309849756,0.00388427046947752,-0.00583682702167837,0.00938951321867349,0.647450565428706
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BSND,Barttin,39500,0.00165739246013778,0.00364481702295551,-0.00548644890485502,0.00880123382513058,0.649315548642996
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39500,0.00245338047610524,0.00543521558002338,-0.00819964206074058,0.0131064030129511,0.651720318013709
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39927,-0.00180125637762921,0.00400279366469147,-0.00964673196042448,0.00604421920516606,0.652719191162938
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,39479,-0.00174725200109245,0.00391585671825322,-0.00942233116886876,0.00592782716668386,0.655462265892261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,42010,-0.00390404057167653,0.00876093620552342,-0.0210754755345024,0.0132673943911494,0.65587959977261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39590,-0.00192351973302471,0.00433415313231167,-0.0104184598723556,0.00657142040630616,0.657192159988292
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42034,-0.0014578804559216,0.00329888373307003,-0.00792369257273885,0.00500793166089565,0.658545928690925
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39512,-0.00226385644287284,0.00515592271494786,-0.0123694649641707,0.00784175207842497,0.660613121780789
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39872,-0.00198470305007551,0.00452322994008297,-0.0108502337326381,0.00688082763248711,0.660829328386562
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,39288,-0.00586792855063227,0.0134495944396862,-0.0322291336524172,0.0204932765511526,0.662634879438286
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,39868,0.00639498426246443,0.0148972192144667,-0.0228035653978903,0.0355935339228192,0.667732268619497
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39512,0.00389892733066628,0.00911560347871484,-0.0139676554876148,0.0217655101489474,0.668863314860319
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,39696,0.0032683111626543,0.00764233326921282,-0.0117106620450028,0.0182472843703114,0.66890784058305
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42236,0.00154865115366958,0.00363174116994246,-0.00556956153941764,0.0086668638467568,0.669807742510688
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41915,-0.00170151856408858,0.00403744617978327,-0.00961491307646379,0.00621187594828662,0.673444733113836
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41766,0.0026881086253233,0.00639328339899385,-0.00984272683670465,0.0152189440873512,0.674157598927601
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,42011,0.00374893610124681,0.00907345900723635,-0.0140350435529364,0.02153291575543,0.679484227792208
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39597,-0.004721396052078,0.0115336701347919,-0.0273273895162701,0.0178845974121141,0.682285189746659
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,39512,0.00175474492940446,0.00429565868627984,-0.00666474609570402,0.0101742359545129,0.682920053347575
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,42048,0.00355700484775238,0.00876641525060314,-0.0136251690434298,0.0207391787389345,0.684930084842704
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39696,0.00227564936162371,0.00566148820204836,-0.00882086751439108,0.0133721662376385,0.687726722782241
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,39895,0.00231995112477628,0.0058071833300706,-0.0090621282021621,0.0137020304517147,0.689534738850349
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39696,-0.00205862854341368,0.00520130067487481,-0.0122531778661683,0.00813592077934095,0.692266748620442
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42048,-0.0024417519064506,0.00617503380537387,-0.0145448181649834,0.00966131435208218,0.692536828968336
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41828,0.00153157260994624,0.00387581234877996,-0.00606501959366248,0.00912816481355496,0.692729925555447
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42048,0.00118793443052771,0.00301416167687629,-0.00471982245614982,0.00709569131720523,0.693500401913175
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41842,-0.00301315788767291,0.00769782304716163,-0.0181008910601097,0.0120745752847639,0.695485813939555
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCT,Secretin,39590,0.00203042547383289,0.00522547921328079,-0.00821151378419746,0.0122723647318632,0.697607309339884
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,42048,0.00339037342139589,0.00873596364069843,-0.013732115314373,0.0205128621571648,0.697952754868209
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39869,0.00318268487947423,0.00822412321664299,-0.012936596625146,0.0193019663840945,0.698768089054857
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,41995,0.00395673042661018,0.0103266033143808,-0.0162834120695761,0.0241968729227965,0.701607997143075
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39512,0.000864144075945613,0.00226527256483975,-0.00357579015114029,0.00530407830303152,0.702858499898455
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39858,0.00446689600063719,0.0117276069213249,-0.0185192135651596,0.027453005566434,0.703294097341013
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,39597,0.00192776030899113,0.00508404591909686,-0.00803696969243872,0.011892490310421,0.704562724122621
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39500,0.00220505083288927,0.00584952551677677,-0.00926001917999321,0.0136701208457717,0.70620892966423
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42041,0.0032904891495041,0.00876178519104872,-0.0138826098249514,0.0204635881239596,0.707257333395085
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39512,0.0043072388729361,0.0115135087224876,-0.0182592382231397,0.0268737159690119,0.708334909055386
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,41943,0.00119185498871878,0.00327701421144407,-0.0052310928657116,0.00761480284314916,0.716086684408226
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,41943,0.00225813309836165,0.00627424965439451,-0.0100393962242516,0.0145556624209749,0.718923960171636
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,39869,-0.00224975832631816,0.00626708011916877,-0.014533235359889,0.0100337187072526,0.719616549138268
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,42048,-0.00283536865675004,0.00791986334765937,-0.0183583008181624,0.0126875635046623,0.720343491821188
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42048,0.00355323083849525,0.00993818814480802,-0.0159256179253285,0.023032079602319,0.720698390399299
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41629,-0.00327881832725821,0.00917929605941136,-0.0212702386037045,0.014712601949188,0.720950009752799
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,39512,0.00154956843103904,0.00438275902503403,-0.00704063925802767,0.0101397761201057,0.723675460478727
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39512,-0.00142416209925893,0.0040349228376862,-0.00933261086112388,0.00648428666260603,0.724126038500638
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,39629,0.00323653920220459,0.00926308627522082,-0.0149191098972282,0.0213921883016374,0.726794338063686
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,42048,0.00127804769395806,0.00367714416200298,-0.00592915486356777,0.0084852502514839,0.728172113385968
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39526,0.00210230702062861,0.00606510569198271,-0.00978530013565751,0.0139899141769147,0.728881005372775
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39526,0.0028138302217378,0.00818404046229676,-0.0132268890843639,0.0188545495278394,0.730988878157856
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39556,0.00139634723706038,0.00407261508198311,-0.00658597832362651,0.00937867279774728,0.731708436237654
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,42048,0.00118077556794551,0.00345783054043168,-0.00559657229130059,0.00795812342719161,0.732748552911375
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,42108,0.00199185753957944,0.00590275567188095,-0.00957754357730722,0.0135612586564661,0.735786435126167
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39500,-0.000924447416814648,0.00275805852675323,-0.00633024212925098,0.00448134729562169,0.737495386267837
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39512,0.00152711739770553,0.00463818926680839,-0.00756373356523891,0.01061796836065,0.741974098150863
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39575,-0.000912081045419012,0.00278393549298879,-0.00636859461167704,0.00454443252083902,0.743203047147908
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42142,0.00206778930366285,0.00635563196144574,-0.0103892493407708,0.0145248279480965,0.744923071326737
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39834,-0.00159644056031229,0.00494260587822451,-0.0112839480816323,0.00809106696100775,0.746704492454513
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",41995,0.00340737719087404,0.0106271569422573,-0.0174218504159503,0.0242366047976984,0.74849638237304
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42172,0.00233718725504552,0.0073621112731073,-0.0120925508402448,0.0167669253503358,0.750898294032065
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,39917,-0.000772742124808815,0.00244776510318552,-0.00557036172705243,0.0040248774774348,0.7522414188096
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42048,-0.00360073862853768,0.0115485333569753,-0.0262358640082092,0.0190343867511338,0.755203548621932
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42048,-0.00337846538689868,0.0108586103484563,-0.024661341669873,0.0179044108960756,0.75570480131808
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,41766,0.00165398464105665,0.00534061025770178,-0.00881361146403884,0.0121215807461521,0.756794339543093
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39526,0.0011042810556345,0.00361401105914265,-0.00597918062028509,0.0081877427315541,0.759948906718627
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39872,0.00197057237541927,0.00646738279171982,-0.0107054978963516,0.0146466426471901,0.760604886956171
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,39597,0.0040598194277817,0.0133495953555093,-0.0221053874690166,0.03022502632458,0.761045620466006
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41771,0.00100900985699711,0.00331846338864137,-0.00549517838473999,0.0075131980987342,0.76108747053412
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39872,-0.000991623319706358,0.00326470415527802,-0.00739044346405127,0.00540719682463855,0.761331102086862
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39512,-0.00164362084069081,0.00542047279249347,-0.012267747513978,0.0089805058325964,0.761724462888307
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42048,0.0012461770805805,0.00411353262456021,-0.00681634686355752,0.00930870102471852,0.761935917903514
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41766,0.00160825531822324,0.00533971136553698,-0.00885757895822924,0.0120740895946757,0.763276134438438
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,39526,0.0026127720283465,0.00889996039555257,-0.0148311503469365,0.0200566944036295,0.769091163630853
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,41842,0.00135566068249072,0.00464956721182499,-0.00775749105268627,0.0104688124176677,0.770622224310007
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39479,0.00272836478729853,0.00939788630999503,-0.0156914923802917,0.0211482219548888,0.771579379725935
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39526,0.000897778953139983,0.00311357713755728,-0.00520483223647228,0.00700039014275225,0.773089472636813
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39696,0.00215043914308995,0.0074988695683748,-0.0125473452109247,0.0168482234971046,0.77429498243096
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41828,0.00186809173800085,0.00654404914744732,-0.0109582445909959,0.0146944280669976,0.775292999534149
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,41995,0.00060520374823731,0.00212650258332614,-0.00356274131508192,0.00477314881155654,0.775954609725233
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,42236,-0.00171716563357582,0.0060867520396944,-0.0136471996313768,0.0102128683642252,0.777859414035842
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,42063,0.00273432234878896,0.00971665463640232,-0.0163103207385596,0.0217789654361375,0.778403543994572
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42063,-0.00112894376845963,0.00404616011925477,-0.00905941760219898,0.00680153006527973,0.780236763968066
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,41984,0.00143268346049982,0.00514252439791998,-0.00864666435942334,0.011512031280423,0.780559674315295
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,42072,0.00188036767827314,0.00684914803934471,-0.0115439624788425,0.0153046978353888,0.783673589122058
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42063,0.00176181498749386,0.0064327377657387,-0.010846351033354,0.0143699810083417,0.78417904021984
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,42060,-0.00570039439810751,0.0209130039134681,-0.046689882068505,0.03528909327229,0.785182923406107
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39526,0.00156569724344084,0.00584176586044925,-0.00988416384303969,0.0130155583299214,0.788690675649526
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41842,-0.00333870690673783,0.012588247215019,-0.028011671448175,0.0213342576346994,0.790840936254362
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39526,-0.00207359463117497,0.00784543935184515,-0.0174506557607915,0.0133034664984415,0.791549324951881
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,39512,0.00119237753065141,0.00453871632995013,-0.00770350647605084,0.0100882615373537,0.792777138290224
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,39512,-0.00111062632115128,0.00423360863148013,-0.00940849923885233,0.00718724659654977,0.793067659029632
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39526,-0.00166607487291777,0.0063891456935264,-0.0141888004322295,0.010856650686394,0.794277529072228
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39500,0.00173489402733688,0.00680742228910276,-0.0116076536593045,0.0150774417139783,0.798841215488786
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,41995,0.000903041085827457,0.00355648088511244,-0.00606766144899293,0.00787374362064785,0.799565722523768
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39858,-0.00154319597489814,0.00610744813552374,-0.0135137943205247,0.0104274023707284,0.800524421993744
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39696,-0.000750494790953087,0.00297218712054353,-0.00657598154721841,0.00507499196531224,0.800654729558471
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39526,-0.00187021086997886,0.00754396637582633,-0.0166563849665985,0.0129159632266407,0.804210120075705
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39575,0.00165460731358669,0.00673293116203083,-0.0115419377639937,0.0148511523911671,0.805881569218209
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,42007,-0.0027718390842937,0.0113048286286794,-0.0249293031965054,0.019385625027918,0.806312513313098
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,39500,0.000790001703417909,0.00328689741404911,-0.00565231722811835,0.00723232063495417,0.810064420934084
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,42149,0.00187150503936903,0.00779224953797848,-0.0134013040550688,0.0171443141338068,0.810198077272273
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39597,0.00161401923586122,0.00675835710404874,-0.0116323606880743,0.0148603991597967,0.811250943144099
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41771,-0.000931935674421302,0.00392607413309053,-0.00862704097527874,0.00676316962643613,0.81237277006446
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39500,-0.000994997149882006,0.00424080015596075,-0.00930696545556507,0.00731697115580106,0.81450431829804
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39512,-0.0012482004589008,0.00533079128651301,-0.0116965513804663,0.00920015046266471,0.814873552252062
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,42236,-0.0013016705177538,0.00556955241978344,-0.0122179932605293,0.00961465222502174,0.815212179447743
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,39675,-0.000971259691949448,0.00416147056779487,-0.0091277420048274,0.0071852226209285,0.815460264778972
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39904,0.000657680490483921,0.00282334088466105,-0.00487606764345174,0.00619142862441959,0.815809061440111
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39512,0.00115561831521419,0.00500935355394913,-0.00866271465052609,0.0109739512809545,0.817558332333595
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39526,0.000783628174246098,0.00342412853560359,-0.00592766375553693,0.00749492010402913,0.818986073292029
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,41771,0.00194911661093099,0.0085217871812998,-0.0147535862644166,0.0186518194862786,0.819088873533005
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,42063,0.00122671119587043,0.00540352838621592,-0.00936420444111277,0.0118176268328536,0.820411323390144
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42149,-0.00156823514639259,0.00692844086609889,-0.0151479792439464,0.0120115089511612,0.820934585387972
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39526,-0.00107038740293584,0.00474911073013006,-0.0103786444339907,0.00823786962811907,0.8216825076481
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,41944,0.00306599438426901,0.0139176955081953,-0.0242126888117937,0.0303446775803318,0.825645027269231
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39895,0.000684195287837448,0.00327023327054227,-0.0057254619224254,0.00709385249810029,0.834280969500581
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,42222,0.00178792030352348,0.00861635584186537,-0.0151001371465327,0.0186759777535796,0.835620095886995
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,42135,0.0035252845683543,0.0170246399613518,-0.0298430097558953,0.0368935788926039,0.835958655771886
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41771,-0.000712547708182498,0.00350445057581843,-0.00758127083678663,0.00615617542042163,0.838882976586555
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,39590,-0.00130315278270415,0.00645291687320995,-0.0139508698541957,0.0113445642887873,0.839961220217057
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39526,0.00158026028413617,0.00792262559426121,-0.0139480858806158,0.0171086064488881,0.841905320496357
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41828,-0.000476838458295055,0.0024004212080527,-0.00518166402607834,0.00422798710948823,0.842541290931178
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,42187,-0.000694996284927324,0.00366403605037048,-0.00787650694365346,0.00648651437379881,0.849562315284551
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39754,0.000530459835534546,0.00284135112024148,-0.00503858836013876,0.00609950803120785,0.851904886159336
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,42041,0.00177461539848084,0.00959320451882945,-0.0170280654584249,0.0205772962553866,0.853242246009343
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,39675,-0.00104998969288587,0.00576062033835395,-0.0123408055560596,0.0102408261702879,0.855373982873426
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41842,-0.000606643775108252,0.00335806716129224,-0.00718845541124104,0.00597516786102454,0.856642981372065
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39500,-0.000579495090666913,0.00321680726090057,-0.00688443732203202,0.0057254471406982,0.857041267678654
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42072,-0.00155393059339477,0.00869004549282897,-0.0185864197593395,0.01547855857255,0.858083838742577
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39500,-0.00149626641291545,0.00838541160296037,-0.0179316731547178,0.0149391403288869,0.858383229484818
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42063,-0.000706949384349405,0.00398311073106504,-0.00851384641723688,0.00709994764853807,0.859128740946499
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41828,0.00092468814012374,0.00528397143166488,-0.00943189586593941,0.0112812721461869,0.861083332120058
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39512,-0.000584682911455982,0.00339641906446111,-0.00724166427779976,0.00607229845488779,0.863325258133596
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42048,0.00191741483872121,0.0112959871463916,-0.0202227199682063,0.0240575496456487,0.865214802423614
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,39500,0.00169864625101659,0.0100352863640742,-0.0179705150225689,0.0213678075246021,0.865589503445365
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42106,-0.000894980626088125,0.00530236692830736,-0.0112876198055706,0.00949765855339431,0.865965225339246
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39895,0.0015085373204798,0.00895806722401022,-0.0160492744385802,0.0190663490795398,0.866271728693582
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39512,0.00101352315634034,0.00602053356718116,-0.0107867226353347,0.0128137689480154,0.866315460166193
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,42072,-0.00128356525608325,0.00767597969686374,-0.0163284854619362,0.0137613549497697,0.867200695108069
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41828,0.000626249783879986,0.00375208190016668,-0.00672783074044671,0.00798033030820668,0.867445556158377
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39512,0.000840098684484058,0.00504051734879089,-0.00903931531914608,0.0107195126881142,0.867633477800741
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41995,0.000504121926185782,0.00306161963223044,-0.00549665255298587,0.00650489640535744,0.869215208658083
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39512,-0.000628387347458097,0.00384742425862301,-0.0081693388943592,0.00691256419944301,0.870264188129249
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41766,0.0011275529108187,0.0070142036802288,-0.0126202863024297,0.0148753921240672,0.87229056479266
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42156,0.000529315983233507,0.00331276371034849,-0.00596370088904954,0.00702233285551656,0.873056142175068
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39278,-0.000879574530327545,0.00561376261281234,-0.0118825492514397,0.0101234001907846,0.875498579590753
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39872,0.00105995461299729,0.00689809194861446,-0.012460305606287,0.0145802148322816,0.877881284426056
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39868,-0.000467869682532915,0.00304770241756601,-0.0064413664209623,0.00550562705589647,0.877994485408069
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42111,0.0016969410493864,0.0112921352219985,-0.0204356439857307,0.0238295260845035,0.880548821394126
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42092,-0.0013022325189252,0.00920456752001445,-0.0193431848581535,0.0167387198203031,0.887495419381221
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39526,0.00108644470761628,0.00770200468148144,-0.0140094844680873,0.0161823738833199,0.8878251509374
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39590,0.000482368813020608,0.00341969680535604,-0.00622023692547723,0.00718497455151844,0.887828274238086
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,39869,0.00131597493498242,0.00948715760522632,-0.0172788539712612,0.019910803841226,0.889680852657239
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39526,-0.000815420073920307,0.00596737244545052,-0.0125114700670033,0.0108806299191627,0.891312801395384
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,41842,-0.000847725991909865,0.00629390512336207,-0.0131837800336995,0.0114883280498798,0.892859038224692
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,39339,-0.00102709802488186,0.00765309722812833,-0.0160271685920134,0.0139729725422497,0.893241529179486
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,39526,0.000712114852391422,0.00533444431432914,-0.00974339600369369,0.0111676257084765,0.893805383623026
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,39526,0.000761303237295539,0.00572254705236134,-0.0104548889853327,0.0119774954599238,0.894167571378907
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,42126,0.000576115590782668,0.00435021783379335,-0.00795031136345229,0.00910254254501763,0.894643203817849
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41828,-0.0011426442647135,0.00887017635667888,-0.0185281899238041,0.0162429013943771,0.897503095525188
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41771,-0.000801693020568974,0.00628062359224285,-0.013111715261365,0.011508329220227,0.898431510620603
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,39526,-0.000467130699270553,0.0036796673519598,-0.00767927870911177,0.00674501731057066,0.898982969121097
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39500,-0.000881880841529829,0.00696903028801266,-0.0145411802060347,0.012777418522975,0.89930457910375
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39526,0.000551149415745304,0.00450229849000385,-0.00827335562466225,0.00937565445615286,0.902572514927877
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42111,0.000388912714106578,0.00318723091211251,-0.00585805987363395,0.0066358853018471,0.902883304421082
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,39590,0.000597621764016931,0.00492618260726395,-0.00905769614622042,0.0102529396742543,0.90344344852786
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39696,0.000544916262434524,0.00458433592494427,-0.00844038215045624,0.00953021467532529,0.905384605776631
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39872,0.00121457322787864,0.0102697525372379,-0.0189141417451076,0.0213432882008649,0.90585818016143
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39705,0.000503433523114404,0.00431497679519692,-0.00795392099547155,0.00896078804170036,0.907122722773066
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39590,0.000354322554022109,0.00305878581825348,-0.00564089764975471,0.00634954275779892,0.907783329208539
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41766,0.000673264194757653,0.00589355700316966,-0.0108781075314549,0.0122246359209702,0.909051405339484
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,42063,0.000321593463262001,0.0029365492863631,-0.00543404313800968,0.00607723006453368,0.912796395086904
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39904,-0.000507039847118827,0.00468305474390163,-0.00968582714516602,0.00867174745092837,0.913782507578069
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39526,-0.000518323283435681,0.00484024043846947,-0.0100051945428358,0.00896854797596448,0.914722507406408
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39590,0.000746694546779097,0.00716187725312241,-0.0132905848693408,0.014783973962899,0.91696523030448
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39872,0.000885347035881733,0.00850235399228397,-0.0157792667889948,0.0175499608607583,0.917068324261098
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,39512,0.000355005890496351,0.00348115144068497,-0.00646805093324619,0.00717806271423889,0.918774864619826
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,39500,-0.000458021888754489,0.00465998052846363,-0.00959158372454321,0.00867553994703423,0.921705120428978
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39512,0.000698336023966506,0.00731040578123724,-0.0136300593072585,0.0150267313551915,0.923898554619218
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39526,0.000481562244166506,0.00507329841803636,-0.00946210265518476,0.0104252271435178,0.924379366219372
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,39590,0.000498956693436708,0.005281133213801,-0.00985206440561325,0.0108499777924867,0.924730309303212
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39500,-0.000318691019323746,0.00338567641456994,-0.00695461679188083,0.00631723475323334,0.925008253609694
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39696,-0.000447830898557853,0.00485189227357179,-0.00995753975475855,0.00906187795764285,0.926461151314763
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,39752,0.00109529597006196,0.0119498148536975,-0.0223263411431851,0.024516933083309,0.926971424906573
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,39526,0.000387028734934476,0.00424524901163191,-0.00793365932786407,0.00870771679773302,0.927361170694753
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42063,-0.000296576669245847,0.00329360301934231,-0.00675203858715677,0.00615888524866508,0.928251784913405
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,39675,-0.000333979149963912,0.00376313392879382,-0.0077097216503998,0.00704176335047198,0.929281985637875
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39858,0.000461035734354288,0.00522977343930082,-0.00978932020667532,0.0107113916753839,0.929754282284031
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39696,-0.00058131174920389,0.00665780298004959,-0.0136306055901011,0.0124679820916933,0.930424416192215
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39526,0.000542600014914651,0.00624632190436629,-0.0117001909176433,0.0127853909474726,0.930778724352436
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39927,-0.000267748536316936,0.00309813549256908,-0.00634009410175233,0.00580459702911846,0.931132109070935
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39868,-0.000242176794111885,0.00296828375597294,-0.00606001295581884,0.00557565936759507,0.934975670190064
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39669,0.000498431648821206,0.00673528421877046,-0.0127027254199689,0.0136995887176113,0.941009286832938
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39500,-0.000667515756734125,0.00910234850892676,-0.0185081188342306,0.0171730873207623,0.941541320892967
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42236,-0.00017873397655825,0.00254689158100241,-0.00517064147532297,0.00481317352220647,0.944053570201089
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39689,-0.000758913480902968,0.0109088319576136,-0.0221402241178257,0.0206223971560198,0.944538188482102
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42222,-0.000263684424964872,0.00382423182088976,-0.00775917879390881,0.00723180994397906,0.945029673160756
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39590,-0.000301602958367931,0.00451770448950894,-0.00915630375780545,0.00855309784106959,0.946773804708517
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39915,0.0008222912842788,0.0123698367433537,-0.0234225887326945,0.0250671713012521,0.94700042419108
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39500,0.000422376544325275,0.00728987646564704,-0.0138657813283429,0.0147105344169935,0.953797362901724
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39526,-0.000423418473199051,0.00771494715988682,-0.0155447149065772,0.0146978779601791,0.956232779315702
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39696,0.00024991945249015,0.00455609824614515,-0.00868003310995434,0.00917987201493464,0.956255899933038
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,42004,0.000326466697927372,0.00639703059131125,-0.0122117132610427,0.0128646466568974,0.959299108633911
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39590,0.000378048061167242,0.00837991011408369,-0.0160465757624368,0.0168026718847713,0.964017566772535
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39872,0.000150851697755981,0.00369627252625217,-0.00709384245369827,0.00739554584921024,0.967446619878662
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39696,-0.000186814431636107,0.00490797185067146,-0.00980643925895217,0.00943281039567995,0.969637762901202
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,42010,0.00013198623853548,0.00354829642023492,-0.00682267474512495,0.00708664722219592,0.970328426629869
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39590,0.000143253594801691,0.00398473309081006,-0.00766682326318603,0.00795333045278941,0.971322392006249
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39869,0.000171517669252811,0.00522815454047698,-0.0100756652300821,0.0104187005685877,0.973829442616033
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39512,0.000431453089853546,0.0135035052873436,-0.0260354172733399,0.026898323453047,0.974511558518291
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42048,0.000121159480606927,0.00404607854908956,-0.00780915447560861,0.00805147343682247,0.976111428799028
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39927,-0.000208642379816497,0.00720363020514629,-0.0143277575819032,0.0139104728222702,0.976894207389335
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,39696,0.000120493962098264,0.00434443508985279,-0.00839459881401321,0.00863558673820974,0.977873813587051
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,39872,-0.000187782986408679,0.00721791633763576,-0.0143348990081748,0.0139593330353574,0.979244852061847
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39512,-0.000102256156611635,0.00393579002948637,-0.00781640461440492,0.00761189230118165,0.979272888005108
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39512,-0.000108845562328116,0.00506407994382553,-0.0100344422522262,0.00981675112756992,0.982852261780049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41842,0.000127461200732218,0.00620861083228186,-0.0120414160305402,0.0122963384320047,0.98362109285204
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39696,0.000177539004573505,0.00890358658340672,-0.0172734906989037,0.0176285687080507,0.984091461295618
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41828,-0.00017902466351815,0.00910908459107626,-0.0180328304620276,0.0176747811349913,0.984320145621399
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39590,8.74963742858385e-05,0.00547516843659334,-0.0106438337614371,0.0108188265100088,0.987250173687539
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,41943,-3.02316823322788e-05,0.00260169733275468,-0.00512955845453146,0.0050690950898669,0.990728976239988
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39590,5.33407689795142e-05,0.00493456660958736,-0.00961840978581172,0.00972509132377075,0.991375538647578
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42137,0.000114435071383264,0.0111478328329852,-0.0217353172812677,0.0219641874240342,0.991809826340183
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,39512,6.29642400365492e-05,0.00632672636786145,-0.0123374194409719,0.012463347921045,0.992059682722376
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,42063,5.84835470140282e-05,0.00606875285844679,-0.0118362720555417,0.0119532391495697,0.992311182951876
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42046,-2.67367470518165e-05,0.0066634460847375,-0.0130870910731373,0.0130336175790337,0.996798595872657
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,39872,1.52690017092687e-05,0.00397991008536535,-0.00778535476560681,0.00781589276902535,0.996938975913201
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,42063,-2.38830045637781e-05,0.00635307818143356,-0.0124759162401736,0.012428150231046,0.997000590686335
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,41842,4.80503893383901e-05,0.0149967039190187,-0.0293454892919382,0.029441590070615,0.997443579962751
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39590,-1.09550003537556e-05,0.00551290378051342,-0.0108162464101601,0.0107943364094525,0.99841451594165
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42048,-2.83878528961398e-05,0.016266902068361,-0.0319115159068837,0.0318547402010914,0.998607614597981
